<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="https://www.alzforum.org"  xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>Alzforum - Papers of the Week: 8-14 May 2026</title>
 <link>https://www.alzforum.org</link>
 <description></description>
 <language>en</language>
<item>
 <title>Expression of concern: &quot;Propofol improved neurobehavioral outcome of cerebral ischemia-reperfusion rats by regulating Bcl-2 and Bax expression&quot; [Brain Res. 1410 (2011) 24-32].</title>
 <link>https://www.alzforum.org/papers/expression-concern-propofol-improved-neurobehavioral-outcome-cerebral-ischemia-reperfusion</link>
 <description>Brain Res. 2026 Aug 15;1885:150342.  Epub 2026 Apr 25&lt;br&gt;Authors: Xi HJ, Zhang TH, Tao T, Song CY, Lu SJ, Cui, Yue ZY&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42106167&quot;&gt;42106167&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/expression-concern-propofol-improved-neurobehavioral-outcome-cerebral-ischemia-reperfusion#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/expression-concern-propofol-improved-neurobehavioral-outcome-cerebral-ischemia-reperfusion#comments</comments>
</item>
<item>
 <title>Mapping the conformational variability in mutants of the amyloid precursor protein intracellular domain.</title>
 <link>https://www.alzforum.org/papers/mapping-conformational-variability-mutants-amyloid-precursor-protein-intracellular-domain</link>
 <description>J Mol Biol. 2026 Jul 15;438(14):169806.  Epub 2026 Apr 11&lt;br&gt;Authors: Mandal N, Skepö M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/41967599&quot;&gt;41967599&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mapping-conformational-variability-mutants-amyloid-precursor-protein-intracellular-domain#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mapping-conformational-variability-mutants-amyloid-precursor-protein-intracellular-domain#comments</comments>
</item>
<item>
 <title>NMR characterization of the structure and interaction of an RNA aptamer targeting α-synuclein.</title>
 <link>https://www.alzforum.org/papers/nmr-characterization-structure-and-interaction-rna-aptamer-targeting-synuclein</link>
 <description>Biochem Biophys Res Commun. 2026 Jul 9;821:153874.  Epub 2026 May 4&lt;br&gt;Authors: Li X, Yamaoki Y, Nagata T, Murakami K, Katahira M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42114215&quot;&gt;42114215&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/nmr-characterization-structure-and-interaction-rna-aptamer-targeting-synuclein#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/nmr-characterization-structure-and-interaction-rna-aptamer-targeting-synuclein#comments</comments>
</item>
<item>
 <title>Advanced diffusion MRI tract signatures in Alzheimer&#039;s disease, dementia with Lewy bodies, and the FTD/PPA spectrum.</title>
 <link>https://www.alzforum.org/papers/advanced-diffusion-mri-tract-signatures-alzheimers-disease-dementia-lewy-bodies-and-ftdppa</link>
 <description>Neuroimage. 2026 Jul 1;334:121984.  Epub 2026 May 8&lt;br&gt;Authors: Tian Y, Whitwell JL&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42107617&quot;&gt;42107617&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/advanced-diffusion-mri-tract-signatures-alzheimers-disease-dementia-lewy-bodies-and-ftdppa#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/advanced-diffusion-mri-tract-signatures-alzheimers-disease-dementia-lewy-bodies-and-ftdppa#comments</comments>
</item>
<item>
 <title>LABMA: Latent-bottleneck attention-based multimodal architecture for integration of transcriptomics, proteomics, and MRI in neurodegeneration.</title>
 <link>https://www.alzforum.org/papers/labma-latent-bottleneck-attention-based-multimodal-architecture-integration-transcriptomics</link>
 <description>Comput Biol Med. 2026 Jul 1;210:111740.  Epub 2026 May 12&lt;br&gt;Authors: Niwarthana A, Rajapakse JC&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42114436&quot;&gt;42114436&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/labma-latent-bottleneck-attention-based-multimodal-architecture-integration-transcriptomics#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/labma-latent-bottleneck-attention-based-multimodal-architecture-integration-transcriptomics#comments</comments>
</item>
<item>
 <title>Integrative systems pharmacology and experimental Assessment of hyaluronic Acid-Curcumin conjugate in an Alzheimer&#039;s disease model.</title>
 <link>https://www.alzforum.org/papers/integrative-systems-pharmacology-and-experimental-assessment-hyaluronic-acid-curcumin</link>
 <description>Comput Biol Med. 2026 Jul 1;210:111744.  Epub 2026 May 12&lt;br&gt;Authors: Gayathri SV, Manjunatha PM, Pai P, Muzzammil Bahawuddeen Khalwathi M, Jana P, Akhila AV, Priya A, Prerna, Satvik, Marwein AS, Nchimbi AH, Atem AE, Sharma UR, Hari Babu T&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42114435&quot;&gt;42114435&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/integrative-systems-pharmacology-and-experimental-assessment-hyaluronic-acid-curcumin#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/integrative-systems-pharmacology-and-experimental-assessment-hyaluronic-acid-curcumin#comments</comments>
</item>
<item>
 <title>The Role of Clinical, Plasma, and Imaging Biomarkers in Assessing Future Dementia Risk in Individuals With Subjective Cognitive Decline.</title>
 <link>https://www.alzforum.org/papers/role-clinical-plasma-and-imaging-biomarkers-assessing-future-dementia-risk-individuals</link>
 <description>Neurology. 2026 Jun 9;106(11):e214983.  Epub 2026 May 14&lt;br&gt;Authors: Rivera Sánchez M, Mastenbroek SE, Janelidze S, Tideman P, Mattsson-Carlgren N, Van Westen D, Stomrud E, Hansson O, Palmqvist S, Ossenkoppele R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42133909&quot;&gt;42133909&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/role-clinical-plasma-and-imaging-biomarkers-assessing-future-dementia-risk-individuals#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/role-clinical-plasma-and-imaging-biomarkers-assessing-future-dementia-risk-individuals#comments</comments>
</item>
<item>
 <title>Asymptomatic Versus Symptomatic Alzheimer&#039;s Disease Neuropathology: A Systematic Review of Differences Reported in Post-Mortem Studies.</title>
 <link>https://www.alzforum.org/papers/asymptomatic-versus-symptomatic-alzheimers-disease-neuropathology-systematic-review</link>
 <description>Neuropathol Appl Neurobiol. 2026 Jun;52(3):e70077. &lt;br&gt;Authors: Barros TG, Grossi LB, da Silva Campos ML, Cardoso IB, Teixeira AL, de Miranda AS, de Brito Toscano EC&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42103686&quot;&gt;42103686&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/asymptomatic-versus-symptomatic-alzheimers-disease-neuropathology-systematic-review#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/asymptomatic-versus-symptomatic-alzheimers-disease-neuropathology-systematic-review#comments</comments>
</item>
<item>
 <title>Bridging the Funding Gap in Drug Development for Amyotrophic Lateral Sclerosis.</title>
 <link>https://www.alzforum.org/papers/bridging-funding-gap-drug-development-amyotrophic-lateral-sclerosis</link>
 <description>Neurol Clin Pract. 2026 Jun;16(3):e200623.  Epub 2026 May 4&lt;br&gt;Authors: Bareamichael PI, Babu S, Hoang T, Socal MP&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42114078&quot;&gt;42114078&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/bridging-funding-gap-drug-development-amyotrophic-lateral-sclerosis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/bridging-funding-gap-drug-development-amyotrophic-lateral-sclerosis#comments</comments>
</item>
<item>
 <title>Evaluating the Duke Iterative Cognitive Examination Against the Montreal Cognitive Assessment: Validity and Clinical Utility.</title>
 <link>https://www.alzforum.org/papers/evaluating-duke-iterative-cognitive-examination-against-montreal-cognitive-assessment</link>
 <description>Neurol Clin Pract. 2026 Jun;16(3):e200617.  Epub 2026 Apr 23&lt;br&gt;Authors: Park C, Farrer TJ, Stuart JZ, Johnson KG, Lutz MW, O&amp;#039;Brien RJ, Quiroga Del Rio CE, Chin PE, Koltai DC&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42114070&quot;&gt;42114070&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/evaluating-duke-iterative-cognitive-examination-against-montreal-cognitive-assessment#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/evaluating-duke-iterative-cognitive-examination-against-montreal-cognitive-assessment#comments</comments>
</item>
<item>
 <title>Clinical Meaningfulness of Donanemab in Early Symptomatic Alzheimer Disease: Data From the Randomized Phase 3 TRAILBLAZER-ALZ 2 Trial.</title>
 <link>https://www.alzforum.org/papers/clinical-meaningfulness-donanemab-early-symptomatic-alzheimer-disease-data-randomized-phase-3</link>
 <description>Neurol Clin Pract. 2026 Jun;16(3):e200621.  Epub 2026 May 13&lt;br&gt;Authors: Atri A, Apostolova LG, Iwata A, Wessels AM, Atkins A, Lu M, Ye W, Ryan S, Doty EG&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42128444&quot;&gt;42128444&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/clinical-meaningfulness-donanemab-early-symptomatic-alzheimer-disease-data-randomized-phase-3#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/clinical-meaningfulness-donanemab-early-symptomatic-alzheimer-disease-data-randomized-phase-3#comments</comments>
</item>
<item>
 <title>New evidence on the clinical, genetic, and biochemical bases of GBA1-Parkinson&#039;s disease: prospects for treatment.</title>
 <link>https://www.alzforum.org/papers/new-evidence-clinical-genetic-and-biochemical-bases-gba1-parkinsons-disease-prospects</link>
 <description>Lancet Neurol. 2026 Jun;25(6):602-614. &lt;br&gt;Authors: Menozzi E, Toffoli M, Deleidi M, Di Monte DA, Blandini F, Krainc D, Sidransky E, Schapira AH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42127935&quot;&gt;42127935&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/new-evidence-clinical-genetic-and-biochemical-bases-gba1-parkinsons-disease-prospects#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/new-evidence-clinical-genetic-and-biochemical-bases-gba1-parkinsons-disease-prospects#comments</comments>
</item>
<item>
 <title>Identification of genetic modifiers of autosomal dominant Alzheimer&#039;s disease: a genome-wide association study.</title>
 <link>https://www.alzforum.org/papers/identification-genetic-modifiers-autosomal-dominant-alzheimers-disease-genome-wide</link>
 <description>Lancet Neurol. 2026 Jun;25(6):581-590. &lt;br&gt;Authors: Patel M, Feng W, Mckay NS, Millar PR, Liu M, Yang C, Cetin A, Johnson M, Budde J, Western D, Marsh TW, Saliu IO, Gordon BA, Guerra JJ, Morris JC, Bateman RJ, McDade E, Holtzman DM, Ryan NS, Benzinger TL, Renton AE, Goate AM, Ibanez L, Sung YJ, Zhao G, Cruchaga C, Pottier C, Dominantly Inherited Alzheimer Network&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42127933&quot;&gt;42127933&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/identification-genetic-modifiers-autosomal-dominant-alzheimers-disease-genome-wide#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/identification-genetic-modifiers-autosomal-dominant-alzheimers-disease-genome-wide#comments</comments>
</item>
<item>
 <title>Safety, tolerability, and efficacy of acetazolamide in idiopathic normal pressure hydrocephalus (DRAIN) in Sweden: a randomised, double-blind, placebo-controlled, phase 2 trial.</title>
 <link>https://www.alzforum.org/papers/safety-tolerability-and-efficacy-acetazolamide-idiopathic-normal-pressure-hydrocephalus-drain</link>
 <description>Lancet Neurol. 2026 Jun;25(6):550-559. &lt;br&gt;Authors: Virhammar J, Fasth O, Ekblom M, Ekman O, Holmstrand N, Fällmar D, Nyholm D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42127932&quot;&gt;42127932&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/safety-tolerability-and-efficacy-acetazolamide-idiopathic-normal-pressure-hydrocephalus-drain#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/safety-tolerability-and-efficacy-acetazolamide-idiopathic-normal-pressure-hydrocephalus-drain#comments</comments>
</item>
<item>
 <title>Genetic modifiers in autosomal dominant Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/genetic-modifiers-autosomal-dominant-alzheimers-disease</link>
 <description>Lancet Neurol. 2026 Jun;25(6):537-538. &lt;br&gt;Authors: Kosik KS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42127918&quot;&gt;42127918&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/genetic-modifiers-autosomal-dominant-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/genetic-modifiers-autosomal-dominant-alzheimers-disease#comments</comments>
</item>
<item>
 <title>FTLD-TDP-43 With Motor Neuron Disease Pathology in an Autopsied Patient With Spastic Paraplegia-30B Harbouring a Homozygous KIF1A Variant.</title>
 <link>https://www.alzforum.org/papers/ftld-tdp-43-motor-neuron-disease-pathology-autopsied-patient-spastic-paraplegia-30b</link>
 <description>Neuropathol Appl Neurobiol. 2026 Jun;52(3):e70079. &lt;br&gt;Authors: Saito R, Hasegawa A, Takahashi T, Koike R, Hara N, Gabdulkhaev R, Koh K, Kawakami A, Takiyama Y, Ikeuchi T, Kakita A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42130092&quot;&gt;42130092&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/ftld-tdp-43-motor-neuron-disease-pathology-autopsied-patient-spastic-paraplegia-30b#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/ftld-tdp-43-motor-neuron-disease-pathology-autopsied-patient-spastic-paraplegia-30b#comments</comments>
</item>
<item>
 <title>Neuronal PRRT3 coordinates amyloidogenic processing and Tau phosphorylation via distinct Ras-ERK-AP-1 and CaMKII/PP2A pathways.</title>
 <link>https://www.alzforum.org/papers/neuronal-prrt3-coordinates-amyloidogenic-processing-and-tau-phosphorylation-distinct-ras-erk</link>
 <description>Acta Biochim Biophys Sin (Shanghai). 2026 May 25; Epub 2026 May 25&lt;br&gt;Authors: Chen F, Zhang H, Huang Y, Zhu J, Cui F, Liang S, Li Y, Wang Y, Xie X, Liu R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42130394&quot;&gt;42130394&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/neuronal-prrt3-coordinates-amyloidogenic-processing-and-tau-phosphorylation-distinct-ras-erk#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/neuronal-prrt3-coordinates-amyloidogenic-processing-and-tau-phosphorylation-distinct-ras-erk#comments</comments>
</item>
<item>
 <title>Using iPSC models to examine neuron-glia interactions in neurodegenerative diseases.</title>
 <link>https://www.alzforum.org/papers/using-ipsc-models-examine-neuron-glia-interactions-neurodegenerative-diseases</link>
 <description>Biosci Rep. 2026 May 20;46(5)&lt;br&gt;Authors: Lopez DM, Keavey LK, Bowles KR&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42101666&quot;&gt;42101666&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/using-ipsc-models-examine-neuron-glia-interactions-neurodegenerative-diseases#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/using-ipsc-models-examine-neuron-glia-interactions-neurodegenerative-diseases#comments</comments>
</item>
<item>
 <title>Integrated clinical and computational data-based repurposing of econazole as a novel autophagic activator in ULK1-related Parkinson disease.</title>
 <link>https://www.alzforum.org/papers/integrated-clinical-and-computational-data-based-repurposing-econazole-novel-autophagic</link>
 <description>Autophagy. 2026 May 17;:1-21.  Epub 2026 May 17&lt;br&gt;Authors: Zhang J, Jin W, Fu Y, Zhen Y, Chen Y, Liu W, Huang W, Wang Z, Zhu HP, Yang QQ, Zhan G, Zhao Q, Peng C, Zhang L, Han B, Liu B&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42112758&quot;&gt;42112758&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/integrated-clinical-and-computational-data-based-repurposing-econazole-novel-autophagic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/integrated-clinical-and-computational-data-based-repurposing-econazole-novel-autophagic#comments</comments>
</item>
<item>
 <title>Advances in modeling memory decline: A critical overview of current animal and human paradigms.</title>
 <link>https://www.alzforum.org/papers/advances-modeling-memory-decline-critical-overview-current-animal-and-human-paradigms</link>
 <description>Ageing Res Rev. 2026 May 15;119:103172.  Epub 2026 May 15&lt;br&gt;Authors: Peng Y, Li Y, Ma L, Wu T, Chen G&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42114723&quot;&gt;42114723&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/advances-modeling-memory-decline-critical-overview-current-animal-and-human-paradigms#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/advances-modeling-memory-decline-critical-overview-current-animal-and-human-paradigms#comments</comments>
</item>
<item>
 <title>Exposure to fibrillar proteins leads to widespread infiltration but only mild tau pathology in cortical organoids.</title>
 <link>https://www.alzforum.org/papers/exposure-fibrillar-proteins-leads-widespread-infiltration-only-mild-tau-pathology-cortical</link>
 <description>iScience. 2026 May 15;29(5):115819.  Epub 2026 Apr 20&lt;br&gt;Authors: Dakhel A, Mothes T, Eltom K, Michno WP, Erlandsson A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42111182&quot;&gt;42111182&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/exposure-fibrillar-proteins-leads-widespread-infiltration-only-mild-tau-pathology-cortical#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/exposure-fibrillar-proteins-leads-widespread-infiltration-only-mild-tau-pathology-cortical#comments</comments>
</item>
<item>
 <title>The intrinsic disorder challenge for AlphaFold: A case study of G3BP1 and pathogenic peptide.</title>
 <link>https://www.alzforum.org/papers/intrinsic-disorder-challenge-alphafold-case-study-g3bp1-and-pathogenic-peptide</link>
 <description>iScience. 2026 May 15;29(5):115737.  Epub 2026 Apr 15&lt;br&gt;Authors: Li Y, Yao Z, Song Z, Yang P, Huang J, Lei K, Xu Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42111176&quot;&gt;42111176&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/intrinsic-disorder-challenge-alphafold-case-study-g3bp1-and-pathogenic-peptide#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/intrinsic-disorder-challenge-alphafold-case-study-g3bp1-and-pathogenic-peptide#comments</comments>
</item>
<item>
 <title>Allele-specific splicing modulates protein isoforms and Alzheimer&#039;s risk.</title>
 <link>https://www.alzforum.org/papers/allele-specific-splicing-modulates-protein-isoforms-and-alzheimers-risk-0</link>
 <description>Genome Res. 2026 May 15; Epub 2026 May 15&lt;br&gt;Authors: King AJ, Amoah K, Zhang L, Bahn JH, Barney RM, Quinones-Valdez G, Xiao X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42134986&quot;&gt;42134986&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/allele-specific-splicing-modulates-protein-isoforms-and-alzheimers-risk-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/allele-specific-splicing-modulates-protein-isoforms-and-alzheimers-risk-0#comments</comments>
</item>
<item>
 <title>A human Staufen1 BAC transgenic mouse exhibits abnormal autophagy and neurodegeneration across the central nervous system.</title>
 <link>https://www.alzforum.org/papers/human-staufen1-bac-transgenic-mouse-exhibits-abnormal-autophagy-and-neurodegeneration-0</link>
 <description>Cell Death Dis. 2026 May 14; Epub 2026 May 14&lt;br&gt;Authors: Pulst SM, Paul S, Nguyen H, Dansithong W, Figueroa KP, Gandelman M, Bonini NM, Scoles DR&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42129145&quot;&gt;42129145&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/human-staufen1-bac-transgenic-mouse-exhibits-abnormal-autophagy-and-neurodegeneration-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/human-staufen1-bac-transgenic-mouse-exhibits-abnormal-autophagy-and-neurodegeneration-0#comments</comments>
</item>
<item>
 <title>Psychiatric and behavioral disorders in Parkinson&#039;s disease: co-pathogenic mechanisms of tau, Aβ, and α-synuclein proteins (narrative review).</title>
 <link>https://www.alzforum.org/papers/psychiatric-and-behavioral-disorders-parkinsons-disease-co-pathogenic-mechanisms-tau-av-and</link>
 <description>Rev Neurosci. 2026 May 14; Epub 2026 May 14&lt;br&gt;Authors: Chai JY, Zhang Y, Zhang ZQ, Ma DR, Cao YH, Zhu SR, Ma YZ, Luo LL, Zhan YL, Fan ZY, Lan R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42125890&quot;&gt;42125890&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/psychiatric-and-behavioral-disorders-parkinsons-disease-co-pathogenic-mechanisms-tau-av-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/psychiatric-and-behavioral-disorders-parkinsons-disease-co-pathogenic-mechanisms-tau-av-and#comments</comments>
</item>
<item>
 <title>Cellular state heterogeneity underlying sex differences in Alzheimer&#039;s disease based on single-cell transcriptome.</title>
 <link>https://www.alzforum.org/papers/cellular-state-heterogeneity-underlying-sex-differences-alzheimers-disease-based-single-cell</link>
 <description>Alzheimers Res Ther. 2026 May 14; Epub 2026 May 14&lt;br&gt;Authors: Wu Z, Tan Q, Xue F, Jiang Z, Zhao H, Zhang Y, Liu Y, Zhang Y, Ding D, Chen H, Xu Y, Li F, Zhang C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42135783&quot;&gt;42135783&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cellular-state-heterogeneity-underlying-sex-differences-alzheimers-disease-based-single-cell#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cellular-state-heterogeneity-underlying-sex-differences-alzheimers-disease-based-single-cell#comments</comments>
</item>
<item>
 <title>Maintenance and disruption of the physiological dimer structure of TDP-43 in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.</title>
 <link>https://www.alzforum.org/papers/maintenance-and-disruption-physiological-dimer-structure-tdp-43-amyotrophic-lateral-sclerosis</link>
 <description>BMC Med. 2026 May 14; Epub 2026 May 14&lt;br&gt;Authors: Tamaki Y, Kaneko S, Urushitani M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42135750&quot;&gt;42135750&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/maintenance-and-disruption-physiological-dimer-structure-tdp-43-amyotrophic-lateral-sclerosis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/maintenance-and-disruption-physiological-dimer-structure-tdp-43-amyotrophic-lateral-sclerosis#comments</comments>
</item>
<item>
 <title>Role of endolysosome iron in amyloid-β protein-induced increases in reactive oxygen species, mitochondrial depolarization, and cytotoxicity.</title>
 <link>https://www.alzforum.org/papers/role-endolysosome-iron-amyloid-v-protein-induced-increases-reactive-oxygen-species</link>
 <description>J Alzheimers Dis. 2026 May 14;:13872877261449714.  Epub 2026 May 14&lt;br&gt;Authors: Quansah DN, Halcrow PW, Kumar N, Liang B, Geiger JD&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42135618&quot;&gt;42135618&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/role-endolysosome-iron-amyloid-v-protein-induced-increases-reactive-oxygen-species#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/role-endolysosome-iron-amyloid-v-protein-induced-increases-reactive-oxygen-species#comments</comments>
</item>
<item>
 <title>The bidirectional association of epilepsy with Alzheimer&#039;s disease and other neurodegenerative dementias: A longitudinal observational study on the UK Biobank.</title>
 <link>https://www.alzforum.org/papers/bidirectional-association-epilepsy-alzheimers-disease-and-other-neurodegenerative-dementias</link>
 <description>J Alzheimers Dis. 2026 May 14;:13872877261450962.  Epub 2026 May 14&lt;br&gt;Authors: Fratto E, Buonocore J, Fortunato F, Sammarra I, Calomino C, Vescio B, Quattrone A, Gambardella A, Quattrone A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42135610&quot;&gt;42135610&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/bidirectional-association-epilepsy-alzheimers-disease-and-other-neurodegenerative-dementias#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/bidirectional-association-epilepsy-alzheimers-disease-and-other-neurodegenerative-dementias#comments</comments>
</item>
<item>
 <title>Reduced ULK1 links impaired autophagy and mitophagy to Alzheimer&#039;s disease pathology.</title>
 <link>https://www.alzforum.org/papers/reduced-ulk1-links-impaired-autophagy-and-mitophagy-alzheimers-disease-pathology</link>
 <description>Nat Aging. 2026 May 14; Epub 2026 May 14&lt;br&gt;Authors: Pan JP, Wang PJ, Zhang J, Knapskog AB, Watne LO, Wang HL, Lagartos-Donate MJ, Lautrup S, Mao LP, Wang Q, Ling ZP, Zhang SQ, Schmauck-Medina T, Ai R, Edwin TH, Zhang T, Saltvedt I, Eldholm RS, Smith A, Veverová K, Caponio D, Kobro-Flatmoen A, Pang H, Wang Z, Wang H, Gao LJ, Halaas NB, Wong G, Vyhnalek M, Luo OJ, McEwan WA, Storm-Mathisen J, Gan L, Hu Z, Zetterberg H, Witter MP, Aarsland D, Selbæk G, Chen G, Fang EF&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42135576&quot;&gt;42135576&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/reduced-ulk1-links-impaired-autophagy-and-mitophagy-alzheimers-disease-pathology#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/reduced-ulk1-links-impaired-autophagy-and-mitophagy-alzheimers-disease-pathology#comments</comments>
</item>
<item>
 <title>Brain Amyloid Deposition Is Negatively Associated with Cardiac Amyloid Retention in Apo E4 Carriers: A Pilot Study.</title>
 <link>https://www.alzforum.org/papers/brain-amyloid-deposition-negatively-associated-cardiac-amyloid-retention-apo-e4-carriers</link>
 <description>Mol Imaging Biol. 2026 May 14; Epub 2026 May 14&lt;br&gt;Authors: Pak K, Kim J, Kim K, Kim K, Kim YJ, Lee H, Suh H, Moon E, Lee BD, Park JM, Choi JH, Lee YM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42135537&quot;&gt;42135537&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/brain-amyloid-deposition-negatively-associated-cardiac-amyloid-retention-apo-e4-carriers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/brain-amyloid-deposition-negatively-associated-cardiac-amyloid-retention-apo-e4-carriers#comments</comments>
</item>
<item>
 <title>Integrated single-cell and spatial transcriptomic profiling in ALS uncovers peripheral-to-central immune infiltration and reprogramming.</title>
 <link>https://www.alzforum.org/papers/integrated-single-cell-and-spatial-transcriptomic-profiling-als-uncovers-peripheral-central</link>
 <description>Nat Neurosci. 2026 May 14; Epub 2026 May 14&lt;br&gt;Authors: Zhang Z, van Olst L, Alessandrini F, Wright M, Edwards AJ, Boles J, Nalbandian A, Forsyth AV, Shepard N, Watson T, Kaspi E, Mittal A, Kuruvilla J, Piehl N, Ramakrishnan A, Appel S, Kiskinis E, Gate D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42135512&quot;&gt;42135512&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/integrated-single-cell-and-spatial-transcriptomic-profiling-als-uncovers-peripheral-central#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/integrated-single-cell-and-spatial-transcriptomic-profiling-als-uncovers-peripheral-central#comments</comments>
</item>
<item>
 <title>Multi-locus genetic dosage shapes cognitive disease progression in Parkinson&#039;s patients: 15-year meta-analysis of 24 cohorts.</title>
 <link>https://www.alzforum.org/papers/multi-locus-genetic-dosage-shapes-cognitive-disease-progression-parkinsons-patients-15-year</link>
 <description>NPJ Parkinsons Dis. 2026 May 14; Epub 2026 May 14&lt;br&gt;Authors: Kang X, Lin Z, Calikusu FZ, Miller LA, Soriano S, Locascio JJ, Corvol JC, Maple-Grødem J, Fan Y, Mead K, Campbell MC, Elbaz A, Lesage S, Brice A, Hung AY, Schwarzschild MA, Hayes MT, Wills AM, Herrington TM, Liu G, Ravina B, Taba P, Kõks S, Simuni T, Forsgren L, Counsell C, Macleod AD, Beach TG, Alves G, Tysnes OB, Perlmutter JS, Heutink P, Kasten M, Mollenhauer B, Trenkwalder C, Klein C, Hepp DH, Backstrom D, Svenningsson P, Hu MT, Williams-Gray CH, Barker RA, International Genetics of Parkinson Disease Progression (IGPP) Consortium, Scherzer CR&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42135313&quot;&gt;42135313&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/multi-locus-genetic-dosage-shapes-cognitive-disease-progression-parkinsons-patients-15-year#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/multi-locus-genetic-dosage-shapes-cognitive-disease-progression-parkinsons-patients-15-year#comments</comments>
</item>
<item>
 <title>1-deoxysphinganine promoted microglial glycolytic reprogramming and neuroinflammation in alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/1-deoxysphinganine-promoted-microglial-glycolytic-reprogramming-and-neuroinflammation</link>
 <description>Transl Psychiatry. 2026 May 14; Epub 2026 May 14&lt;br&gt;Authors: Ye T, Lv X, Fang Z, Li Q, Chen F, Dong Y, Xiang K, Yang Y, Dai C, Do QL, Sun J, Su KP, Liu J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42135307&quot;&gt;42135307&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/1-deoxysphinganine-promoted-microglial-glycolytic-reprogramming-and-neuroinflammation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/1-deoxysphinganine-promoted-microglial-glycolytic-reprogramming-and-neuroinflammation#comments</comments>
</item>
<item>
 <title>Single-nucleus epigenomic dysregulation unmasks genetic risk-associated neurodegenerative glia states.</title>
 <link>https://www.alzforum.org/papers/single-nucleus-epigenomic-dysregulation-unmasks-genetic-risk-associated-neurodegenerative-0</link>
 <description>Nat Commun. 2026 May 14; Epub 2026 May 14&lt;br&gt;Authors: Han X, Rosenberg GM, Kisling VM, Zhang T, Lee CY, Ravi A, Melnik M, Bilousova T, Spina S, Nana AL, Grinberg LT, Seeley WW, Gylys KH, Huckins LM, Raj T, Brennand KJ, Rexach JE&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42135303&quot;&gt;42135303&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/single-nucleus-epigenomic-dysregulation-unmasks-genetic-risk-associated-neurodegenerative-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/single-nucleus-epigenomic-dysregulation-unmasks-genetic-risk-associated-neurodegenerative-0#comments</comments>
</item>
<item>
 <title>Epigenetic noise in the aging brain: tuning neuronal vulnerability to neurodegeneration.</title>
 <link>https://www.alzforum.org/papers/epigenetic-noise-aging-brain-tuning-neuronal-vulnerability-neurodegeneration</link>
 <description>Trends Neurosci. 2026 May 14; Epub 2026 May 14&lt;br&gt;Authors: Yin X, Zhang H, Zhang R, Xue J, Hou Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42135109&quot;&gt;42135109&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/epigenetic-noise-aging-brain-tuning-neuronal-vulnerability-neurodegeneration#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/epigenetic-noise-aging-brain-tuning-neuronal-vulnerability-neurodegeneration#comments</comments>
</item>
<item>
 <title>Epigenetic aging and blood based neurodegeneration markers in LASI-DAD.</title>
 <link>https://www.alzforum.org/papers/epigenetic-aging-and-blood-based-neurodegeneration-markers-lasi-dad</link>
 <description>J Prev Alzheimers Dis. 2026 May 14;13(7):100595.  Epub 2026 May 14&lt;br&gt;Authors: Kim JK, Arpawong TE, Thyagarajan B, Smith JA, Vivek S, Ratliff S, Dey S, Lee J, Crimmins EM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42134227&quot;&gt;42134227&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/epigenetic-aging-and-blood-based-neurodegeneration-markers-lasi-dad#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/epigenetic-aging-and-blood-based-neurodegeneration-markers-lasi-dad#comments</comments>
</item>
<item>
 <title>Glucagon-Like Peptide-1 Receptor Agonists Inhibit the Initiation of Toxic Amyloid-β42 Aggregation.</title>
 <link>https://www.alzforum.org/papers/glucagon-peptide-1-receptor-agonists-inhibit-initiation-toxic-amyloid-v42-aggregation</link>
 <description>J Am Chem Soc. 2026 May 14; Epub 2026 May 14&lt;br&gt;Authors: Fallot LB, Anderson CA, Pinc JR, Stevenson A, Schleck MC, Hawryschuk E, Li OZ, Palchak JC, Toole JR, Kubiak Ii RW, Dear AJ, Michaels TC, Limbocker R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42133988&quot;&gt;42133988&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/glucagon-peptide-1-receptor-agonists-inhibit-initiation-toxic-amyloid-v42-aggregation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/glucagon-peptide-1-receptor-agonists-inhibit-initiation-toxic-amyloid-v42-aggregation#comments</comments>
</item>
<item>
 <title>Dementia studies come to grips with overlapping diseases.</title>
 <link>https://www.alzforum.org/papers/dementia-studies-come-grips-overlapping-diseases</link>
 <description>Science. 2026 May 14;392(6799):675-676.  Epub 2026 May 14&lt;br&gt;Authors: Smith JE&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42133777&quot;&gt;42133777&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/dementia-studies-come-grips-overlapping-diseases#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/dementia-studies-come-grips-overlapping-diseases#comments</comments>
</item>
<item>
 <title>Exploring Lymphovenous Anastomosis for Alzheimer&#039;s Disease: Addressing Brain Lymphatic Dysfunction, Feasibility, and Outcome Metrics.</title>
 <link>https://www.alzforum.org/papers/exploring-lymphovenous-anastomosis-alzheimers-disease-addressing-brain-lymphatic-0</link>
 <description>Plast Reconstr Surg. 2026 May 14; Epub 2026 May 14&lt;br&gt;Authors: Brown S, Klimitz FJ, Kipnis J, Benveniste H, Ringstad G, Eide PK, Azizi S, Mecca A, Haykal S, Pomahac B&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42133667&quot;&gt;42133667&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/exploring-lymphovenous-anastomosis-alzheimers-disease-addressing-brain-lymphatic-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/exploring-lymphovenous-anastomosis-alzheimers-disease-addressing-brain-lymphatic-0#comments</comments>
</item>
<item>
 <title>Regulation between LRRK2 and PP2A signaling in cellular models of Parkinsons disease.</title>
 <link>https://www.alzforum.org/papers/regulation-between-lrrk2-and-pp2a-signaling-cellular-models-parkinsons-disease</link>
 <description>Biochem J. 2026 May 14; Epub 2026 May 14&lt;br&gt;Authors: Athanasopoulos PS, Memou A, Ho FY, Soliman A, Pots H, Papadopoulou V, von Zweydorf F, Sriraman S, Thouin AM, Vandewynckel L, Sibran W, Chartier-Harlin MC, Nichols RJ, Greggio E, Taymans JM, Gloeckner CJ, Rideout HJ, Kortholt A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42133347&quot;&gt;42133347&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/regulation-between-lrrk2-and-pp2a-signaling-cellular-models-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/regulation-between-lrrk2-and-pp2a-signaling-cellular-models-parkinsons-disease#comments</comments>
</item>
<item>
 <title>Alterations of homotopic functional connectivity and correlates with core neuropsychological impairments in mild cognitive impairment: a resting-state fMRI study.</title>
 <link>https://www.alzforum.org/papers/alterations-homotopic-functional-connectivity-and-correlates-core-neuropsychological</link>
 <description>Brain Imaging Behav. 2026 May 14;20(3)&lt;br&gt;Authors: Guo Y, Gao Y, Liu Y, Nie X, Xiong Q, Ren Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42133147&quot;&gt;42133147&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/alterations-homotopic-functional-connectivity-and-correlates-core-neuropsychological#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/alterations-homotopic-functional-connectivity-and-correlates-core-neuropsychological#comments</comments>
</item>
<item>
 <title>Purinergic modulation in Parkinson&#039;s disease: the dual role of istradefylline in motor and cognitive outcomes.</title>
 <link>https://www.alzforum.org/papers/purinergic-modulation-parkinsons-disease-dual-role-istradefylline-motor-and-cognitive</link>
 <description>Purinergic Signal. 2026 May 14;22(3)&lt;br&gt;Authors: Rejili M, Al-Kuraishy HM, Al-Gareeb AI, Albuhadily AK, Jabir MS, Shokr MM, Batiha GE&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42133141&quot;&gt;42133141&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/purinergic-modulation-parkinsons-disease-dual-role-istradefylline-motor-and-cognitive#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/purinergic-modulation-parkinsons-disease-dual-role-istradefylline-motor-and-cognitive#comments</comments>
</item>
<item>
 <title>From epigenetic scripts to kinase signals: linking DOT1L and RIPK1 in the neurobiology of degeneration.</title>
 <link>https://www.alzforum.org/papers/epigenetic-scripts-kinase-signals-linking-dot1l-and-ripk1-neurobiology-degeneration</link>
 <description>Mol Biol Rep. 2026 May 14;53(1)&lt;br&gt;Authors: Kalra P, Grewal AK, Khan H, Chaturvedi D, Singh TG&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42133133&quot;&gt;42133133&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/epigenetic-scripts-kinase-signals-linking-dot1l-and-ripk1-neurobiology-degeneration#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/epigenetic-scripts-kinase-signals-linking-dot1l-and-ripk1-neurobiology-degeneration#comments</comments>
</item>
<item>
 <title>Detecting the seeds of Parkinson&#039;s disease: the evolution of α‑synuclein seed amplification assay as a clinical biomarker.</title>
 <link>https://www.alzforum.org/papers/detecting-seeds-parkinsons-disease-evolution-synuclein-seed-amplification-assay-clinical</link>
 <description>J Neural Transm (Vienna). 2026 May 14; Epub 2026 May 14&lt;br&gt;Authors: Bautista JM, Quanico CJ, Cataniag P, Guillermo JG, Hattori N&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42133018&quot;&gt;42133018&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/detecting-seeds-parkinsons-disease-evolution-synuclein-seed-amplification-assay-clinical#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/detecting-seeds-parkinsons-disease-evolution-synuclein-seed-amplification-assay-clinical#comments</comments>
</item>
<item>
 <title>The correlates of hyperechogenicity of the substantia nigra in subjects at risk of dementia with Lewy bodies.</title>
 <link>https://www.alzforum.org/papers/correlates-hyperechogenicity-substantia-nigra-subjects-risk-dementia-lewy-bodies</link>
 <description>J Neural Transm (Vienna). 2026 May 14; Epub 2026 May 14&lt;br&gt;Authors: Zelníčková K, Ondráček D, Mikulec M, Mekyska J, Farkaš J, Lamoš M, Rektorová I&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42133012&quot;&gt;42133012&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/correlates-hyperechogenicity-substantia-nigra-subjects-risk-dementia-lewy-bodies#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/correlates-hyperechogenicity-substantia-nigra-subjects-risk-dementia-lewy-bodies#comments</comments>
</item>
<item>
 <title>Visual memory in Parkinson&#039;s Disease: a non-graphomotor approach to assessment.</title>
 <link>https://www.alzforum.org/papers/visual-memory-parkinsons-disease-non-graphomotor-approach-assessment</link>
 <description>J Neural Transm (Vienna). 2026 May 14; Epub 2026 May 14&lt;br&gt;Authors: Bhardwaj M, Prasad S, Kumar KJ, Nagaraj T, Bhat SG, Mailankody P, Mahale RR, Holla VV, Kamble N, Yadav R, Pal PK&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42133010&quot;&gt;42133010&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/visual-memory-parkinsons-disease-non-graphomotor-approach-assessment#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/visual-memory-parkinsons-disease-non-graphomotor-approach-assessment#comments</comments>
</item>
<item>
 <title>From MRI to 3D printing: a tangible neuroeducational tool for visualizing hippocampal morphology and Alzheimer&#039;s disease progression.</title>
 <link>https://www.alzforum.org/papers/mri-3d-printing-tangible-neuroeducational-tool-visualizing-hippocampal-morphology-and</link>
 <description>J Neural Transm (Vienna). 2026 May 14; Epub 2026 May 14&lt;br&gt;Authors: Sodaei F, Vafaee MS, Michel TM, Rad HS, Noroozian M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42133009&quot;&gt;42133009&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mri-3d-printing-tangible-neuroeducational-tool-visualizing-hippocampal-morphology-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mri-3d-printing-tangible-neuroeducational-tool-visualizing-hippocampal-morphology-and#comments</comments>
</item>
<item>
 <title>Oleic and omega-3 fatty acids buffer neuroinflammation in a scopolamine model with Alzheimer&#039;s-like features via target-level interactions.</title>
 <link>https://www.alzforum.org/papers/oleic-and-omega-3-fatty-acids-buffer-neuroinflammation-scopolamine-model-alzheimers-features</link>
 <description>Food Funct. 2026 May 14; Epub 2026 May 14&lt;br&gt;Authors: Albertuni M, Torrecillas-Lopez M, Gonzalez-de la Rosa T, Barrera-Chamorro L, Marquez-Paradas E, Del Rio-Vazquez JL, Navarro-Hortal MD, Claro-Cala CM, Montserrat-de la Paz S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42132882&quot;&gt;42132882&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/oleic-and-omega-3-fatty-acids-buffer-neuroinflammation-scopolamine-model-alzheimers-features#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/oleic-and-omega-3-fatty-acids-buffer-neuroinflammation-scopolamine-model-alzheimers-features#comments</comments>
</item>
<item>
 <title>α-synuclein PET imaging: early human evidence and the path toward clinical proof-of-concept.</title>
 <link>https://www.alzforum.org/papers/synuclein-pet-imaging-early-human-evidence-and-path-toward-clinical-proof-concept</link>
 <description>Expert Rev Mol Diagn. 2026 May 14; Epub 2026 May 14&lt;br&gt;Authors: Filippi L, Urbano N&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42132158&quot;&gt;42132158&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/synuclein-pet-imaging-early-human-evidence-and-path-toward-clinical-proof-concept#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/synuclein-pet-imaging-early-human-evidence-and-path-toward-clinical-proof-concept#comments</comments>
</item>
<item>
 <title>Photocontrollable Electrochemical Molecular Probe for the Detection of Cu2+ in Brain Dialysates of Alzheimer&#039;s Disease Mice.</title>
 <link>https://www.alzforum.org/papers/photocontrollable-electrochemical-molecular-probe-detection-cu2-brain-dialysates-alzheimers</link>
 <description>ACS Sens. 2026 May 14; Epub 2026 May 14&lt;br&gt;Authors: Dong H, Zhao L, Guo G, Chang A, Cheng M, Qian Y, Hu L, Zhou J, Ye Y, Zhou Y, Ma Y, Li Z, Xu M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42132079&quot;&gt;42132079&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/photocontrollable-electrochemical-molecular-probe-detection-cu2-brain-dialysates-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/photocontrollable-electrochemical-molecular-probe-detection-cu2-brain-dialysates-alzheimers#comments</comments>
</item>
<item>
 <title>Identification and Enrollment of Individuals Prior to Parkinson&#039;s Disease Diagnosis: Biomarker-Driven Adaptive Eligibility and Enrollment into the Parkinson&#039;s Progression Markers Initiative.</title>
 <link>https://www.alzforum.org/papers/identification-and-enrollment-individuals-prior-parkinsons-disease-diagnosis-biomarker-driven</link>
 <description>Ann Neurol. 2026 May 14; Epub 2026 May 14&lt;br&gt;Authors: Brown EG, Chahine LM, Dobkin RD, Simuni T, Foroud T, Heathers LE, Tropea TF, Stanley CE Jr, McMahon BA, Brüggemann N, Klein C, Postuma RB, Johnson NS, Gochanour C, Caspell-Garcia C, Kurth R, Brumm MC, Coffey CS, Marek K, Tanner CM, Parkinson&amp;#039;s Progression Markers Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42132059&quot;&gt;42132059&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/identification-and-enrollment-individuals-prior-parkinsons-disease-diagnosis-biomarker-driven#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/identification-and-enrollment-individuals-prior-parkinsons-disease-diagnosis-biomarker-driven#comments</comments>
</item>
<item>
 <title>Gut Microbiota Dysbiosis Drives Early Alzheimer&#039;s Pathogenesis via Microglial TREM2/SYK/NF-κB Signaling Axis.</title>
 <link>https://www.alzforum.org/papers/gut-microbiota-dysbiosis-drives-early-alzheimers-pathogenesis-microglial-trem2syknf-kb</link>
 <description>ACS Chem Neurosci. 2026 May 14; Epub 2026 May 14&lt;br&gt;Authors: Tian M, Wang D, Zhang C, Fan J, Li W, Liu X, Shi J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42130461&quot;&gt;42130461&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/gut-microbiota-dysbiosis-drives-early-alzheimers-pathogenesis-microglial-trem2syknf-kb#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/gut-microbiota-dysbiosis-drives-early-alzheimers-pathogenesis-microglial-trem2syknf-kb#comments</comments>
</item>
<item>
 <title>Molecular Insights into Parkinson&#039;s Disease Progression: A Multi-omics Analysis of the Substantia Nigra Pars Compacta across Braak Stages.</title>
 <link>https://www.alzforum.org/papers/molecular-insights-parkinsons-disease-progression-multi-omics-analysis-substantia-nigra-pars</link>
 <description>Exp Neurobiol. 2026 May 14; Epub 2026 May 14&lt;br&gt;Authors: Kim S, Choi JG, Kim SW, Son M, Kim D, Nam SJ, Kim SJ, Kim S, Korea Brain Bank Network&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42130054&quot;&gt;42130054&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/molecular-insights-parkinsons-disease-progression-multi-omics-analysis-substantia-nigra-pars#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/molecular-insights-parkinsons-disease-progression-multi-omics-analysis-substantia-nigra-pars#comments</comments>
</item>
<item>
 <title>Emotion recognition deficits in Alzheimer&#039;s disease: A meta-analysis.</title>
 <link>https://www.alzforum.org/papers/emotion-recognition-deficits-alzheimers-disease-meta-analysis</link>
 <description>Neurosci Biobehav Rev. 2026 May 13;187:106745.  Epub 2026 May 13&lt;br&gt;Authors: Zamora A, Balboa-Bandeira Y, Peña J, Ojeda N&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42114728&quot;&gt;42114728&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/emotion-recognition-deficits-alzheimers-disease-meta-analysis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/emotion-recognition-deficits-alzheimers-disease-meta-analysis#comments</comments>
</item>
<item>
 <title>Investigating how changes in the levels of kinesins impact neuronal health in Drosophila and human iPSC-derived neurons AD model.</title>
 <link>https://www.alzforum.org/papers/investigating-how-changes-levels-kinesins-impact-neuronal-health-drosophila-and-human-ipsc</link>
 <description>Open Biol. 2026 May 13;16(5)&lt;br&gt;Authors: Francis D, Paonessa F, Hewitt VL, Southall M, Peset I, Whitworth AJ, Livesey FJ, Fabre CC, Palacios IM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42120060&quot;&gt;42120060&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/investigating-how-changes-levels-kinesins-impact-neuronal-health-drosophila-and-human-ipsc#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/investigating-how-changes-levels-kinesins-impact-neuronal-health-drosophila-and-human-ipsc#comments</comments>
</item>
<item>
 <title>Spatiotemporal brain transcriptomics reveal risk gene hot-spots in major neuropsychiatric disorders.</title>
 <link>https://www.alzforum.org/papers/spatiotemporal-brain-transcriptomics-reveal-risk-gene-hot-spots-major-neuropsychiatric-0</link>
 <description>Commun Biol. 2026 May 13;9(1)&lt;br&gt;Authors: Liu W, Shimogori T&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42129508&quot;&gt;42129508&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/spatiotemporal-brain-transcriptomics-reveal-risk-gene-hot-spots-major-neuropsychiatric-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/spatiotemporal-brain-transcriptomics-reveal-risk-gene-hot-spots-major-neuropsychiatric-0#comments</comments>
</item>
<item>
 <title>Cytokine gene polymorphisms and serum cytokine levels identify a neuroinflammatory nexus in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/cytokine-gene-polymorphisms-and-serum-cytokine-levels-identify-neuroinflammatory-nexus</link>
 <description>Sci Rep. 2026 May 13; Epub 2026 May 13&lt;br&gt;Authors: Wang Z, Xia X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42129267&quot;&gt;42129267&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cytokine-gene-polymorphisms-and-serum-cytokine-levels-identify-neuroinflammatory-nexus#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cytokine-gene-polymorphisms-and-serum-cytokine-levels-identify-neuroinflammatory-nexus#comments</comments>
</item>
<item>
 <title>Functional system-specific brain aging across the Alzheimer&#039;s disease continuum.</title>
 <link>https://www.alzforum.org/papers/functional-system-specific-brain-aging-across-alzheimers-disease-continuum</link>
 <description>Transl Psychiatry. 2026 May 13; Epub 2026 May 13&lt;br&gt;Authors: Huo Y, Huang W, Liu Z, Chen H, Bai T, Wang Y, Wang K, Zhang D, Cheng J, Sun Y, Ma G, Zhao C, Zhang Z, Shu N&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42129136&quot;&gt;42129136&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/functional-system-specific-brain-aging-across-alzheimers-disease-continuum#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/functional-system-specific-brain-aging-across-alzheimers-disease-continuum#comments</comments>
</item>
<item>
 <title>Correction: EEG-based classification of alzheimer&#039;s disease and frontotemporal dementia using functional connectivity.</title>
 <link>https://www.alzforum.org/papers/correction-eeg-based-classification-alzheimers-disease-and-frontotemporal-dementia-using</link>
 <description>Sci Rep. 2026 May 13;16(1)&lt;br&gt;Authors: Mlinarič T, Van Den Kerchove A, Barinaga ZI, Van Hulle MM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42128892&quot;&gt;42128892&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/correction-eeg-based-classification-alzheimers-disease-and-frontotemporal-dementia-using#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/correction-eeg-based-classification-alzheimers-disease-and-frontotemporal-dementia-using#comments</comments>
</item>
<item>
 <title>Interaction of diet and physical activity on dementia risk: the Rotterdam study.</title>
 <link>https://www.alzforum.org/papers/interaction-diet-and-physical-activity-dementia-risk-rotterdam-study</link>
 <description>J Prev Alzheimers Dis. 2026 May 13;13(7):100594.  Epub 2026 May 13&lt;br&gt;Authors: Sambou ML, Ikram MA, Ikram MK, Labrecque JA, Wolters FJ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42128461&quot;&gt;42128461&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/interaction-diet-and-physical-activity-dementia-risk-rotterdam-study#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/interaction-diet-and-physical-activity-dementia-risk-rotterdam-study#comments</comments>
</item>
<item>
 <title>Modeling Alzheimer&#039;s disease with human multi-omics profiles: Promise to personalized medicine.</title>
 <link>https://www.alzforum.org/papers/modeling-alzheimers-disease-human-multi-omics-profiles-promise-personalized-medicine</link>
 <description>Curr Opin Neurobiol. 2026 May 13;99:103210.  Epub 2026 May 13&lt;br&gt;Authors: Ip NY&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42127889&quot;&gt;42127889&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/modeling-alzheimers-disease-human-multi-omics-profiles-promise-personalized-medicine#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/modeling-alzheimers-disease-human-multi-omics-profiles-promise-personalized-medicine#comments</comments>
</item>
<item>
 <title>Relationship between intracranial pressure waveform parameters and quantitative biomarkers of Alzheimer&#039;s disease from brain tissue and cerebrospinal fluid in idiopathic normal pressure hydrocephalus.</title>
 <link>https://www.alzforum.org/papers/relationship-between-intracranial-pressure-waveform-parameters-and-quantitative-biomarkers</link>
 <description>J Clin Neurosci. 2026 May 13;151:112082.  Epub 2026 May 13&lt;br&gt;Authors: Jaeger M, McMahon S, Murambi RT, Chakravorty A, Ecroyd HW&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42127521&quot;&gt;42127521&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/relationship-between-intracranial-pressure-waveform-parameters-and-quantitative-biomarkers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/relationship-between-intracranial-pressure-waveform-parameters-and-quantitative-biomarkers#comments</comments>
</item>
<item>
 <title>A phase 1, safety, tolerability, and pharmacokinetics study of bisnorcymserine, a highly selective inhibitor of butyrylcholinesterase.</title>
 <link>https://www.alzforum.org/papers/phase-1-safety-tolerability-and-pharmacokinetics-study-bisnorcymserine-highly-selective</link>
 <description>Neurotherapeutics. 2026 May 13;23(3):e00918.  Epub 2026 May 13&lt;br&gt;Authors: Tzieras I, Manolopoulos A, Tweedie D, Luo W, Maccecchini M, Egan JM, Greig NH, Kapogiannis D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42127455&quot;&gt;42127455&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/phase-1-safety-tolerability-and-pharmacokinetics-study-bisnorcymserine-highly-selective#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/phase-1-safety-tolerability-and-pharmacokinetics-study-bisnorcymserine-highly-selective#comments</comments>
</item>
<item>
 <title>MusicAlzheimer: AI-Powered, Culturally Tailored Digital Music Therapy Prototype for Alzheimer Disease Care.</title>
 <link>https://www.alzforum.org/papers/musicalzheimer-ai-powered-culturally-tailored-digital-music-therapy-prototype-alzheimer</link>
 <description>JMIR Form Res. 2026 May 13;10:e89535. &lt;br&gt;Authors: Yang S, Zhang DY, Zhang M, Yang H, Ma Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42127381&quot;&gt;42127381&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/musicalzheimer-ai-powered-culturally-tailored-digital-music-therapy-prototype-alzheimer#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/musicalzheimer-ai-powered-culturally-tailored-digital-music-therapy-prototype-alzheimer#comments</comments>
</item>
<item>
 <title>Conjugation of Dietary Carnosine to Phe-Leu Dipeptide Affords a Potent Inhibitor of Multifaceted Aβ-Induced Neurotoxicity.</title>
 <link>https://www.alzforum.org/papers/conjugation-dietary-carnosine-phe-leu-dipeptide-affords-potent-inhibitor-multifaceted-av</link>
 <description>Bioconjug Chem. 2026 May 13; Epub 2026 May 13&lt;br&gt;Authors: Singh K, Priyadarshi N, Goyal B, Singhal NK, Goyal D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42127283&quot;&gt;42127283&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/conjugation-dietary-carnosine-phe-leu-dipeptide-affords-potent-inhibitor-multifaceted-av#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/conjugation-dietary-carnosine-phe-leu-dipeptide-affords-potent-inhibitor-multifaceted-av#comments</comments>
</item>
<item>
 <title>Cognitive and Neuroanatomical Effects of Fatty Acid Amide Hydrolase Polymorphism rs324420 in Aging and Alzheimer Disease.</title>
 <link>https://www.alzforum.org/papers/cognitive-and-neuroanatomical-effects-fatty-acid-amide-hydrolase-polymorphism-rs324420-aging</link>
 <description>Alzheimer Dis Assoc Disord. 2026 May 13; Epub 2026 May 13&lt;br&gt;Authors: Mori-Fegan DK, Wong YY, Noor S, Wu CY, Ryoo S, Mielnik C, Ross RA, Swardfager W&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42127232&quot;&gt;42127232&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cognitive-and-neuroanatomical-effects-fatty-acid-amide-hydrolase-polymorphism-rs324420-aging#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cognitive-and-neuroanatomical-effects-fatty-acid-amide-hydrolase-polymorphism-rs324420-aging#comments</comments>
</item>
<item>
 <title>Early Detection of Alzheimer&#039;s Disease and Related Dementias From Spontaneous Speech Using Foundation Speech and Language Models: Comparative Evaluation.</title>
 <link>https://www.alzforum.org/papers/early-detection-alzheimers-disease-and-related-dementias-spontaneous-speech-using-foundation</link>
 <description>JMIR Form Res. 2026 May 13;10:e79411. &lt;br&gt;Authors: Li J, Mao L, Mao X, Wang H, Wang Z, Ni XS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42126910&quot;&gt;42126910&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/early-detection-alzheimers-disease-and-related-dementias-spontaneous-speech-using-foundation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/early-detection-alzheimers-disease-and-related-dementias-spontaneous-speech-using-foundation#comments</comments>
</item>
<item>
 <title>Subjective Cognitive Complaints and Hearing Loss in Older Adults-A Cross-Sectional Study on the Possible Association.</title>
 <link>https://www.alzforum.org/papers/subjective-cognitive-complaints-and-hearing-loss-older-adults-cross-sectional-study-possible</link>
 <description>Scand J Psychol. 2026 May 13; Epub 2026 May 13&lt;br&gt;Authors: Vogel A, Hendel RK, Jørgensen M, Kressner AA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42126868&quot;&gt;42126868&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/subjective-cognitive-complaints-and-hearing-loss-older-adults-cross-sectional-study-possible#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/subjective-cognitive-complaints-and-hearing-loss-older-adults-cross-sectional-study-possible#comments</comments>
</item>
<item>
 <title>Semaglutide ameliorates neuroinflammation and cognitive impairment in APP/PS1 mice.</title>
 <link>https://www.alzforum.org/papers/semaglutide-ameliorates-neuroinflammation-and-cognitive-impairment-appps1-mice</link>
 <description>Mol Cell Biochem. 2026 May 13; Epub 2026 May 13&lt;br&gt;Authors: Yuan Y, Zhang J, Zhang Z, Zhai Y, Cheng XJ, Xue L, Zhao F, Cao L, Wang H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42126676&quot;&gt;42126676&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/semaglutide-ameliorates-neuroinflammation-and-cognitive-impairment-appps1-mice#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/semaglutide-ameliorates-neuroinflammation-and-cognitive-impairment-appps1-mice#comments</comments>
</item>
<item>
 <title>When bad turns good: a systematic review on cholesterol and LDL in longitudinal patient cohorts with Parkinson&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/when-bad-turns-good-systematic-review-cholesterol-and-ldl-longitudinal-patient-cohorts</link>
 <description>Neurol Sci. 2026 May 13;47(6)&lt;br&gt;Authors: Lumi R, Tartakovskaja J, Ye L, Abraham B, Niesmann C, Greten S, Wegner F, Klietz M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42126660&quot;&gt;42126660&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/when-bad-turns-good-systematic-review-cholesterol-and-ldl-longitudinal-patient-cohorts#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/when-bad-turns-good-systematic-review-cholesterol-and-ldl-longitudinal-patient-cohorts#comments</comments>
</item>
<item>
 <title>Engineered Exosomes: Innovative Strategies for Precision Drug Delivery in Parkinson&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/engineered-exosomes-innovative-strategies-precision-drug-delivery-parkinsons-disease</link>
 <description>Mol Neurobiol. 2026 May 13;63(1)&lt;br&gt;Authors: Yuan X, Wang C, Yan J, Wang J, Li F, You Y, Qi Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42126515&quot;&gt;42126515&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/engineered-exosomes-innovative-strategies-precision-drug-delivery-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/engineered-exosomes-innovative-strategies-precision-drug-delivery-parkinsons-disease#comments</comments>
</item>
<item>
 <title>Comparing the value of dynamic versus static image-based tests of emotion recognition in neurodegenerative disease.</title>
 <link>https://www.alzforum.org/papers/comparing-value-dynamic-versus-static-image-based-tests-emotion-recognition-neurodegenerative</link>
 <description>J Neuropsychol. 2026 May 13; Epub 2026 May 13&lt;br&gt;Authors: Ulugut H, Shany-Ur T, Quagletti A, Syed F, McEachen B, Callahan P, Rijpma MG, Antoniou R, Kramer JH, Miller BL, Rabinovici GD, Possin KL, Seeley WW, Rosen HJ, Gorno-Tempini ML, Sturm VE, Rankin KP&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42126186&quot;&gt;42126186&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/comparing-value-dynamic-versus-static-image-based-tests-emotion-recognition-neurodegenerative#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/comparing-value-dynamic-versus-static-image-based-tests-emotion-recognition-neurodegenerative#comments</comments>
</item>
<item>
 <title>Cognitive Impairment in Parkinson&#039;s Disease: Contributions from the Parkinson&#039;s Progression Markers Initiative.</title>
 <link>https://www.alzforum.org/papers/cognitive-impairment-parkinsons-disease-contributions-parkinsons-progression-markers</link>
 <description>Ann Neurol. 2026 May 13; Epub 2026 May 13&lt;br&gt;Authors: Weintraub D, Dobkin RD, York MK, Chahine LM, Tropea TF, Marek K, Parkinson&amp;#039;s Progression Markers Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42125954&quot;&gt;42125954&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cognitive-impairment-parkinsons-disease-contributions-parkinsons-progression-markers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cognitive-impairment-parkinsons-disease-contributions-parkinsons-progression-markers#comments</comments>
</item>
<item>
 <title>Comprehensive Characterization of 98 Chinese Cases of Genetic Creutzfeldt-Jakob Disease With T188K Mutation.</title>
 <link>https://www.alzforum.org/papers/comprehensive-characterization-98-chinese-cases-genetic-creutzfeldt-jakob-disease-t188k</link>
 <description>Ann Clin Transl Neurol. 2026 May 13; Epub 2026 May 13&lt;br&gt;Authors: Li CJ, Liang DL, Gao LP, Zhang WW, Zhou W, Ruhan A, Xu B, Cao RD, Xiao K, Chen C, Shi Q, Dong XP&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42125878&quot;&gt;42125878&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/comprehensive-characterization-98-chinese-cases-genetic-creutzfeldt-jakob-disease-t188k#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/comprehensive-characterization-98-chinese-cases-genetic-creutzfeldt-jakob-disease-t188k#comments</comments>
</item>
<item>
 <title>Effects of age and APOE ϵ4 genotype on the relationship between pulse pressure and executive function in older adults without Dementia.</title>
 <link>https://www.alzforum.org/papers/effects-age-and-apoe-4-genotype-relationship-between-pulse-pressure-and-executive-function</link>
 <description>J Int Neuropsychol Soc. 2026 May 13;:1-10.  Epub 2026 May 13&lt;br&gt;Authors: Quiring ML, Edwards L, Bangen KJ, Ho EH, Carlsson CM, Galasko D, Weintraub S, Gershon R, Salmon DP&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42124479&quot;&gt;42124479&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/effects-age-and-apoe-4-genotype-relationship-between-pulse-pressure-and-executive-function#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/effects-age-and-apoe-4-genotype-relationship-between-pulse-pressure-and-executive-function#comments</comments>
</item>
<item>
 <title>The Glymphatic system: A dynamic regulator of brain health and therapeutic target.</title>
 <link>https://www.alzforum.org/papers/glymphatic-system-dynamic-regulator-brain-health-and-therapeutic-target</link>
 <description>Exp Neurol. 2026 May 13;:115825.  Epub 2026 May 13&lt;br&gt;Authors: Wang X, Gao M, Sui S, Liu F, Tian W, Wu S, Ding J, Chao X, Xie X, Gu M, Hu T, Sun W&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42134763&quot;&gt;42134763&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/glymphatic-system-dynamic-regulator-brain-health-and-therapeutic-target#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/glymphatic-system-dynamic-regulator-brain-health-and-therapeutic-target#comments</comments>
</item>
<item>
 <title>Carboplatin alleviates astrocytic TDP-43 neurotoxicity by inhibiting NF-κB activation.</title>
 <link>https://www.alzforum.org/papers/carboplatin-alleviates-astrocytic-tdp-43-neurotoxicity-inhibiting-nf-kb-activation</link>
 <description>Eur J Pharmacol. 2026 May 13;1026:178968.  Epub 2026 May 13&lt;br&gt;Authors: Song J, Lee S, Lee J, Gil Y, Kim T, Kim SY, Cha SJ, Kim HJ, Kim K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42134762&quot;&gt;42134762&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/carboplatin-alleviates-astrocytic-tdp-43-neurotoxicity-inhibiting-nf-kb-activation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/carboplatin-alleviates-astrocytic-tdp-43-neurotoxicity-inhibiting-nf-kb-activation#comments</comments>
</item>
<item>
 <title>The impact of long-term feeding with curcuminoids phospholipids enriched diet on disease progression of fALS.</title>
 <link>https://www.alzforum.org/papers/impact-long-term-feeding-curcuminoids-phospholipids-enriched-diet-disease-progression-fals</link>
 <description>Neurochem Int. 2026 May 13;197:106183.  Epub 2026 May 13&lt;br&gt;Authors: Purushotham SS, Chesworth R, Keembiyage N, Münch G, Gyengesi E, Buskila Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42134658&quot;&gt;42134658&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/impact-long-term-feeding-curcuminoids-phospholipids-enriched-diet-disease-progression-fals#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/impact-long-term-feeding-curcuminoids-phospholipids-enriched-diet-disease-progression-fals#comments</comments>
</item>
<item>
 <title>TDP-43 expression in the cytoplasm leads to early synaptic and mitochondrial abnormalities in an inducible mouse model of ALS/FTD.</title>
 <link>https://www.alzforum.org/papers/tdp-43-expression-cytoplasm-leads-early-synaptic-and-mitochondrial-abnormalities-inducible</link>
 <description>Neurochem Int. 2026 May 13;197:106180.  Epub 2026 May 13&lt;br&gt;Authors: Vassallu F, López M, López Ambrosioni F, Casal J, Caltana L, Igaz LM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42134656&quot;&gt;42134656&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/tdp-43-expression-cytoplasm-leads-early-synaptic-and-mitochondrial-abnormalities-inducible#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/tdp-43-expression-cytoplasm-leads-early-synaptic-and-mitochondrial-abnormalities-inducible#comments</comments>
</item>
<item>
 <title>Parkinson&#039;s Disease as a Disorder of Synaptic Raft Integrity: A Unified Explanation for Motor Subtypes and Non-motor Symptoms.</title>
 <link>https://www.alzforum.org/papers/parkinsons-disease-disorder-synaptic-raft-integrity-unified-explanation-motor-subtypes-and</link>
 <description>Neurochem Int. 2026 May 13;:106177.  Epub 2026 May 13&lt;br&gt;Authors: Sakoda S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42134654&quot;&gt;42134654&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/parkinsons-disease-disorder-synaptic-raft-integrity-unified-explanation-motor-subtypes-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/parkinsons-disease-disorder-synaptic-raft-integrity-unified-explanation-motor-subtypes-and#comments</comments>
</item>
<item>
 <title>The Influence of Blood Lipids on Cerebral Perfusion by Apolipoprotein E Status.</title>
 <link>https://www.alzforum.org/papers/influence-blood-lipids-cerebral-perfusion-apolipoprotein-e-status</link>
 <description>J Lipid Res. 2026 May 13;:101057.  Epub 2026 May 13&lt;br&gt;Authors: Decker KP, Rizzi NA, Rigas Z, Awad C, Habash EM, Kramer MK, Cerjanic AM, Cohen ML, Johnson CL, Martens CR&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42134547&quot;&gt;42134547&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/influence-blood-lipids-cerebral-perfusion-apolipoprotein-e-status#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/influence-blood-lipids-cerebral-perfusion-apolipoprotein-e-status#comments</comments>
</item>
<item>
 <title>Tetramethylpyrazine improving cerebral microcirculation in Alzheimer&#039;s Disease mice.</title>
 <link>https://www.alzforum.org/papers/tetramethylpyrazine-improving-cerebral-microcirculation-alzheimers-disease-mice</link>
 <description>Brain Res Bull. 2026 May 13;:111936.  Epub 2026 May 13&lt;br&gt;Authors: Wu Q, Cui X, Liu X, Yuan X, Wang P, Li H, Xiu R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42134480&quot;&gt;42134480&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/tetramethylpyrazine-improving-cerebral-microcirculation-alzheimers-disease-mice#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/tetramethylpyrazine-improving-cerebral-microcirculation-alzheimers-disease-mice#comments</comments>
</item>
<item>
 <title>Continuous-time causal distribution learning with identifiability for brain dynamic effective connectivity inference.</title>
 <link>https://www.alzforum.org/papers/continuous-time-causal-distribution-learning-identifiability-brain-dynamic-effective</link>
 <description>Med Image Anal. 2026 May 13;112:104124.  Epub 2026 May 13&lt;br&gt;Authors: Wang Y, Chen L, Qiao C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42134283&quot;&gt;42134283&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/continuous-time-causal-distribution-learning-identifiability-brain-dynamic-effective#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/continuous-time-causal-distribution-learning-identifiability-brain-dynamic-effective#comments</comments>
</item>
<item>
 <title>In vitro and in vivo inhibition of amyloid β aggregation by a Ru(II)-naphthalene diimide complex.</title>
 <link>https://www.alzforum.org/papers/vitro-and-vivo-inhibition-amyloid-v-aggregation-ruii-naphthalene-diimide-complex</link>
 <description>Dalton Trans. 2026 May 13; Epub 2026 May 13&lt;br&gt;Authors: Tiburcio MA, Cali MP, Pereira LM, Graminha AE, Atienza-Navarro I, Vendruscolo M, Garcia-Alloza M, Carlos RM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42132855&quot;&gt;42132855&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/vitro-and-vivo-inhibition-amyloid-v-aggregation-ruii-naphthalene-diimide-complex#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/vitro-and-vivo-inhibition-amyloid-v-aggregation-ruii-naphthalene-diimide-complex#comments</comments>
</item>
<item>
 <title>Causal associations of dietary habits and blood metabolites with Parkinson&#039;s disease risk.</title>
 <link>https://www.alzforum.org/papers/causal-associations-dietary-habits-and-blood-metabolites-parkinsons-disease-risk</link>
 <description>Food Funct. 2026 May 13; Epub 2026 May 13&lt;br&gt;Authors: Zhao J, Wei L, Zhao M, Sheng H, Yan X, Nie S, Huang Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42132746&quot;&gt;42132746&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/causal-associations-dietary-habits-and-blood-metabolites-parkinsons-disease-risk#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/causal-associations-dietary-habits-and-blood-metabolites-parkinsons-disease-risk#comments</comments>
</item>
<item>
 <title>Mutation-Driven Remodeling of the LRRK2 Kinase Free-Energy Landscape and Its Consequences for Conformational Transitions and Inhibitor Binding Affinity.</title>
 <link>https://www.alzforum.org/papers/mutation-driven-remodeling-lrrk2-kinase-free-energy-landscape-and-its-consequences</link>
 <description>J Chem Inf Model. 2026 May 13; Epub 2026 May 13&lt;br&gt;Authors: Ghosh R, Bhanja KK, Patra N&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42130234&quot;&gt;42130234&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mutation-driven-remodeling-lrrk2-kinase-free-energy-landscape-and-its-consequences#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mutation-driven-remodeling-lrrk2-kinase-free-energy-landscape-and-its-consequences#comments</comments>
</item>
<item>
 <title>Age-dependent peripheral dissemination of α-synuclein seeds: mechanistic basis for blood-based early detection of Parkinson&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/age-dependent-peripheral-dissemination-synuclein-seeds-mechanistic-basis-blood-based-early</link>
 <description>Acta Neuropathol Commun. 2026 May 13; Epub 2026 May 13&lt;br&gt;Authors: Kuang Y, Mao H, Lin H, Dai W, Su Z, Luo Y, Zou WQ, Yang XL, Xu PY&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42129944&quot;&gt;42129944&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/age-dependent-peripheral-dissemination-synuclein-seeds-mechanistic-basis-blood-based-early#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/age-dependent-peripheral-dissemination-synuclein-seeds-mechanistic-basis-blood-based-early#comments</comments>
</item>
<item>
 <title>Clinical correlates of sleep profiles in dementia with Lewy bodies: a latent class approach.</title>
 <link>https://www.alzforum.org/papers/clinical-correlates-sleep-profiles-dementia-lewy-bodies-latent-class-approach</link>
 <description>Alzheimers Res Ther. 2026 May 13; Epub 2026 May 13&lt;br&gt;Authors: Renard L, Aveneau C, Götze K, Varnet O, Dieudonné A, Hourrègue C, Cognat E, Dumurgier J, Diard C, d&amp;#039;Ortho MP, Paquet C, Vrillon A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42129862&quot;&gt;42129862&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/clinical-correlates-sleep-profiles-dementia-lewy-bodies-latent-class-approach#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/clinical-correlates-sleep-profiles-dementia-lewy-bodies-latent-class-approach#comments</comments>
</item>
<item>
 <title>Valosin-containing Protein is cargo in Amyloid Precursor Protein extracellular vesicles.</title>
 <link>https://www.alzforum.org/papers/valosin-containing-protein-cargo-amyloid-precursor-protein-extracellular-vesicles-0</link>
 <description>Cell Commun Signal. 2026 May 13; Epub 2026 May 13&lt;br&gt;Authors: Lu Y, Abdullah M, Healy LR, Yin T, Yesiltepe M, D&amp;#039;Adamio L, Tambini MD&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42129847&quot;&gt;42129847&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/valosin-containing-protein-cargo-amyloid-precursor-protein-extracellular-vesicles-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/valosin-containing-protein-cargo-amyloid-precursor-protein-extracellular-vesicles-0#comments</comments>
</item>
<item>
 <title>Molecular and statistical weaknesses of the p-tau217/Aβ1-42 plasma ratio for alzheimer&#039;s diagnosis.</title>
 <link>https://www.alzforum.org/papers/molecular-and-statistical-weaknesses-p-tau217av1-42-plasma-ratio-alzheimers-diagnosis</link>
 <description>J Mol Med (Berl). 2026 May 12;104(1)&lt;br&gt;Authors: Ferré CG, Pallàs M, Franco R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42115432&quot;&gt;42115432&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/molecular-and-statistical-weaknesses-p-tau217av1-42-plasma-ratio-alzheimers-diagnosis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/molecular-and-statistical-weaknesses-p-tau217av1-42-plasma-ratio-alzheimers-diagnosis#comments</comments>
</item>
<item>
 <title>α/Sulfonyl-γ-AApeptide foldamers mitigate Alzheimer&#039;s disease pathology by stabilizing transient helical domains in Aβ.</title>
 <link>https://www.alzforum.org/papers/asulfonyl-g-aapeptide-foldamers-mitigate-alzheimers-disease-pathology-stabilizing-transient</link>
 <description>Nat Commun. 2026 May 12; Epub 2026 May 12&lt;br&gt;Authors: Liu H, Akhter F, Akhter A, Zhao X, Wang X, Yang H, Chen J, Xia X, Calcul L, He Y, Cao C, Ye L, Zhu D, Cai J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42115163&quot;&gt;42115163&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/asulfonyl-g-aapeptide-foldamers-mitigate-alzheimers-disease-pathology-stabilizing-transient#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/asulfonyl-g-aapeptide-foldamers-mitigate-alzheimers-disease-pathology-stabilizing-transient#comments</comments>
</item>
<item>
 <title>Knockout of Rab27b exacerbates neuropathology in alpha-synuclein mouse models.</title>
 <link>https://www.alzforum.org/papers/knockout-rab27b-exacerbates-neuropathology-alpha-synuclein-mouse-models-0</link>
 <description>Acta Neuropathol Commun. 2026 May 12; Epub 2026 May 12&lt;br&gt;Authors: Scholz K, Gannon MA, Matheny L, Syed R, Stone WJ, Craig C, Ekkatine R, Yacoubian TA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42121002&quot;&gt;42121002&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/knockout-rab27b-exacerbates-neuropathology-alpha-synuclein-mouse-models-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/knockout-rab27b-exacerbates-neuropathology-alpha-synuclein-mouse-models-0#comments</comments>
</item>
<item>
 <title>Porcine plasma-derived extracellular vesicles orchestrate multi-target neuroimmune reconfiguration to alleviate Alzheimer&#039;s disease pathology in a 5×FAD mouse model.</title>
 <link>https://www.alzforum.org/papers/porcine-plasma-derived-extracellular-vesicles-orchestrate-multi-target-neuroimmune</link>
 <description>J Neuroinflammation. 2026 May 12; Epub 2026 May 12&lt;br&gt;Authors: Lu X, Jiang Y, Lin X, Zhang Y, Liu Q, Chen S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42120990&quot;&gt;42120990&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/porcine-plasma-derived-extracellular-vesicles-orchestrate-multi-target-neuroimmune#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/porcine-plasma-derived-extracellular-vesicles-orchestrate-multi-target-neuroimmune#comments</comments>
</item>
<item>
 <title>Cell Cycle Dysfunction and Metabolic Alterations Consistent With Pathological Tau in Progressive Supranuclear Palsy Derived Fibroblasts.</title>
 <link>https://www.alzforum.org/papers/cell-cycle-dysfunction-and-metabolic-alterations-consistent-pathological-tau-progressive</link>
 <description>Mol Neurobiol. 2026 May 12;63(1)&lt;br&gt;Authors: De Mori R, Ciaiola F, Nesci V, Gimenez J, de Bardi M, Pieroni L, de Stefano S, Borsellino G, Valle C, Ferri A, Stefani A, Mascioli D, Mancini M, Mercuri NB, Spalloni A, Schirinzi T, Longone P&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42120786&quot;&gt;42120786&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cell-cycle-dysfunction-and-metabolic-alterations-consistent-pathological-tau-progressive#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cell-cycle-dysfunction-and-metabolic-alterations-consistent-pathological-tau-progressive#comments</comments>
</item>
<item>
 <title>Early α-synuclein-mediated mitochondrial dysfunction in a human cell model of Parkinson&#039;s disease dementia.</title>
 <link>https://www.alzforum.org/papers/early-synuclein-mediated-mitochondrial-dysfunction-human-cell-model-parkinsons-disease</link>
 <description>Commun Biol. 2026 May 12; Epub 2026 May 12&lt;br&gt;Authors: Alfaidi MS, Wenger LM, Szebényi K, Stoker TB, He X, Fazal SV, Sebestikova J, Jassim A, Gilbertson RJ, Garza R, Jakobsson J, Spillantini MG, Barker RA, Kuan WL&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42120738&quot;&gt;42120738&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/early-synuclein-mediated-mitochondrial-dysfunction-human-cell-model-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/early-synuclein-mediated-mitochondrial-dysfunction-human-cell-model-parkinsons-disease#comments</comments>
</item>
<item>
 <title>Somatic variants in microglia-like cells linked to Alzheimer&#039;s disease pathology.</title>
 <link>https://www.alzforum.org/papers/somatic-variants-microglia-cells-linked-alzheimers-disease-pathology</link>
 <description>Nat Aging. 2026 May 12; Epub 2026 May 12&lt;br&gt;Authors: Walters H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42120736&quot;&gt;42120736&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/somatic-variants-microglia-cells-linked-alzheimers-disease-pathology#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/somatic-variants-microglia-cells-linked-alzheimers-disease-pathology#comments</comments>
</item>
<item>
 <title>Brain endothelial cell-derived extracellular vesicles (c-BEEVs) as a promising biomarker for brain vascular pathology and cognitive decline.</title>
 <link>https://www.alzforum.org/papers/brain-endothelial-cell-derived-extracellular-vesicles-c-beevs-promising-biomarker-brain</link>
 <description>Nat Aging. 2026 May 12; Epub 2026 May 12&lt;br&gt;Authors: You T, Wang Y, Xu J, Zhao Y, Peng S, Han Q, Wang X, Zhang M, Shen W, Guo M, Zhang J, Yu H, Yu J, Dong Q, Cui M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42120733&quot;&gt;42120733&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/brain-endothelial-cell-derived-extracellular-vesicles-c-beevs-promising-biomarker-brain#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/brain-endothelial-cell-derived-extracellular-vesicles-c-beevs-promising-biomarker-brain#comments</comments>
</item>
<item>
 <title>Associations between REM sleep EEG slowing and brain cholinergic denervation in aging and Mild Cognitive Impairment.</title>
 <link>https://www.alzforum.org/papers/associations-between-rem-sleep-eeg-slowing-and-brain-cholinergic-denervation-aging-and-mild</link>
 <description>Mol Psychiatry. 2026 May 12; Epub 2026 May 12&lt;br&gt;Authors: André C, Bédard MA, Daneault V, Wickens R, Fliaguine O, Soucy JP, Gauthier S, Lorrain D, Bastien C, Hudon C, Marchi NA, Montplaisir J, Gosselin N, Carrier J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42120556&quot;&gt;42120556&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/associations-between-rem-sleep-eeg-slowing-and-brain-cholinergic-denervation-aging-and-mild#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/associations-between-rem-sleep-eeg-slowing-and-brain-cholinergic-denervation-aging-and-mild#comments</comments>
</item>
<item>
 <title>Preformed fibrils of α-synuclein rapidly activate LRRK2 on early endosomes, driving Rab5 phosphorylation and disrupting endolysosomal and synaptic function.</title>
 <link>https://www.alzforum.org/papers/preformed-fibrils-synuclein-rapidly-activate-lrrk2-early-endosomes-driving-rab5</link>
 <description>NPJ Parkinsons Dis. 2026 May 12; Epub 2026 May 12&lt;br&gt;Authors: Zuo X, Chen Z, Chen XQ, Guan D, Shaw PX, Johnstone A, Becker A, Das U, Mobley WC&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42120407&quot;&gt;42120407&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/preformed-fibrils-synuclein-rapidly-activate-lrrk2-early-endosomes-driving-rab5#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/preformed-fibrils-synuclein-rapidly-activate-lrrk2-early-endosomes-driving-rab5#comments</comments>
</item>
<item>
 <title>Gpnmb defines a phagocytic state of microglia linked to cell death in prion disease mouse model.</title>
 <link>https://www.alzforum.org/papers/gpnmb-defines-phagocytic-state-microglia-linked-cell-death-prion-disease-mouse-model</link>
 <description>Nat Commun. 2026 May 12; Epub 2026 May 12&lt;br&gt;Authors: Caredio D, Mariutti G, Polzer L, Gatta B, Cerisoli M, Laimeche Y, Miracca G, Droux J, El Amki M, Emmenegger M, Hruska-Plochan M, Wegener S, Polymenidou M, Schmitz M, Zerr I, De Cecco E, Aguzzi A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42120390&quot;&gt;42120390&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/gpnmb-defines-phagocytic-state-microglia-linked-cell-death-prion-disease-mouse-model#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/gpnmb-defines-phagocytic-state-microglia-linked-cell-death-prion-disease-mouse-model#comments</comments>
</item>
<item>
 <title>Patterns and Trends of Glucose-Lowering Therapy in Alzheimer&#039;s Disease and Related Dementias.</title>
 <link>https://www.alzforum.org/papers/patterns-and-trends-glucose-lowering-therapy-alzheimers-disease-and-related-dementias</link>
 <description>Diabetes Obes Metab. 2026 May 12; Epub 2026 May 12&lt;br&gt;Authors: Tang H, Zhang B, Lu Y, Lu Y, Amaro A, Lu Y, Wolk DA, Chen Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42119996&quot;&gt;42119996&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/patterns-and-trends-glucose-lowering-therapy-alzheimers-disease-and-related-dementias#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/patterns-and-trends-glucose-lowering-therapy-alzheimers-disease-and-related-dementias#comments</comments>
</item>
<item>
 <title>Postnatal particulate matter exposure alters developmental milestones and brain gene expression in apoE transgenic mice in a sex- and genotype-dependent manner.</title>
 <link>https://www.alzforum.org/papers/postnatal-particulate-matter-exposure-alters-developmental-milestones-and-brain-gene</link>
 <description>Neurotoxicology. 2026 May 12;114:103466.  Epub 2026 May 12&lt;br&gt;Authors: Rodulfo-Cárdenas R, Biosca-Brull J, Barberà-Parada S, Gabaldón-Díaz R, Ruiz-Sobremazas D, Blanco J, Cabré M, Domingo JL, López-Granero C, Sanchez-Santed F, Colomina MT&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42119734&quot;&gt;42119734&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/postnatal-particulate-matter-exposure-alters-developmental-milestones-and-brain-gene#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/postnatal-particulate-matter-exposure-alters-developmental-milestones-and-brain-gene#comments</comments>
</item>
<item>
 <title>Age-adjusted neurofilament light chain cutoffs for diagnosing neurodegenerative dementia: a two-threshold machine learning approach.</title>
 <link>https://www.alzforum.org/papers/age-adjusted-neurofilament-light-chain-cutoffs-diagnosing-neurodegenerative-dementia-two</link>
 <description>Geroscience. 2026 May 12; Epub 2026 May 12&lt;br&gt;Authors: Gallingani C, Maramotti R, Carbone C, Vinceti G, Cossutti S, Iacovino N, Ballotta D, Salemme S, Urbano T, Bedin R, Chiari A, Zamboni G, Tondelli M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42118476&quot;&gt;42118476&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/age-adjusted-neurofilament-light-chain-cutoffs-diagnosing-neurodegenerative-dementia-two#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/age-adjusted-neurofilament-light-chain-cutoffs-diagnosing-neurodegenerative-dementia-two#comments</comments>
</item>
<item>
 <title>Elevated levels of circulating plasma sPDGFRβ in cognitively impaired APOE4 carriers.</title>
 <link>https://www.alzforum.org/papers/elevated-levels-circulating-plasma-spdgfrv-cognitively-impaired-apoe4-carriers</link>
 <description>Geroscience. 2026 May 12; Epub 2026 May 12&lt;br&gt;Authors: Sagare AP, Lohman T, Ramirez I, Joe EB, Harrington MG, Chui HC, Schneider LS, Yassine HN, Ringman JM, Toga AW, Nation DA, Zlokovic BV&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42118474&quot;&gt;42118474&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/elevated-levels-circulating-plasma-spdgfrv-cognitively-impaired-apoe4-carriers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/elevated-levels-circulating-plasma-spdgfrv-cognitively-impaired-apoe4-carriers#comments</comments>
</item>
<item>
 <title>STAT6-Mediated SOCS2 Alleviates Cognitive Impairments and Neuronal Damage in Alzheimer&#039;s Disease Rat Models and Aβ1-42-Stimulated HT-22 Cells.</title>
 <link>https://www.alzforum.org/papers/stat6-mediated-socs2-alleviates-cognitive-impairments-and-neuronal-damage-alzheimers-disease</link>
 <description>Mol Neurobiol. 2026 May 12;63(1)&lt;br&gt;Authors: Liu Y, Peng L, Li M, Yan W, Xiang Q&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42118457&quot;&gt;42118457&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/stat6-mediated-socs2-alleviates-cognitive-impairments-and-neuronal-damage-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/stat6-mediated-socs2-alleviates-cognitive-impairments-and-neuronal-damage-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Mechanism of the N87D mutation in SOD1-atypical amyotrophic lateral sclerosis case report and literature review molecular mechanism of N87D mutation in SOD1.</title>
 <link>https://www.alzforum.org/papers/mechanism-n87d-mutation-sod1-atypical-amyotrophic-lateral-sclerosis-case-report-and</link>
 <description>Neurogenetics. 2026 May 12;27(1)&lt;br&gt;Authors: Pi C, Liu Y, Jia Z, Zhang M, Wang X, Zhao H, Dong Z, Yu S, Liu R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42118400&quot;&gt;42118400&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mechanism-n87d-mutation-sod1-atypical-amyotrophic-lateral-sclerosis-case-report-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mechanism-n87d-mutation-sod1-atypical-amyotrophic-lateral-sclerosis-case-report-and#comments</comments>
</item>
<item>
 <title>From Molecular Networks to Medicines: Targeting Complexity in Alzheimer&#039;s Disease (AD) Therapy.</title>
 <link>https://www.alzforum.org/papers/molecular-networks-medicines-targeting-complexity-alzheimers-disease-ad-therapy</link>
 <description>Mol Neurobiol. 2026 May 12;63(1)&lt;br&gt;Authors: Kumar R, Patel S, Mishra PS, Srivastava S, Sridhar SB, Shareef J, Sahu R, Tariq M, Uddin J, Muhsinah AB&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42118396&quot;&gt;42118396&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/molecular-networks-medicines-targeting-complexity-alzheimers-disease-ad-therapy#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/molecular-networks-medicines-targeting-complexity-alzheimers-disease-ad-therapy#comments</comments>
</item>
<item>
 <title>Aspirin as a neuroprotective scaffold in Alzheimer&#039;s disease: inflammation, oxidative stress, and future directions.</title>
 <link>https://www.alzforum.org/papers/aspirin-neuroprotective-scaffold-alzheimers-disease-inflammation-oxidative-stress-and-future</link>
 <description>Mol Biol Rep. 2026 May 12;53(1)&lt;br&gt;Authors: S K, L G, S PP, C K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42118381&quot;&gt;42118381&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/aspirin-neuroprotective-scaffold-alzheimers-disease-inflammation-oxidative-stress-and-future#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/aspirin-neuroprotective-scaffold-alzheimers-disease-inflammation-oxidative-stress-and-future#comments</comments>
</item>
<item>
 <title>Gut Microbiota Dysbiosis and Neuroinflammation in Alzheimer&#039;s Disease: a Systematic Review of Mechanistic Insights.</title>
 <link>https://www.alzforum.org/papers/gut-microbiota-dysbiosis-and-neuroinflammation-alzheimers-disease-systematic-review</link>
 <description>Mol Neurobiol. 2026 May 12;63(1)&lt;br&gt;Authors: Katsigianni S, Koutsouraki E&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42118364&quot;&gt;42118364&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/gut-microbiota-dysbiosis-and-neuroinflammation-alzheimers-disease-systematic-review#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/gut-microbiota-dysbiosis-and-neuroinflammation-alzheimers-disease-systematic-review#comments</comments>
</item>
<item>
 <title>Modeling human neurodegenerative disorders in Drosophila: strategies and translational opportunities.</title>
 <link>https://www.alzforum.org/papers/modeling-human-neurodegenerative-disorders-drosophila-strategies-and-translational</link>
 <description>Mol Biol Rep. 2026 May 12;53(1)&lt;br&gt;Authors: Mohamed SA, Badr OA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42118343&quot;&gt;42118343&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/modeling-human-neurodegenerative-disorders-drosophila-strategies-and-translational#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/modeling-human-neurodegenerative-disorders-drosophila-strategies-and-translational#comments</comments>
</item>
<item>
 <title>Molecular profiling of alpha-synuclein pathology and seeding activity in Parkinson&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/molecular-profiling-alpha-synuclein-pathology-and-seeding-activity-parkinsons-disease</link>
 <description>Acta Neuropathol. 2026 May 12;151(1)&lt;br&gt;Authors: Kaya ZB, Amerna D, Susarla A, Lim MJ, Bregendahl M, Sekiya H, DeTure M, Ross OA, Dickson DW, Boschen SL, McLean PJ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42118167&quot;&gt;42118167&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/molecular-profiling-alpha-synuclein-pathology-and-seeding-activity-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/molecular-profiling-alpha-synuclein-pathology-and-seeding-activity-parkinsons-disease#comments</comments>
</item>
<item>
 <title>Plasma Phosphorylated Tau217-A Pivotal Plasma Biomarker for Predicting the Progression of Mild Cognitive Impairment to Alzheimer&#039;s Disease: A Reanalysis of ADNI Data.</title>
 <link>https://www.alzforum.org/papers/plasma-phosphorylated-tau217-pivotal-plasma-biomarker-predicting-progression-mild-cognitive</link>
 <description>J Clin Exp Neuropsychol. 2026 May 12;:1-17.  Epub 2026 May 12&lt;br&gt;Authors: Lian Q, Sun Q, Han X, Ma H, Guo J, Wen B, Wang P, Li R, Shan A, Cui T, Gong J, Sun W, Wei C, Alzheimer’s Disease Neuroimaging Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42117479&quot;&gt;42117479&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/plasma-phosphorylated-tau217-pivotal-plasma-biomarker-predicting-progression-mild-cognitive#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/plasma-phosphorylated-tau217-pivotal-plasma-biomarker-predicting-progression-mild-cognitive#comments</comments>
</item>
<item>
 <title>White matter lesions disrupt cholinergic pathways important for cognition in Parkinson&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/white-matter-lesions-disrupt-cholinergic-pathways-important-cognition-parkinsons-disease</link>
 <description>Brain. 2026 May 12; Epub 2026 May 12&lt;br&gt;Authors: Carli G, Brown T, Michalakis F, Biddix A, Roytman S, Vangel R, Van Hout A, Kanel P, Scott P, Albin RL, Bohnen NI&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42117428&quot;&gt;42117428&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/white-matter-lesions-disrupt-cholinergic-pathways-important-cognition-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/white-matter-lesions-disrupt-cholinergic-pathways-important-cognition-parkinsons-disease#comments</comments>
</item>
<item>
 <title>Mechanism of Aggregation of the NACore of α-Synuclein: Stable Oligomer Formation Competes with Fibril Formation with Implications for the Etiology of Parkinson&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/mechanism-aggregation-nacore-synuclein-stable-oligomer-formation-competes-fibril-formation</link>
 <description>J Am Chem Soc. 2026 May 12; Epub 2026 May 12&lt;br&gt;Authors: Jin Y, Ganguly P, Wessel L, Zhu Z, Rijs AM, Shea JE, Buratto SK, Bowers MT&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42117267&quot;&gt;42117267&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mechanism-aggregation-nacore-synuclein-stable-oligomer-formation-competes-fibril-formation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mechanism-aggregation-nacore-synuclein-stable-oligomer-formation-competes-fibril-formation#comments</comments>
</item>
<item>
 <title>[Effect of medicated-thread moxibustion of Zhuang medicine on amnestic mild cognitive impairment with sleep disorder and its influence on event-related potential P300].</title>
 <link>https://www.alzforum.org/papers/effect-medicated-thread-moxibustion-zhuang-medicine-amnestic-mild-cognitive-impairment-sleep</link>
 <description>Zhongguo Zhen Jiu. 2026 May 12;46(5):704-712.  Epub 2026 Feb 26&lt;br&gt;Authors: Zhao L, Huang N, Zhou Y, Zhou L, Huang D, Huang X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42116773&quot;&gt;42116773&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/effect-medicated-thread-moxibustion-zhuang-medicine-amnestic-mild-cognitive-impairment-sleep#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/effect-medicated-thread-moxibustion-zhuang-medicine-amnestic-mild-cognitive-impairment-sleep#comments</comments>
</item>
<item>
 <title>A novel nasal mucosal peptide-modified co-delivery system for ginsenoside Rg1, Rb1, and notoginseng saponin R1 in the amelioration of AD.</title>
 <link>https://www.alzforum.org/papers/novel-nasal-mucosal-peptide-modified-co-delivery-system-ginsenoside-rg1-rb1-and-notoginseng</link>
 <description>J Nanobiotechnology. 2026 May 12; Epub 2026 May 12&lt;br&gt;Authors: Li Y, Hu C, Xia C, Wang X, Zhou X, Xu R, Li Y, Mo F, Zhao B, Xu L, Zhu C, Chen Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42116113&quot;&gt;42116113&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/novel-nasal-mucosal-peptide-modified-co-delivery-system-ginsenoside-rg1-rb1-and-notoginseng#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/novel-nasal-mucosal-peptide-modified-co-delivery-system-ginsenoside-rg1-rb1-and-notoginseng#comments</comments>
</item>
<item>
 <title>Differential cholinergic white matter microstructural alterations in multiple system atrophy and Parkinson&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/differential-cholinergic-white-matter-microstructural-alterations-multiple-system-atrophy-and</link>
 <description>Neurobiol Dis. 2026 May 12;:107449.  Epub 2026 May 12&lt;br&gt;Authors: Rong S, Yang R, Li Z, Cui X, He C, Zhang P, Li Y, Luo Q, Gao Z, Du T, Zhang Y, Cai R, Liu Z, Vyslouzilova L, Teipel SJ, Ferreira D, Nemy M, Li H, Wang L, Cai M, Zhang Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42128307&quot;&gt;42128307&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/differential-cholinergic-white-matter-microstructural-alterations-multiple-system-atrophy-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/differential-cholinergic-white-matter-microstructural-alterations-multiple-system-atrophy-and#comments</comments>
</item>
<item>
 <title>Glycocalyx and Basal Lamina in Neurological Disorders.</title>
 <link>https://www.alzforum.org/papers/glycocalyx-and-basal-lamina-neurological-disorders</link>
 <description>Matrix Biol. 2026 May 12;:102015.  Epub 2026 May 12&lt;br&gt;Authors: Nasrollahi A, Yurchenco PD, Yao Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42128066&quot;&gt;42128066&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/glycocalyx-and-basal-lamina-neurological-disorders#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/glycocalyx-and-basal-lamina-neurological-disorders#comments</comments>
</item>
<item>
 <title>Secreted GPNMB enhances uptake of fibrillar alpha-synuclein in a non-cell-autonomous process that can be blocked by anti-GPNMB antibodies.</title>
 <link>https://www.alzforum.org/papers/secreted-gpnmb-enhances-uptake-fibrillar-alpha-synuclein-non-cell-autonomous-process-can-be-0</link>
 <description>Neuron. 2026 May 12; Epub 2026 May 12&lt;br&gt;Authors: Carceles-Cordon M, Brody EM, Boucher ML, Gallagher MD, Skrinak RT, Unger TL, Penner CK, Berndt AJ, Das S, Lam K, Jaenisch R, Van Deerlin V, Lee EB, Brunden K, Luk KC, Chen-Plotkin AS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42127911&quot;&gt;42127911&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/secreted-gpnmb-enhances-uptake-fibrillar-alpha-synuclein-non-cell-autonomous-process-can-be-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/secreted-gpnmb-enhances-uptake-fibrillar-alpha-synuclein-non-cell-autonomous-process-can-be-0#comments</comments>
</item>
<item>
 <title>High-throughput screening approach identifies substrate-selective Hsp104 variants that counter amyloid seeding with diminished off-target effects.</title>
 <link>https://www.alzforum.org/papers/high-throughput-screening-approach-identifies-substrate-selective-hsp104-variants-counter</link>
 <description>Mol Cell. 2026 May 12; Epub 2026 May 12&lt;br&gt;Authors: Ryan JJ, Miller KR, Puri A, Sprunger ML, Bochantine MM, Lopez A, Chen S, Bao A, Ling C, Xu A, Bell B, Sohn BS, Li L, Chang C, Mohammed K, Staller MV, Jackrel ME&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42127909&quot;&gt;42127909&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/high-throughput-screening-approach-identifies-substrate-selective-hsp104-variants-counter#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/high-throughput-screening-approach-identifies-substrate-selective-hsp104-variants-counter#comments</comments>
</item>
<item>
 <title>S-acylation of TDP43 regulates its condensation in amyotrophic lateral sclerosis.</title>
 <link>https://www.alzforum.org/papers/s-acylation-tdp43-regulates-its-condensation-amyotrophic-lateral-sclerosis</link>
 <description>Mol Cell. 2026 May 12; Epub 2026 May 12&lt;br&gt;Authors: Xu W, Li H, Zhang W, Bai G, Shen C, Zhang K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42127907&quot;&gt;42127907&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/s-acylation-tdp43-regulates-its-condensation-amyotrophic-lateral-sclerosis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/s-acylation-tdp43-regulates-its-condensation-amyotrophic-lateral-sclerosis#comments</comments>
</item>
<item>
 <title>Integrating molecular representations for machine learning-based virtual screening of Glutaminyl Cyclase inhibitors.</title>
 <link>https://www.alzforum.org/papers/integrating-molecular-representations-machine-learning-based-virtual-screening-glutaminyl</link>
 <description>J Mol Graph Model. 2026 May 12;146:109441.  Epub 2026 May 12&lt;br&gt;Authors: Ha HM, Tung HT, Anh NV, Cong NT, Hang NT, Phuong NV&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42127661&quot;&gt;42127661&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/integrating-molecular-representations-machine-learning-based-virtual-screening-glutaminyl#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/integrating-molecular-representations-machine-learning-based-virtual-screening-glutaminyl#comments</comments>
</item>
<item>
 <title>AI for Relational Reconnection and Social Support in Alzheimer&#039;s Disease: A Conceptual Framework for Socially Embedded Systems.</title>
 <link>https://www.alzforum.org/papers/ai-relational-reconnection-and-social-support-alzheimers-disease-conceptual-framework</link>
 <description>Gerontologist. 2026 May 12; Epub 2026 May 12&lt;br&gt;Authors: Zhang C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42121397&quot;&gt;42121397&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/ai-relational-reconnection-and-social-support-alzheimers-disease-conceptual-framework#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/ai-relational-reconnection-and-social-support-alzheimers-disease-conceptual-framework#comments</comments>
</item>
<item>
 <title>Neuroprotective effects of quercetin in animal models of neurodegenerative diseases: A systematic review and meta-analysis.</title>
 <link>https://www.alzforum.org/papers/neuroprotective-effects-quercetin-animal-models-neurodegenerative-diseases-systematic-review</link>
 <description>J Sci Food Agric. 2026 May 12; Epub 2026 May 12&lt;br&gt;Authors: Cho IH, Putra HM, Jung CW, Hyun GH, Jang HH, Hwang IG, Kwon SW&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42121268&quot;&gt;42121268&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/neuroprotective-effects-quercetin-animal-models-neurodegenerative-diseases-systematic-review#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/neuroprotective-effects-quercetin-animal-models-neurodegenerative-diseases-systematic-review#comments</comments>
</item>
<item>
 <title>Comparative performance of semi-quantitative methods for amyloid deposition in preclinical autosomal dominant Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/comparative-performance-semi-quantitative-methods-amyloid-deposition-preclinical-autosomal</link>
 <description>Alzheimers Res Ther. 2026 May 12; Epub 2026 May 12&lt;br&gt;Authors: Zhou Z, Gao J, Wang Q, Wang Q, Liu L, Zhang X, Li C, Liu J, Wei Y, Zhang S, Wang R, Jia J, Fu L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42121220&quot;&gt;42121220&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/comparative-performance-semi-quantitative-methods-amyloid-deposition-preclinical-autosomal#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/comparative-performance-semi-quantitative-methods-amyloid-deposition-preclinical-autosomal#comments</comments>
</item>
<item>
 <title>Blood biomarkers of Alzheimer&#039;s disease and 15-year decline in cognitive and motor functions in older adults.</title>
 <link>https://www.alzforum.org/papers/blood-biomarkers-alzheimers-disease-and-15-year-decline-cognitive-and-motor-functions-older</link>
 <description>J Intern Med. 2026 May 12; Epub 2026 May 12&lt;br&gt;Authors: Pinardi E, Grande G, Ornago AM, Valletta M, Rizzuto D, Fredolini C, Dale M, Laukka EJ, Mecocci P, Winblad B, Fratiglioni L, Bellelli G, Vetrano DL&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42121219&quot;&gt;42121219&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/blood-biomarkers-alzheimers-disease-and-15-year-decline-cognitive-and-motor-functions-older#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/blood-biomarkers-alzheimers-disease-and-15-year-decline-cognitive-and-motor-functions-older#comments</comments>
</item>
<item>
 <title>Calbindin-D28k deficiency mediates tau-driven hippocampal hyperexcitement and cognitive impairment.</title>
 <link>https://www.alzforum.org/papers/calbindin-d28k-deficiency-mediates-tau-driven-hippocampal-hyperexcitement-and-cognitive</link>
 <description>Transl Neurodegener. 2026 May 12;15(1)&lt;br&gt;Authors: Gao Y, Tao X, Wang Y, Wang Y, Li H, Yu Y, Tu M, Liu Y, Zhou J, Li Y, Wei W, Wang X, Zheng J, Zhang Y, Xu H, Wang JZ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42121190&quot;&gt;42121190&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/calbindin-d28k-deficiency-mediates-tau-driven-hippocampal-hyperexcitement-and-cognitive#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/calbindin-d28k-deficiency-mediates-tau-driven-hippocampal-hyperexcitement-and-cognitive#comments</comments>
</item>
<item>
 <title>Residential green spaces and neurodegenerative diseases in middle-aged and older adults: a systematic review and dose-response meta-analysis.</title>
 <link>https://www.alzforum.org/papers/residential-green-spaces-and-neurodegenerative-diseases-middle-aged-and-older-adults</link>
 <description>Arch Public Health. 2026 May 12; Epub 2026 May 12&lt;br&gt;Authors: Shen C, Su J, Liu L, Li J, Zhao X, Wang Z, Jiang Y, Zhao D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42121182&quot;&gt;42121182&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/residential-green-spaces-and-neurodegenerative-diseases-middle-aged-and-older-adults#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/residential-green-spaces-and-neurodegenerative-diseases-middle-aged-and-older-adults#comments</comments>
</item>
<item>
 <title>A deep hybrid CNN-BiLSTM-BiGRU architecture with explainability for mild cognitive impairment detection using EEG.</title>
 <link>https://www.alzforum.org/papers/deep-hybrid-cnn-bilstm-bigru-architecture-explainability-mild-cognitive-impairment-detection</link>
 <description>Brain Inform. 2026 May 11; Epub 2026 May 11&lt;br&gt;Authors: Tokdar A, Agarwal L, Chatterjee S, Sukriti&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42108320&quot;&gt;42108320&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/deep-hybrid-cnn-bilstm-bigru-architecture-explainability-mild-cognitive-impairment-detection#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/deep-hybrid-cnn-bilstm-bigru-architecture-explainability-mild-cognitive-impairment-detection#comments</comments>
</item>
<item>
 <title>iS2C2: a cointelligent platform for mechanistic discovery of disease cellular crosstalk.</title>
 <link>https://www.alzforum.org/papers/is2c2-cointelligent-platform-mechanistic-discovery-disease-cellular-crosstalk</link>
 <description>Signal Transduct Target Ther. 2026 May 11;11(1)&lt;br&gt;Authors: Sheng J, Ahn JY, Yang L, Wan Z, Qi S, Yu X, Xu Z, Cao Y, Vasquez M, Irfan A, Zhu Y, Zhao H, Yin Z, Zhu Y, Ding Y, Faridar A, Wang L, Liu F, Wang H, Ji Z, Mao D, Chan M, Kermany D, Dong W, Kim DY, Zhang XH, Wong ST&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42108258&quot;&gt;42108258&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/is2c2-cointelligent-platform-mechanistic-discovery-disease-cellular-crosstalk#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/is2c2-cointelligent-platform-mechanistic-discovery-disease-cellular-crosstalk#comments</comments>
</item>
<item>
 <title>Beyond association: A quantitative analysis of the infectious burden in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/beyond-association-quantitative-analysis-infectious-burden-alzheimers-disease</link>
 <description>J Alzheimers Dis. 2026 May 11;:13872877261447530.  Epub 2026 May 11&lt;br&gt;Authors: Bender O, Shemesh OA, Bar DZ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42115784&quot;&gt;42115784&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/beyond-association-quantitative-analysis-infectious-burden-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/beyond-association-quantitative-analysis-infectious-burden-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Resolving protein condensates and aggregates in vivo by boxcar-enhanced Fluorescence-detected mid-Infrared photothermaL Microscopy (FILM).</title>
 <link>https://www.alzforum.org/papers/resolving-protein-condensates-and-aggregates-vivo-boxcar-enhanced-fluorescence-detected-mid</link>
 <description>Commun Chem. 2026 May 11; Epub 2026 May 11&lt;br&gt;Authors: Weinberg B, Guo Z, Tang R, Ao J, Yin J, Ding G, Blute TA, Savini M, Chiesa G, Wang W, Good M, Wang MC, Cheng JX&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42115735&quot;&gt;42115735&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/resolving-protein-condensates-and-aggregates-vivo-boxcar-enhanced-fluorescence-detected-mid#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/resolving-protein-condensates-and-aggregates-vivo-boxcar-enhanced-fluorescence-detected-mid#comments</comments>
</item>
<item>
 <title>Shared and distinct lipid profiles in amygdala from sporadic and GBA-associated Parkinson&#039;s diseases.</title>
 <link>https://www.alzforum.org/papers/shared-and-distinct-lipid-profiles-amygdala-sporadic-and-gba-associated-parkinsons-diseases</link>
 <description>NPJ Parkinsons Dis. 2026 May 11; Epub 2026 May 11&lt;br&gt;Authors: Muñoz SS, Marlet FR, Dreier JE, Bilgin M, Schott K, Neergaard KB, Bezard E, Dehay B, Jaunmuktane Z, Maeda K, Galvagnion C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42115606&quot;&gt;42115606&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/shared-and-distinct-lipid-profiles-amygdala-sporadic-and-gba-associated-parkinsons-diseases#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/shared-and-distinct-lipid-profiles-amygdala-sporadic-and-gba-associated-parkinsons-diseases#comments</comments>
</item>
<item>
 <title>CPNE1 modulates Parkinson&#039;s disease risk through peripheral immune cell function: a cross-tissue and single-cell causal inference study.</title>
 <link>https://www.alzforum.org/papers/cpne1-modulates-parkinsons-disease-risk-through-peripheral-immune-cell-function-cross-tissue</link>
 <description>Mamm Genome. 2026 May 11;37(1)&lt;br&gt;Authors: Zhao J, Fu J, Zhang J, Zhang Z, Bai X, Yao L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42115417&quot;&gt;42115417&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cpne1-modulates-parkinsons-disease-risk-through-peripheral-immune-cell-function-cross-tissue#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cpne1-modulates-parkinsons-disease-risk-through-peripheral-immune-cell-function-cross-tissue#comments</comments>
</item>
<item>
 <title>Cognitive and behavioral disturbances in PSP and MSA: clinical features and imaging correlates.</title>
 <link>https://www.alzforum.org/papers/cognitive-and-behavioral-disturbances-psp-and-msa-clinical-features-and-imaging-correlates</link>
 <description>J Neural Transm (Vienna). 2026 May 11; Epub 2026 May 11&lt;br&gt;Authors: Ruiz-Barrio I, Horta-Barba A, Martinez-Horta S, Kulisevsky J, Pagonabarraga J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42115350&quot;&gt;42115350&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cognitive-and-behavioral-disturbances-psp-and-msa-clinical-features-and-imaging-correlates#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cognitive-and-behavioral-disturbances-psp-and-msa-clinical-features-and-imaging-correlates#comments</comments>
</item>
<item>
 <title>AI-powered evaluation of dementia severity based on clinical data and visual scoring systems (MTA, ERICA, GCA) from MRI.</title>
 <link>https://www.alzforum.org/papers/ai-powered-evaluation-dementia-severity-based-clinical-data-and-visual-scoring-systems-mta</link>
 <description>Sci Rep. 2026 May 11; Epub 2026 May 11&lt;br&gt;Authors: Naing LT, Kunapinun A, Dailey MN, Patanasantichai R, Buathong S, Keatmanee C, Wongsripuemtet J, Rattanabannakit C, Senanarong V, Ekpanyapong M, Songsaeng D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42115238&quot;&gt;42115238&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/ai-powered-evaluation-dementia-severity-based-clinical-data-and-visual-scoring-systems-mta#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/ai-powered-evaluation-dementia-severity-based-clinical-data-and-visual-scoring-systems-mta#comments</comments>
</item>
<item>
 <title>Application of resting-state EEG theta /alpha power ratio analysis for diagnosing amnestic mild cognitive impairment.</title>
 <link>https://www.alzforum.org/papers/application-resting-state-eeg-theta-alpha-power-ratio-analysis-diagnosing-amnestic-mild</link>
 <description>Sci Rep. 2026 May 11; Epub 2026 May 11&lt;br&gt;Authors: Liang Y, Li P, Wang Y, Jing F, Dong C, Zhao L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42115191&quot;&gt;42115191&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/application-resting-state-eeg-theta-alpha-power-ratio-analysis-diagnosing-amnestic-mild#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/application-resting-state-eeg-theta-alpha-power-ratio-analysis-diagnosing-amnestic-mild#comments</comments>
</item>
<item>
 <title>Aggregation in gut: on the link between neurodegeneration and bacterial functional amyloids.</title>
 <link>https://www.alzforum.org/papers/aggregation-gut-link-between-neurodegeneration-and-bacterial-functional-amyloids</link>
 <description>NPJ Biofilms Microbiomes. 2026 May 11; Epub 2026 May 11&lt;br&gt;Authors: Wojciechowska AW, Wojciechowski JW, Zielinska K, Soeding J, Kosciolek T, Kotulska M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42115189&quot;&gt;42115189&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/aggregation-gut-link-between-neurodegeneration-and-bacterial-functional-amyloids#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/aggregation-gut-link-between-neurodegeneration-and-bacterial-functional-amyloids#comments</comments>
</item>
<item>
 <title>Nanoparticle-enriched mass spectrometry enables comprehensive plasma proteomics and reveals novel candidates for mild cognitive impairment.</title>
 <link>https://www.alzforum.org/papers/nanoparticle-enriched-mass-spectrometry-enables-comprehensive-plasma-proteomics-and-reveals</link>
 <description>Sci Rep. 2026 May 11; Epub 2026 May 11&lt;br&gt;Authors: Kim JH, Kwon OK, Jang WC, Jeong HK, Lee KJ, Oh C, Lee KM, Choi KH, Han X, Lee SJ, Lee SB&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42115184&quot;&gt;42115184&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/nanoparticle-enriched-mass-spectrometry-enables-comprehensive-plasma-proteomics-and-reveals#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/nanoparticle-enriched-mass-spectrometry-enables-comprehensive-plasma-proteomics-and-reveals#comments</comments>
</item>
<item>
 <title>Comparative effectiveness of recreational therapies on cognition, neuropsychiatric symptoms, and psychosocial outcomes in individuals with mild cognitive impairment and dementia: A network meta-analysis.</title>
 <link>https://www.alzforum.org/papers/comparative-effectiveness-recreational-therapies-cognition-neuropsychiatric-symptoms-and</link>
 <description>Int J Nurs Stud. 2026 May 11;180:105553.  Epub 2026 May 11&lt;br&gt;Authors: Aini N, Su PY, Sung CM, Chen R, Chiang KJ, Chang LF, Maharani PA, Martini NM, Arifin H, Chou KR&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42114453&quot;&gt;42114453&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/comparative-effectiveness-recreational-therapies-cognition-neuropsychiatric-symptoms-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/comparative-effectiveness-recreational-therapies-cognition-neuropsychiatric-symptoms-and#comments</comments>
</item>
<item>
 <title>Mechanisms and Therapeutic Targeting of the Gut Microbiota-Immune-Brain Axis in Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/mechanisms-and-therapeutic-targeting-gut-microbiota-immune-brain-axis-alzheimers-disease</link>
 <description>Immunol Invest. 2026 May 11;:1-31.  Epub 2026 May 11&lt;br&gt;Authors: Wang S, Yuan X, Wang T, Yang M, Dong P, Han H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42113681&quot;&gt;42113681&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mechanisms-and-therapeutic-targeting-gut-microbiota-immune-brain-axis-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mechanisms-and-therapeutic-targeting-gut-microbiota-immune-brain-axis-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Incidence and Prevalence of Dementia With Lewy Bodies: A Systematic Review and Meta-Analysis.</title>
 <link>https://www.alzforum.org/papers/incidence-and-prevalence-dementia-lewy-bodies-systematic-review-and-meta-analysis</link>
 <description>JAMA Neurol. 2026 May 11; Epub 2026 May 11&lt;br&gt;Authors: Urso D, Giannoni-Luza S, Giannelli T, Brayne C, Ray N, Logroscino G&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42113545&quot;&gt;42113545&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/incidence-and-prevalence-dementia-lewy-bodies-systematic-review-and-meta-analysis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/incidence-and-prevalence-dementia-lewy-bodies-systematic-review-and-meta-analysis#comments</comments>
</item>
<item>
 <title>Genetic Testing by Age at Onset in Parkinson Disease.</title>
 <link>https://www.alzforum.org/papers/genetic-testing-age-onset-parkinson-disease</link>
 <description>JAMA Neurol. 2026 May 11; Epub 2026 May 11&lt;br&gt;Authors: Balck A, Vollstedt EJ, Westenberger A, Lange LM, Trinh J, Kasten M, Lohmann K, Brüggemann N, Trenkwalder C, Mollenhauer B, Alcalay R, Galvelis KG, Beck JC, Bauer P, Klein C, König IR, Global Parkinson’s Genetics Program (GP2), the ROPAD Study Group, and the PDGENEration Study&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42113543&quot;&gt;42113543&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/genetic-testing-age-onset-parkinson-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/genetic-testing-age-onset-parkinson-disease#comments</comments>
</item>
<item>
 <title>Exploratory serum biomarker profiling in idiopathic REM sleep behavior disorder: evidence of early neurodegenerative signatures: a pilot study.</title>
 <link>https://www.alzforum.org/papers/exploratory-serum-biomarker-profiling-idiopathic-rem-sleep-behavior-disorder-evidence-early</link>
 <description>Sleep Breath. 2026 May 11;30(3)&lt;br&gt;Authors: Torres DM, Pereira FH, da Silva Viana M, Ramos MM, Cunha EG, de Araújo Melo LJ, Sobreira ES, Lopes FC, Frota AF, Soares MV, de-Almeida RT, Braga-Neto P, Macedo DS, Sobreira-Neto MA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42113395&quot;&gt;42113395&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/exploratory-serum-biomarker-profiling-idiopathic-rem-sleep-behavior-disorder-evidence-early#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/exploratory-serum-biomarker-profiling-idiopathic-rem-sleep-behavior-disorder-evidence-early#comments</comments>
</item>
<item>
 <title>A53T α-Synuclein Expression is Associated with Altered Dopaminergic-Like Differentiation and Reduced DNA Topoisomerase IIβ Levels in an In Vitro Model of Parkinson&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/a53t-synuclein-expression-associated-altered-dopaminergic-differentiation-and-reduced-dna</link>
 <description>Mol Neurobiol. 2026 May 11;63(1)&lt;br&gt;Authors: Selim A, Avşar T, Neğiş Y, Işık S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42113340&quot;&gt;42113340&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/a53t-synuclein-expression-associated-altered-dopaminergic-differentiation-and-reduced-dna#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/a53t-synuclein-expression-associated-altered-dopaminergic-differentiation-and-reduced-dna#comments</comments>
</item>
<item>
 <title>Spastic paraparesis linked to a rare presenilin-1 mutation.</title>
 <link>https://www.alzforum.org/papers/spastic-paraparesis-linked-rare-presenilin-1-mutation</link>
 <description>Neurogenetics. 2026 May 11;27(1)&lt;br&gt;Authors: Teles C, Durães J, Faustino P, Baldeiras I, Gens H, Pereira MT, Almeida MR, Santana I&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42113316&quot;&gt;42113316&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/spastic-paraparesis-linked-rare-presenilin-1-mutation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/spastic-paraparesis-linked-rare-presenilin-1-mutation#comments</comments>
</item>
<item>
 <title>Exosomes in Amyloid Propagation-Roles in Neurodegeneration.</title>
 <link>https://www.alzforum.org/papers/exosomes-amyloid-propagation-roles-neurodegeneration</link>
 <description>Mol Neurobiol. 2026 May 11;63(1)&lt;br&gt;Authors: Mishra R, Upadhyay A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42113315&quot;&gt;42113315&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/exosomes-amyloid-propagation-roles-neurodegeneration#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/exosomes-amyloid-propagation-roles-neurodegeneration#comments</comments>
</item>
<item>
 <title>Subjective and objective cognition in early-stage, treatment-naïve Parkinson&#039;s disease: Relationships with mood.</title>
 <link>https://www.alzforum.org/papers/subjective-and-objective-cognition-early-stage-treatment-naive-parkinsons-disease</link>
 <description>Neuropsychology. 2026 May 11; Epub 2026 May 11&lt;br&gt;Authors: Varela JL, Margolis SA, Akbar U, Prieto S, Kenney LE, Daiello LA, Davis JD&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42113176&quot;&gt;42113176&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/subjective-and-objective-cognition-early-stage-treatment-naive-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/subjective-and-objective-cognition-early-stage-treatment-naive-parkinsons-disease#comments</comments>
</item>
<item>
 <title>Fecal miRNome and Proteome Profiling Uncovers Stage-Specific Biomarkers of Alzheimer&#039;s Disease in 3×Tg-AD Mice.</title>
 <link>https://www.alzforum.org/papers/fecal-mirnome-and-proteome-profiling-uncovers-stage-specific-biomarkers-alzheimers-disease</link>
 <description>Cell Mol Neurobiol. 2026 May 11; Epub 2026 May 11&lt;br&gt;Authors: Vitali R, Tanno B, Casciati A, Palone F, Pieroni L, Morotti M, Santoro M, Fratini E, Pazzaglia S, Podda MV, Mancuso M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42113045&quot;&gt;42113045&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/fecal-mirnome-and-proteome-profiling-uncovers-stage-specific-biomarkers-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/fecal-mirnome-and-proteome-profiling-uncovers-stage-specific-biomarkers-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Perspectives in dementia risk reduction - food for thought.</title>
 <link>https://www.alzforum.org/papers/perspectives-dementia-risk-reduction-food-thought</link>
 <description>Neurodegener Dis Manag. 2026 May 11;:1-12.  Epub 2026 May 11&lt;br&gt;Authors: Rasmussen J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42112907&quot;&gt;42112907&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/perspectives-dementia-risk-reduction-food-thought#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/perspectives-dementia-risk-reduction-food-thought#comments</comments>
</item>
<item>
 <title>Development and Evaluation of Intranasal Nanostructured Lipid Carriers Encapsulating Donepezil HCl and Caesalpinia bonduc Seed Extract for Targeting Alzheimer&#039;s Disease: in vitro and in vivo evaluation.</title>
 <link>https://www.alzforum.org/papers/development-and-evaluation-intranasal-nanostructured-lipid-carriers-encapsulating-donepezil</link>
 <description>J Drug Target. 2026 May 11;:1-26.  Epub 2026 May 11&lt;br&gt;Authors: Tekade A, Shinde R, Nimbalkar J, Kadam P, Aswar M, H N S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42112871&quot;&gt;42112871&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/development-and-evaluation-intranasal-nanostructured-lipid-carriers-encapsulating-donepezil#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/development-and-evaluation-intranasal-nanostructured-lipid-carriers-encapsulating-donepezil#comments</comments>
</item>
<item>
 <title>Alzheimer&#039;s Disease Co-Pathology and Cognitive Impairment in Amyotrophic Lateral Sclerosis.</title>
 <link>https://www.alzforum.org/papers/alzheimers-disease-co-pathology-and-cognitive-impairment-amyotrophic-lateral-sclerosis</link>
 <description>Ann Neurol. 2026 May 11; Epub 2026 May 11&lt;br&gt;Authors: Kasper E, Lehto A, Jürs A, Nordmann N, Peters O, Hellmann J, Priller J, Spruth EJ, Petzold GC, Voigt I, Weydt P, Bernsen S, Dinter E, Falkenburger B, Günther R, Düzel E, Glanz W, Synofzik M, Beichert L, Spottke A, Wagner M, Brosseron F, Schmid MC, Halle A, Herms J, Schneider A, Teipel S, Prudlo J, Neumann M, Hermann A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42112660&quot;&gt;42112660&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/alzheimers-disease-co-pathology-and-cognitive-impairment-amyotrophic-lateral-sclerosis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/alzheimers-disease-co-pathology-and-cognitive-impairment-amyotrophic-lateral-sclerosis#comments</comments>
</item>
<item>
 <title>Latinos&#039; appraisals of and responses to memory problems.</title>
 <link>https://www.alzforum.org/papers/latinos-appraisals-and-responses-memory-problems</link>
 <description>J Health Psychol. 2026 May 11;:13591053261442545.  Epub 2026 May 11&lt;br&gt;Authors: Siegel K, Cabán M, Wetmore JB, Ottman R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42109151&quot;&gt;42109151&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/latinos-appraisals-and-responses-memory-problems#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/latinos-appraisals-and-responses-memory-problems#comments</comments>
</item>
<item>
 <title>The interplay of APOE genotype, plasma levels, and cognitive functions in middle-aged adults with a parental history of Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/interplay-apoe-genotype-plasma-levels-and-cognitive-functions-middle-aged-adults-parental</link>
 <description>World J Biol Psychiatry. 2026 May 11;:1-14.  Epub 2026 May 11&lt;br&gt;Authors: Mattar YA, Refaat O, El-Makawi S, Medhat E, Khalifa D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42109080&quot;&gt;42109080&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/interplay-apoe-genotype-plasma-levels-and-cognitive-functions-middle-aged-adults-parental#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/interplay-apoe-genotype-plasma-levels-and-cognitive-functions-middle-aged-adults-parental#comments</comments>
</item>
<item>
 <title>Influence of local spontaneous activity and hippocampal volume on the relationship between APOE genotype, ATN biomarkers, and cognitive function across the Alzheimer&#039;s disease spectrum.</title>
 <link>https://www.alzforum.org/papers/influence-local-spontaneous-activity-and-hippocampal-volume-relationship-between-apoe</link>
 <description>Chin Med J (Engl). 2026 May 11; Epub 2026 May 11&lt;br&gt;Authors: Zhu Y, Wang A, Wu Y, Yang L, Duan Y, Zhao Y, Zhao X, Hu W, Qun S, Alzheimer’s disease Neuroimaging Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42108496&quot;&gt;42108496&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/influence-local-spontaneous-activity-and-hippocampal-volume-relationship-between-apoe#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/influence-local-spontaneous-activity-and-hippocampal-volume-relationship-between-apoe#comments</comments>
</item>
<item>
 <title>Neuroinvasion Pathways of Treponema denticola and Its Role in Amyloidogenesis and Neuroinflammation: A Systematic Review.</title>
 <link>https://www.alzforum.org/papers/neuroinvasion-pathways-treponema-denticola-and-its-role-amyloidogenesis-and-neuroinflammation</link>
 <description>Microb Pathog. 2026 May 11;:108554.  Epub 2026 May 11&lt;br&gt;Authors: Semnani PM, Afiyat S, Tabibian SS, Ariaee A, Keshtehgar H, Ahmadi S, Eslami M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42119956&quot;&gt;42119956&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/neuroinvasion-pathways-treponema-denticola-and-its-role-amyloidogenesis-and-neuroinflammation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/neuroinvasion-pathways-treponema-denticola-and-its-role-amyloidogenesis-and-neuroinflammation#comments</comments>
</item>
<item>
 <title>Plasma p-Tau217 and Aβ42/40 for Identifying Amyloid PET Positivity in Cognitively Unimpaired Asian Individuals: A Systematic Review and Meta-Analysis.</title>
 <link>https://www.alzforum.org/papers/plasma-p-tau217-and-av4240-identifying-amyloid-pet-positivity-cognitively-unimpaired-asian</link>
 <description>Ageing Res Rev. 2026 May 11;:103173.  Epub 2026 May 11&lt;br&gt;Authors: Terao I, Kodama W&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42119901&quot;&gt;42119901&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/plasma-p-tau217-and-av4240-identifying-amyloid-pet-positivity-cognitively-unimpaired-asian#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/plasma-p-tau217-and-av4240-identifying-amyloid-pet-positivity-cognitively-unimpaired-asian#comments</comments>
</item>
<item>
 <title>Ameliorative effect of AYUSH formulation against scopolamine induced learning and memory impairment in rat via attenuation of oxidative stress, neuroinflammation, acetylcholinesterase inhibition and Aβ plaques.</title>
 <link>https://www.alzforum.org/papers/ameliorative-effect-ayush-formulation-against-scopolamine-induced-learning-and-memory</link>
 <description>J Ethnopharmacol. 2026 May 11;:121853.  Epub 2026 May 11&lt;br&gt;Authors: Samal M, Zahiruddin S, Srivastava V, Penumallu NR, Parveen B, Parveen R, Ansari SH, Ahmad S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42119864&quot;&gt;42119864&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/ameliorative-effect-ayush-formulation-against-scopolamine-induced-learning-and-memory#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/ameliorative-effect-ayush-formulation-against-scopolamine-induced-learning-and-memory#comments</comments>
</item>
<item>
 <title>Immune receptor LAG3 regulates microglia function during Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/immune-receptor-lag3-regulates-microglia-function-during-alzheimers-disease</link>
 <description>Neurobiol Dis. 2026 May 11;:107447.  Epub 2026 May 11&lt;br&gt;Authors: Perl AT, Wu J, Dong JD, Brooks AM, Yoblinski AR, Vierling TT, Li JL, Ruby DR, Radzicki D, Dudek SM, Cushman JD, Gjoneska E&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42119858&quot;&gt;42119858&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/immune-receptor-lag3-regulates-microglia-function-during-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/immune-receptor-lag3-regulates-microglia-function-during-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Offset Conduction Velocity Reveals Prognostic Slowing of Motor Axons in Amyotrophic Lateral Sclerosis.</title>
 <link>https://www.alzforum.org/papers/offset-conduction-velocity-reveals-prognostic-slowing-motor-axons-amyotrophic-lateral</link>
 <description>Muscle Nerve. 2026 May 11; Epub 2026 May 11&lt;br&gt;Authors: Shimizu T, Myojin H, Bokuda K, Kawazoe T, Morishima R, Kimura H, Takahashi K, Nakayama Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42116669&quot;&gt;42116669&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/offset-conduction-velocity-reveals-prognostic-slowing-motor-axons-amyotrophic-lateral#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/offset-conduction-velocity-reveals-prognostic-slowing-motor-axons-amyotrophic-lateral#comments</comments>
</item>
<item>
 <title>Rituximab Beyond Oncology: Targeting B-Cell-Mediated Immunomodulatory Therapy in Neurodegenerative and Neuropsychiatric Disorders.</title>
 <link>https://www.alzforum.org/papers/rituximab-beyond-oncology-targeting-b-cell-mediated-immunomodulatory-therapy</link>
 <description>Immunopharmacol Immunotoxicol. 2026 May 11;:1-77.  Epub 2026 May 11&lt;br&gt;Authors: Saha T, Vats T, Mehan S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42116599&quot;&gt;42116599&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/rituximab-beyond-oncology-targeting-b-cell-mediated-immunomodulatory-therapy#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/rituximab-beyond-oncology-targeting-b-cell-mediated-immunomodulatory-therapy#comments</comments>
</item>
<item>
 <title>Systemic interleukin signaling and Alzheimer&#039;s disease risk: A two-sample cross-replication Mendelian randomization study.</title>
 <link>https://www.alzforum.org/papers/systemic-interleukin-signaling-and-alzheimers-disease-risk-two-sample-cross-replication</link>
 <description>J Alzheimers Dis. 2026 May 11;:13872877261449516.  Epub 2026 May 11&lt;br&gt;Authors: Ahmed HM, Ali Siddique M, Shaheer Ul Islam M, Khan Lodhi AR, Owais M, Rehman UU&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42116542&quot;&gt;42116542&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/systemic-interleukin-signaling-and-alzheimers-disease-risk-two-sample-cross-replication#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/systemic-interleukin-signaling-and-alzheimers-disease-risk-two-sample-cross-replication#comments</comments>
</item>
<item>
 <title>Stakeholder perspectives on the potential benefits, risks, and implications of an interactive cognitive monitoring app for the identification and monitoring of cognitive decline in adults at risk of dementia.</title>
 <link>https://www.alzforum.org/papers/stakeholder-perspectives-potential-benefits-risks-and-implications-interactive-cognitive</link>
 <description>BMC Health Serv Res. 2026 May 11; Epub 2026 May 11&lt;br&gt;Authors: Syukriyah D, Hulme C, Davis C, Llewellyn DJ, Allan L, Aarsland D, Ballard C, Fox C, Lamb SE, Corbett A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42116097&quot;&gt;42116097&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/stakeholder-perspectives-potential-benefits-risks-and-implications-interactive-cognitive#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/stakeholder-perspectives-potential-benefits-risks-and-implications-interactive-cognitive#comments</comments>
</item>
<item>
 <title>A longitudinal analysis of T1-weighted MRI features associated with progression from mild cognitive impairment to Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/longitudinal-analysis-t1-weighted-mri-features-associated-progression-mild-cognitive</link>
 <description>BMC Med Imaging. 2026 May 11; Epub 2026 May 11&lt;br&gt;Authors: Wang Y, Song W, Yang X, Meng W, Ma Y, Wang A, Guo G, Zhang Z, Li Z, Han H, Wang S, Shi F&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42115951&quot;&gt;42115951&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/longitudinal-analysis-t1-weighted-mri-features-associated-progression-mild-cognitive#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/longitudinal-analysis-t1-weighted-mri-features-associated-progression-mild-cognitive#comments</comments>
</item>
<item>
 <title>Comparison of hippocampus, entorhinal cortex, and amygdala volumes in individuals with Alzheimer&#039;s disease, mild cognitive impairment, and healthy individuals.</title>
 <link>https://www.alzforum.org/papers/comparison-hippocampus-entorhinal-cortex-and-amygdala-volumes-individuals-alzheimers-disease</link>
 <description>J Alzheimers Dis. 2026 May 11;:13872877261450574.  Epub 2026 May 11&lt;br&gt;Authors: Senol D, Secgin Y, Kaya S, Ozturk O, Harmandaoglu O, Alzheimer’s Disease Neuroimaging Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42115829&quot;&gt;42115829&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/comparison-hippocampus-entorhinal-cortex-and-amygdala-volumes-individuals-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/comparison-hippocampus-entorhinal-cortex-and-amygdala-volumes-individuals-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Blood-based biomarkers for Alzheimer&#039;s disease. &#039;Treat the test, not the patient?&#039;; are we ready to defy Osler?</title>
 <link>https://www.alzforum.org/papers/blood-based-biomarkers-alzheimers-disease-treat-test-not-patient-are-we-ready-defy-osler</link>
 <description>Expert Rev Mol Diagn. 2026 May 10;:1-5.  Epub 2026 May 10&lt;br&gt;Authors: Connon P, McKenna MC, Black SE, Masellis M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42107929&quot;&gt;42107929&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/blood-based-biomarkers-alzheimers-disease-treat-test-not-patient-are-we-ready-defy-osler#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/blood-based-biomarkers-alzheimers-disease-treat-test-not-patient-are-we-ready-defy-osler#comments</comments>
</item>
<item>
 <title>A Skull Bone Marrow-to-Brain Axis Links Osteoblastic Activity to Myeloid Cell Trafficking, Cerebral Blood Flow, and Cognition in Alzheimer&#039;s Progression.</title>
 <link>https://www.alzforum.org/papers/skull-bone-marrow-brain-axis-links-osteoblastic-activity-myeloid-cell-trafficking-cerebral</link>
 <description>Adv Sci (Weinh). 2026 May 10;:e75622.  Epub 2026 May 10&lt;br&gt;Authors: Xiong L, Sun D, Guo HH, Lee D, Liu Z, Mei L, Xiong WC&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42107073&quot;&gt;42107073&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/skull-bone-marrow-brain-axis-links-osteoblastic-activity-myeloid-cell-trafficking-cerebral#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/skull-bone-marrow-brain-axis-links-osteoblastic-activity-myeloid-cell-trafficking-cerebral#comments</comments>
</item>
<item>
 <title>Recruitment Strategies across the Spectrum of Neuronal Synuclein Disease.</title>
 <link>https://www.alzforum.org/papers/recruitment-strategies-across-spectrum-neuronal-synuclein-disease</link>
 <description>Ann Neurol. 2026 May 10; Epub 2026 May 10&lt;br&gt;Authors: Siderowf A, Heathers LE, Fabrizio K, Kuhl MM, Kopil CM, Flagg E, McMahon BA, Coffey CS, Bright A, Totten M, Lemon LP, Bryan E, Prakash N, Pavese N, Bloem BR, Alcalay RN, Mirelman A, Stefanis L, Okubadejo N, Tolosa E, Tanner CM, Simuni T, Chowdhury S, Tropea TF, Marek K, Foroud T, Parkinson&amp;#039;s Progression Markers Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42108682&quot;&gt;42108682&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/recruitment-strategies-across-spectrum-neuronal-synuclein-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/recruitment-strategies-across-spectrum-neuronal-synuclein-disease#comments</comments>
</item>
<item>
 <title>Expanding PPMI through Remote Data Acquisition and Analysis: Early Success and Future Growth with myPPMI.</title>
 <link>https://www.alzforum.org/papers/expanding-ppmi-through-remote-data-acquisition-and-analysis-early-success-and-future-growth</link>
 <description>Ann Neurol. 2026 May 10; Epub 2026 May 10&lt;br&gt;Authors: Tanner CM, Stanley CE, Brown EG, Chahine LM, Weintraub D, Dobkin RD, Poewe W, Tolosa E, Marras C, Schade S, Chou KL, Pavese N, Coffey CS, Brumm MC, Kurth R, Noyce AJ, Gonzalez-Latapi P, Matthews-McGee A, Korell M, Meng C, Chen X, Racelo L, Ricci J, Fitzgerald C, Rigby NH, Battles JA, Carley JK, Singh Z, Kruchkow L, McMahon BA, Flagg E, Lemon LP, Talarico JM, Brodkin K, Destro C, Kuhl MM, Fabrizio K, Marek K, Tropea TF, Parkinson&amp;#039;s Progression Markers Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42108656&quot;&gt;42108656&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/expanding-ppmi-through-remote-data-acquisition-and-analysis-early-success-and-future-growth#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/expanding-ppmi-through-remote-data-acquisition-and-analysis-early-success-and-future-growth#comments</comments>
</item>
<item>
 <title>The social value of lecanemab for patients with early Alzheimer&#039;s disease in Japan.</title>
 <link>https://www.alzforum.org/papers/social-value-lecanemab-patients-early-alzheimers-disease-japan</link>
 <description>J Alzheimers Dis. 2026 May 10;:13872877261447312.  Epub 2026 May 10&lt;br&gt;Authors: Igarashi A, Azuma-Kasai M, Tani M, Utsumi T, Shibahara H, Inoue S, Rothwell S, Kamanaka G, Sakata Y, Hiyoshi H, Tomita K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42108615&quot;&gt;42108615&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/social-value-lecanemab-patients-early-alzheimers-disease-japan#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/social-value-lecanemab-patients-early-alzheimers-disease-japan#comments</comments>
</item>
<item>
 <title>A novel synaptic compartmentalization failure framework for neurodegeneration.</title>
 <link>https://www.alzforum.org/papers/novel-synaptic-compartmentalization-failure-framework-neurodegeneration</link>
 <description>J Alzheimers Dis. 2026 May 9;:13872877261449379.  Epub 2026 May 9&lt;br&gt;Authors: Panigrahi B&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42104730&quot;&gt;42104730&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/novel-synaptic-compartmentalization-failure-framework-neurodegeneration#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/novel-synaptic-compartmentalization-failure-framework-neurodegeneration#comments</comments>
</item>
<item>
 <title>A Systematic Review on Disease-Modifying Therapies in Parkinsonian Disorders.</title>
 <link>https://www.alzforum.org/papers/systematic-review-disease-modifying-therapies-parkinsonian-disorders</link>
 <description>Clin Pharmacol Ther. 2026 May 9; Epub 2026 May 9&lt;br&gt;Authors: Eijsvogel PP, Smits LM, Kremer PH, Groeneveld GJ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42104724&quot;&gt;42104724&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/systematic-review-disease-modifying-therapies-parkinsonian-disorders#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/systematic-review-disease-modifying-therapies-parkinsonian-disorders#comments</comments>
</item>
<item>
 <title>Real-world clinical profile of individuals with cerebrospinal fluid Aβ-/pTau181.</title>
 <link>https://www.alzforum.org/papers/real-world-clinical-profile-individuals-cerebrospinal-fluid-av-ptau181</link>
 <description>J Alzheimers Dis. 2026 May 9;:13872877261445561.  Epub 2026 May 9&lt;br&gt;Authors: Keret O, Xia T, Wilkins S, Ncube LN, Smaw B, Xiong Y, Gandy S, Pereira A, Georges N, Elahi FM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42104723&quot;&gt;42104723&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/real-world-clinical-profile-individuals-cerebrospinal-fluid-av-ptau181#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/real-world-clinical-profile-individuals-cerebrospinal-fluid-av-ptau181#comments</comments>
</item>
<item>
 <title>Early diagnosis of Alzheimer&#039;s disease through handwriting analysis and deep learning: A review.</title>
 <link>https://www.alzforum.org/papers/early-diagnosis-alzheimers-disease-through-handwriting-analysis-and-deep-learning-review</link>
 <description>J Alzheimers Dis. 2026 May 9;:13872877261446573.  Epub 2026 May 9&lt;br&gt;Authors: Tang Q, Liu J, Fan C, Zhang X, Zhang C, Qi H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42104715&quot;&gt;42104715&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/early-diagnosis-alzheimers-disease-through-handwriting-analysis-and-deep-learning-review#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/early-diagnosis-alzheimers-disease-through-handwriting-analysis-and-deep-learning-review#comments</comments>
</item>
<item>
 <title>Letter to the Editor: Comments on &quot;Neural network disruptions between default mode network and salience network in mild cognitive impairment with neuropsychiatric symptoms&quot;.</title>
 <link>https://www.alzforum.org/papers/letter-editor-comments-neural-network-disruptions-between-default-mode-network-and-salience</link>
 <description>Int Psychogeriatr. 2026 May 9;:100219.  Epub 2026 May 9&lt;br&gt;Authors: Harihar SA, Kurhade AS, Waware SY&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42108145&quot;&gt;42108145&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/letter-editor-comments-neural-network-disruptions-between-default-mode-network-and-salience#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/letter-editor-comments-neural-network-disruptions-between-default-mode-network-and-salience#comments</comments>
</item>
<item>
 <title>PACAP in Parkinson&#039;s disease: A multifunctional neuropeptide at the crossroad of autophagy, inflammation, and metabolic repurposing.</title>
 <link>https://www.alzforum.org/papers/pacap-parkinsons-disease-multifunctional-neuropeptide-crossroad-autophagy-inflammation-and</link>
 <description>Neuropharmacology. 2026 May 9;296:111013.  Epub 2026 May 9&lt;br&gt;Authors: Hassan ME, Al-Kuraishy HM, Fawzy MN, Hussain NR, Al-Gareeb AI, Rashwan EK, Albuhadily AK, Batiha GE&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42107921&quot;&gt;42107921&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/pacap-parkinsons-disease-multifunctional-neuropeptide-crossroad-autophagy-inflammation-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/pacap-parkinsons-disease-multifunctional-neuropeptide-crossroad-autophagy-inflammation-and#comments</comments>
</item>
<item>
 <title>Microglia crosstalk with T cells in neurodegenerative diseases: pathogenesis and treatment targets.</title>
 <link>https://www.alzforum.org/papers/microglia-crosstalk-t-cells-neurodegenerative-diseases-pathogenesis-and-treatment-targets</link>
 <description>Int Immunopharmacol. 2026 May 9;182:116781.  Epub 2026 May 9&lt;br&gt;Authors: Chen G, Zhao C, Wang C, Chen G, Shi J, Chen H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42107892&quot;&gt;42107892&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/microglia-crosstalk-t-cells-neurodegenerative-diseases-pathogenesis-and-treatment-targets#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/microglia-crosstalk-t-cells-neurodegenerative-diseases-pathogenesis-and-treatment-targets#comments</comments>
</item>
<item>
 <title>Longitudinal metabolomic profiling of biogenic amines in plasma and CSF, and their correlation, reveals sex-specific and age changes in TgF344 Alzheimer&#039;s disease transgenic and wildtype rats.</title>
 <link>https://www.alzforum.org/papers/longitudinal-metabolomic-profiling-biogenic-amines-plasma-and-csf-and-their-correlation</link>
 <description>Fluids Barriers CNS. 2026 May 9;23(1)&lt;br&gt;Authors: Yin C, Nelen I, Harms A, Hartman R, Bos S, Nijgh-van Kooij C, Hankemeier T, Kindt A, de Lange E&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42106823&quot;&gt;42106823&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/longitudinal-metabolomic-profiling-biogenic-amines-plasma-and-csf-and-their-correlation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/longitudinal-metabolomic-profiling-biogenic-amines-plasma-and-csf-and-their-correlation#comments</comments>
</item>
<item>
 <title>A nomogram combined substantia nigra hyperechogenicity with third ventricular width assessed by transcranial sonography in prediction Parkinson&#039;s disease-related cognitive impairment.</title>
 <link>https://www.alzforum.org/papers/nomogram-combined-substantia-nigra-hyperechogenicity-third-ventricular-width-assessed</link>
 <description>BMC Med Imaging. 2026 May 9; Epub 2026 May 9&lt;br&gt;Authors: Yang QH, Hou C, Li MX&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42106687&quot;&gt;42106687&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/nomogram-combined-substantia-nigra-hyperechogenicity-third-ventricular-width-assessed#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/nomogram-combined-substantia-nigra-hyperechogenicity-third-ventricular-width-assessed#comments</comments>
</item>
<item>
 <title>Bacterial polar metabolites modulate β-amyloid toxicity and cholinergic dysfunction in models of Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/bacterial-polar-metabolites-modulate-v-amyloid-toxicity-and-cholinergic-dysfunction-models</link>
 <description>Sci Rep. 2026 May 9; Epub 2026 May 9&lt;br&gt;Authors: Santos AC, Corrêa JL, Duarte RM, Malta SM, Rodrigues TS, de Oliveira Santos D, de Faria PR, do Prado Mascarenhas FN, Zanon RG, Cassemiro NS, Carollo CA, Espindola FS, Martins MM, Mendes-Silva AP, Bonetti AM, Dos Santos AR, Ueira-Vieira C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42106468&quot;&gt;42106468&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/bacterial-polar-metabolites-modulate-v-amyloid-toxicity-and-cholinergic-dysfunction-models#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/bacterial-polar-metabolites-modulate-v-amyloid-toxicity-and-cholinergic-dysfunction-models#comments</comments>
</item>
<item>
 <title>Sound-evoked auditory neurophysiological signals are a window into prodromal functional differences in a preclinical model of Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/sound-evoked-auditory-neurophysiological-signals-are-window-prodromal-functional-0</link>
 <description>Sci Rep. 2026 May 9; Epub 2026 May 9&lt;br&gt;Authors: Aydin AG, Manoj P, Ramadan F, Rajan S, Youssef E, Torres EB, Bieszczad KM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42106438&quot;&gt;42106438&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/sound-evoked-auditory-neurophysiological-signals-are-window-prodromal-functional-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/sound-evoked-auditory-neurophysiological-signals-are-window-prodromal-functional-0#comments</comments>
</item>
<item>
 <title>Mapping research trends and gaps in cognitive dysfunction in Parkinson&#039;s disease: A bibliometric and scientometric analysis.</title>
 <link>https://www.alzforum.org/papers/mapping-research-trends-and-gaps-cognitive-dysfunction-parkinsons-disease-bibliometric-and</link>
 <description>J Health Psychol. 2026 May 9;:13591053261442336.  Epub 2026 May 9&lt;br&gt;Authors: Naeim M, Narimani M, Mikaeili N&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42105346&quot;&gt;42105346&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mapping-research-trends-and-gaps-cognitive-dysfunction-parkinsons-disease-bibliometric-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mapping-research-trends-and-gaps-cognitive-dysfunction-parkinsons-disease-bibliometric-and#comments</comments>
</item>
<item>
 <title>Neuroprotective role of phenolic acids: mechanistic insights into cognitive decline and neurodegenerative disorder.</title>
 <link>https://www.alzforum.org/papers/neuroprotective-role-phenolic-acids-mechanistic-insights-cognitive-decline-and</link>
 <description>Nutr Neurosci. 2026 May 9;:1-25.  Epub 2026 May 9&lt;br&gt;Authors: Balwant Patil K, Sugunan S, Padiyar A, Mishra AK, Jain S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42105317&quot;&gt;42105317&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/neuroprotective-role-phenolic-acids-mechanistic-insights-cognitive-decline-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/neuroprotective-role-phenolic-acids-mechanistic-insights-cognitive-decline-and#comments</comments>
</item>
<item>
 <title>Molecular and genetic landscape of amyotrophic lateral sclerosis in Latin America: a scoping review of pathogenic hypotheses and ancestral heterogeneity.</title>
 <link>https://www.alzforum.org/papers/molecular-and-genetic-landscape-amyotrophic-lateral-sclerosis-latin-america-scoping-review</link>
 <description>Amyotroph Lateral Scler Frontotemporal Degener. 2026 May 9;:1-9.  Epub 2026 May 9&lt;br&gt;Authors: Flores SV, Lillo P, Briceño-Moya J, Pedro AP&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42105306&quot;&gt;42105306&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/molecular-and-genetic-landscape-amyotrophic-lateral-sclerosis-latin-america-scoping-review#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/molecular-and-genetic-landscape-amyotrophic-lateral-sclerosis-latin-america-scoping-review#comments</comments>
</item>
<item>
 <title>Targeting the NLRP3 inflammasome with antibody-based Therapeutics for chronic neurodegenerative diseases.</title>
 <link>https://www.alzforum.org/papers/targeting-nlrp3-inflammasome-antibody-based-therapeutics-chronic-neurodegenerative-diseases</link>
 <description>Expert Opin Ther Targets. 2026 May 9; Epub 2026 May 9&lt;br&gt;Authors: Sandhu JK, Tanha J, Arbabi-Ghahroudi M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42105291&quot;&gt;42105291&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/targeting-nlrp3-inflammasome-antibody-based-therapeutics-chronic-neurodegenerative-diseases#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/targeting-nlrp3-inflammasome-antibody-based-therapeutics-chronic-neurodegenerative-diseases#comments</comments>
</item>
<item>
 <title>Lipid metabolism, neuroinflammation, and oxidative stress in Alzheimer disease: an integrated mechanistic review.</title>
 <link>https://www.alzforum.org/papers/lipid-metabolism-neuroinflammation-and-oxidative-stress-alzheimer-disease-integrated</link>
 <description>Acta Neurol Belg. 2026 May 9; Epub 2026 May 9&lt;br&gt;Authors: Lai L, Tang Y, Song G, Long Y, Chen C, Chen C, Li W&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42105174&quot;&gt;42105174&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/lipid-metabolism-neuroinflammation-and-oxidative-stress-alzheimer-disease-integrated#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/lipid-metabolism-neuroinflammation-and-oxidative-stress-alzheimer-disease-integrated#comments</comments>
</item>
<item>
 <title>Abnormal Amyloidogenesis Identified in Plasma of Patients with Spinocerebellar Ataxia Type 12.</title>
 <link>https://www.alzforum.org/papers/abnormal-amyloidogenesis-identified-plasma-patients-spinocerebellar-ataxia-type-12</link>
 <description>Cerebellum. 2026 May 9;25(3)&lt;br&gt;Authors: Banerjee R, Sengupta S, Rungta J, Ansari S, Banerjee S, Biswas B, Pal R, Chattarji S, Choudhury S, Kumar H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42105155&quot;&gt;42105155&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/abnormal-amyloidogenesis-identified-plasma-patients-spinocerebellar-ataxia-type-12#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/abnormal-amyloidogenesis-identified-plasma-patients-spinocerebellar-ataxia-type-12#comments</comments>
</item>
<item>
 <title>Differentiation of normal pressure hydrocephalus from alzheimer&#039;s and Parkinson&#039;s Diseases using the splenial angle measured on brain CT: diagnostic performance and reliability study.</title>
 <link>https://www.alzforum.org/papers/differentiation-normal-pressure-hydrocephalus-alzheimers-and-parkinsons-diseases-using</link>
 <description>Neuroradiology. 2026 May 9; Epub 2026 May 9&lt;br&gt;Authors: Kaya M, Konukoglu O, Genç H, Cindemir E, Onay M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42105113&quot;&gt;42105113&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/differentiation-normal-pressure-hydrocephalus-alzheimers-and-parkinsons-diseases-using#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/differentiation-normal-pressure-hydrocephalus-alzheimers-and-parkinsons-diseases-using#comments</comments>
</item>
<item>
 <title>Efficacy and safety of GLP-1 receptor agonists in Parkinson&#039;s disease: a systematic review and meta-analysis of randomized clinical trials.</title>
 <link>https://www.alzforum.org/papers/efficacy-and-safety-glp-1-receptor-agonists-parkinsons-disease-systematic-review-and-meta</link>
 <description>Neurol Sci. 2026 May 9;47(6)&lt;br&gt;Authors: Mendonça MF, Interaminense AC, do R Barros GS, Rabelo LA, de Oliveira PG, Sales RF, de C Lyra AM, de S E Silva HR&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42105060&quot;&gt;42105060&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/efficacy-and-safety-glp-1-receptor-agonists-parkinsons-disease-systematic-review-and-meta#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/efficacy-and-safety-glp-1-receptor-agonists-parkinsons-disease-systematic-review-and-meta#comments</comments>
</item>
<item>
 <title>Clinical patterns in social cognition &amp; personality changes in progressive supranuclear palsy.</title>
 <link>https://www.alzforum.org/papers/clinical-patterns-social-cognition-personality-changes-progressive-supranuclear-palsy</link>
 <description>J Neurol. 2026 May 9;273(6)&lt;br&gt;Authors: Hebron LP, Wever LM, Callahan P, Rijpma MG, Antoniou R, Hirst RB, Brown LM, Kramer JH, Seeley WW, Gorno-Tempini ML, Rosen H, Miller BL, Rankin KP&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42104994&quot;&gt;42104994&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/clinical-patterns-social-cognition-personality-changes-progressive-supranuclear-palsy#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/clinical-patterns-social-cognition-personality-changes-progressive-supranuclear-palsy#comments</comments>
</item>
<item>
 <title>Galectin-3 in microglia mediates neuroinflammation-induced cognitive dysfunction via selective elimination of excitatory synapses in hippocampal CA1.</title>
 <link>https://www.alzforum.org/papers/galectin-3-microglia-mediates-neuroinflammation-induced-cognitive-dysfunction-selective</link>
 <description>Brain Res. 2026 May 9;1887:150382.  Epub 2026 May 9&lt;br&gt;Authors: Wu HP, Hu XY, Liu K, He QL, Zhu SY, Shi JY, Yang JJ, Fan D, Ji MH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42114797&quot;&gt;42114797&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/galectin-3-microglia-mediates-neuroinflammation-induced-cognitive-dysfunction-selective#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/galectin-3-microglia-mediates-neuroinflammation-induced-cognitive-dysfunction-selective#comments</comments>
</item>
<item>
 <title>Proteomic analysis in Alzheimer&#039;s disease and other dementias: a focus on sex-specific differences.</title>
 <link>https://www.alzforum.org/papers/proteomic-analysis-alzheimers-disease-and-other-dementias-focus-sex-specific-differences</link>
 <description>Alzheimers Res Ther. 2026 May 8; Epub 2026 May 8&lt;br&gt;Authors: Comas-Albertí A, Lladó A, Esteller-Gauxax D, Borrego-Écija S, Falgàs N, Dakterzada F, Pérez-Millan A, Puey R, Collet-Romà T, Guillén N, Massons M, Tort-Merino A, Augé JM, Fernandez-Villullas G, Bosch B, Ruiz-García R, Naranjo L, Balasa M, Piñol-Ripoll G, Antonell A, Sánchez-Valle R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42104459&quot;&gt;42104459&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/proteomic-analysis-alzheimers-disease-and-other-dementias-focus-sex-specific-differences#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/proteomic-analysis-alzheimers-disease-and-other-dementias-focus-sex-specific-differences#comments</comments>
</item>
<item>
 <title>ODIN Biobank: a Danish cohort for dementia research- cohort profile.</title>
 <link>https://www.alzforum.org/papers/odin-biobank-danish-cohort-dementia-research-cohort-profile</link>
 <description>BMJ Open. 2026 May 8;16(5):e114084. &lt;br&gt;Authors: Laugesen K, Skjærbæk C, Okkels N, Møller HJ, Borghammer P, Gottrup H, Parkner T&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42103387&quot;&gt;42103387&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/odin-biobank-danish-cohort-dementia-research-cohort-profile#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/odin-biobank-danish-cohort-dementia-research-cohort-profile#comments</comments>
</item>
<item>
 <title>King&#039;s stages of amyotrophic lateral sclerosis: an 18F-FDG-PET study of brain connectivity.</title>
 <link>https://www.alzforum.org/papers/kings-stages-amyotrophic-lateral-sclerosis-18f-fdg-pet-study-brain-connectivity</link>
 <description>Brain. 2026 May 8; Epub 2026 May 8&lt;br&gt;Authors: Di Pede F, Cabras S, Manera U, Vasta R, Zocco G, Minerva E, Matteoni E, De Mattei F, Pellegrino G, Palumbo F, Pascariu D, Callegaro S, Maccabeo A, Polverari G, Martino A, Giuliani A, Moglia C, Calvo A, Chiò A, Pagani M, Canosa A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42102258&quot;&gt;42102258&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/kings-stages-amyotrophic-lateral-sclerosis-18f-fdg-pet-study-brain-connectivity#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/kings-stages-amyotrophic-lateral-sclerosis-18f-fdg-pet-study-brain-connectivity#comments</comments>
</item>
<item>
 <title>A Proline-Rich-Domain-Binding Single Domain Antibody Selectively Inhibits RNA-Induced Phase Separation of Tau.</title>
 <link>https://www.alzforum.org/papers/proline-rich-domain-binding-single-domain-antibody-selectively-inhibits-rna-induced-phase</link>
 <description>ACS Chem Neurosci. 2026 May 8; Epub 2026 May 8&lt;br&gt;Authors: Thiou S, Martin L, Manousaki E, Nguyen M, Mortelecque J, Heidsieck L, Cantrelle FX, Blum D, Buée-Scherrer V, Buée L, Landrieu I, Dupré E, Danis C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42102067&quot;&gt;42102067&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/proline-rich-domain-binding-single-domain-antibody-selectively-inhibits-rna-induced-phase#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/proline-rich-domain-binding-single-domain-antibody-selectively-inhibits-rna-induced-phase#comments</comments>
</item>
<item>
 <title>Utility of the 4-meter backward walking speed test in older adults with neurodegenerative diseases.</title>
 <link>https://www.alzforum.org/papers/utility-4-meter-backward-walking-speed-test-older-adults-neurodegenerative-diseases</link>
 <description>Ir J Med Sci. 2026 May 8; Epub 2026 May 8&lt;br&gt;Authors: Seydi KA, Kaya D, Yavuz I, Mahser AC, Mutlay F, Dost FS, Isik AT&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42101771&quot;&gt;42101771&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/utility-4-meter-backward-walking-speed-test-older-adults-neurodegenerative-diseases#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/utility-4-meter-backward-walking-speed-test-older-adults-neurodegenerative-diseases#comments</comments>
</item>
<item>
 <title>Plasma pTau181 is associated with subjective cognitive concerns but not objective cognitive decline or structural brain integrity measures in midlife.</title>
 <link>https://www.alzforum.org/papers/plasma-ptau181-associated-subjective-cognitive-concerns-not-objective-cognitive-decline-or</link>
 <description>Geroscience. 2026 May 8; Epub 2026 May 8&lt;br&gt;Authors: Barrett-Young A, Cawston EE, Ryan B, Abraham WC, Ambler A, Anderson T, Cheyne K, Goodin E, Hogan S, Houts RM, Ireland D, Knodt AR, Kokaua J, Melzer TR, Ramrakha S, Sugden K, Williams B, Wilson P, Caspi A, Hariri AR, Moffitt TE, Poulton R, Theodore R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42101744&quot;&gt;42101744&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/plasma-ptau181-associated-subjective-cognitive-concerns-not-objective-cognitive-decline-or#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/plasma-ptau181-associated-subjective-cognitive-concerns-not-objective-cognitive-decline-or#comments</comments>
</item>
<item>
 <title>Placebo-controlled three-armed pilot trial of Escitalopram or Nortriptyline for depressive symptoms in Parkinson&#039;s disease (ADepT-PD).</title>
 <link>https://www.alzforum.org/papers/placebo-controlled-three-armed-pilot-trial-escitalopram-or-nortriptyline-depressive-symptoms</link>
 <description>J Neural Transm (Vienna). 2026 May 8; Epub 2026 May 8&lt;br&gt;Authors: Schrag A, Embleton-Thirsk A, Carroll C, Serfaty M, Duncan G, Molloy S, Whipps J, McLennan B, Lewis G&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42101650&quot;&gt;42101650&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/placebo-controlled-three-armed-pilot-trial-escitalopram-or-nortriptyline-depressive-symptoms#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/placebo-controlled-three-armed-pilot-trial-escitalopram-or-nortriptyline-depressive-symptoms#comments</comments>
</item>
<item>
 <title>Streamlining Alzheimer&#039;s disease diagnosis: real-world validation of two-cut-off diagnostic models based on plasma p-tau/Aβ42 ratios.</title>
 <link>https://www.alzforum.org/papers/streamlining-alzheimers-disease-diagnosis-real-world-validation-two-cut-diagnostic-models</link>
 <description>J Neurol. 2026 May 8;273(6)&lt;br&gt;Authors: Poli M, Bonomi CG, Di Donna MG, Barberis I, Ginevra EL, Nuccetelli M, Bernardini S, Centonze D, Martorana A, Motta C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42101517&quot;&gt;42101517&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/streamlining-alzheimers-disease-diagnosis-real-world-validation-two-cut-diagnostic-models#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/streamlining-alzheimers-disease-diagnosis-real-world-validation-two-cut-diagnostic-models#comments</comments>
</item>
<item>
 <title>Compatibility of Acorus tatarinowii Schott and Polygala tenuifolia Willd. alleviate Alzheimer&#039;s disease through regulating Nos2-mediated calcium signaling pathway.</title>
 <link>https://www.alzforum.org/papers/compatibility-acorus-tatarinowii-schott-and-polygala-tenuifolia-willd-alleviate-alzheimers</link>
 <description>Neurochem Res. 2026 May 8;51(3)&lt;br&gt;Authors: Zhou B, Wu X, Wang J, Li L, Xu H, Shao W&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42101516&quot;&gt;42101516&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/compatibility-acorus-tatarinowii-schott-and-polygala-tenuifolia-willd-alleviate-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/compatibility-acorus-tatarinowii-schott-and-polygala-tenuifolia-willd-alleviate-alzheimers#comments</comments>
</item>
<item>
 <title>Biomaterials and Nanoparticle-Based Therapeutics in Neurodegenerative Diseases: Bridging the Gap Between Innovation and Translation.</title>
 <link>https://www.alzforum.org/papers/biomaterials-and-nanoparticle-based-therapeutics-neurodegenerative-diseases-bridging-gap</link>
 <description>ACS Chem Neurosci. 2026 May 8; Epub 2026 May 8&lt;br&gt;Authors: Panchal D, Solanki D, Solanki R, Yadav AK, Bhatia D, Yadav P&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42101470&quot;&gt;42101470&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/biomaterials-and-nanoparticle-based-therapeutics-neurodegenerative-diseases-bridging-gap#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/biomaterials-and-nanoparticle-based-therapeutics-neurodegenerative-diseases-bridging-gap#comments</comments>
</item>
<item>
 <title>A comprehensive systematic review of human trials investigating herbal treatments for Alzheimer&#039;s disease and dementia.</title>
 <link>https://www.alzforum.org/papers/comprehensive-systematic-review-human-trials-investigating-herbal-treatments-alzheimers</link>
 <description>Acta Neuropsychiatr. 2026 May 8;:1-55.  Epub 2026 May 8&lt;br&gt;Authors: Kaczmarek-Kryszak KA, Dobrzyńska M, Banaszak M, Drzymała-Czyż S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42100836&quot;&gt;42100836&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/comprehensive-systematic-review-human-trials-investigating-herbal-treatments-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/comprehensive-systematic-review-human-trials-investigating-herbal-treatments-alzheimers#comments</comments>
</item>
<item>
 <title>Association of mitochondrial genome variants with Alzheimer&#039;s disease in a Chinese population.</title>
 <link>https://www.alzforum.org/papers/association-mitochondrial-genome-variants-alzheimers-disease-chinese-population</link>
 <description>J Alzheimers Dis. 2026 May 8;:13872877261442231.  Epub 2026 May 8&lt;br&gt;Authors: Hao X, Jiao B, Wang Y, Xu T, Yang Q, Zhu Y, Liu Y, Zhang C, Liang X, Zhou Y, Liao X, Luo S, Tang B, Li J, Xiao X, Shen L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42104711&quot;&gt;42104711&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/association-mitochondrial-genome-variants-alzheimers-disease-chinese-population#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/association-mitochondrial-genome-variants-alzheimers-disease-chinese-population#comments</comments>
</item>
<item>
 <title>Development of AI-assisted 3D-printed degradable hydrogel microneedles for transdermal delivery of progesterone-loaded solid lipid nanoparticles: a novel approach to slowing Alzheimer&#039;s disease progression.</title>
 <link>https://www.alzforum.org/papers/development-ai-assisted-3d-printed-degradable-hydrogel-microneedles-transdermal-delivery</link>
 <description>Int J Pharm. 2026 May 8;698:126967.  Epub 2026 May 8&lt;br&gt;Authors: Suriyaamporn P, Wongprayoon P, Pannakkong W, Pamornpathomkul B, Ngawhirunpat T, Rojanarata T, Opanasopit P&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42107748&quot;&gt;42107748&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/development-ai-assisted-3d-printed-degradable-hydrogel-microneedles-transdermal-delivery#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/development-ai-assisted-3d-printed-degradable-hydrogel-microneedles-transdermal-delivery#comments</comments>
</item>
<item>
 <title>The emerging role of polo-like kinase 2 in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/emerging-role-polo-kinase-2-alzheimers-disease</link>
 <description>Exp Neurol. 2026 May 8;403:115806.  Epub 2026 May 8&lt;br&gt;Authors: Martínez-Drudis L, Sheta R, Musiol D, Teixeira M, Oueslati A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42107623&quot;&gt;42107623&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/emerging-role-polo-kinase-2-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/emerging-role-polo-kinase-2-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Aluminum chloride in Alzheimer&#039;s disease: A dual focus on molecular mechanisms and rat experimental models.</title>
 <link>https://www.alzforum.org/papers/aluminum-chloride-alzheimers-disease-dual-focus-molecular-mechanisms-and-rat-experimental</link>
 <description>Exp Neurol. 2026 May 8;403:115814.  Epub 2026 May 8&lt;br&gt;Authors: Khattab NA, El Kadeem A, Goda AE, El-Mahdy NA, El-Shitany N&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42107621&quot;&gt;42107621&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/aluminum-chloride-alzheimers-disease-dual-focus-molecular-mechanisms-and-rat-experimental#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/aluminum-chloride-alzheimers-disease-dual-focus-molecular-mechanisms-and-rat-experimental#comments</comments>
</item>
<item>
 <title>Bayesian modelling of amyloid-beta dynamics and astrocyte influence in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/bayesian-modelling-amyloid-beta-dynamics-and-astrocyte-influence-alzheimers-disease</link>
 <description>J Neurosci Methods. 2026 May 8;433:110785.  Epub 2026 May 8&lt;br&gt;Authors: Shaheen H, Melnik R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42107604&quot;&gt;42107604&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/bayesian-modelling-amyloid-beta-dynamics-and-astrocyte-influence-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/bayesian-modelling-amyloid-beta-dynamics-and-astrocyte-influence-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Defective regulated secretion: A trigger for Alzheimer&#039;s pathology?</title>
 <link>https://www.alzforum.org/papers/defective-regulated-secretion-trigger-alzheimers-pathology</link>
 <description>Prog Neurobiol. 2026 May 8;262:102926.  Epub 2026 May 8&lt;br&gt;Authors: Verma B, Singh P, Goberdhan DC, Wilson C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42107515&quot;&gt;42107515&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/defective-regulated-secretion-trigger-alzheimers-pathology#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/defective-regulated-secretion-trigger-alzheimers-pathology#comments</comments>
</item>
<item>
 <title>The design, synthesis and evaluation of the first carbon-11 positron emission tomography radiotracer for ASK1 imaging.</title>
 <link>https://www.alzforum.org/papers/design-synthesis-and-evaluation-first-carbon-11-positron-emission-tomography-radiotracer-ask1</link>
 <description>Bioorg Chem. 2026 May 8;178:109970.  Epub 2026 May 8&lt;br&gt;Authors: Huang Y, Wang Y, Wang Y, Cheng H, Yang H, Wang C, Xu Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42107260&quot;&gt;42107260&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/design-synthesis-and-evaluation-first-carbon-11-positron-emission-tomography-radiotracer-ask1#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/design-synthesis-and-evaluation-first-carbon-11-positron-emission-tomography-radiotracer-ask1#comments</comments>
</item>
<item>
 <title>Restoring miRNA biogenesis in ALS: Enoxacin enhances DICER activity in a first-in-human trial.</title>
 <link>https://www.alzforum.org/papers/restoring-mirna-biogenesis-als-enoxacin-enhances-dicer-activity-first-human-trial</link>
 <description>Mol Ther. 2026 May 8; Epub 2026 May 8&lt;br&gt;Authors: Sivasubramanian R, Sterneckert J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42105767&quot;&gt;42105767&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/restoring-mirna-biogenesis-als-enoxacin-enhances-dicer-activity-first-human-trial#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/restoring-mirna-biogenesis-als-enoxacin-enhances-dicer-activity-first-human-trial#comments</comments>
</item>
<item>
 <title>Head injuries as a risk factor for amyotrophic lateral sclerosis: A systematic review and meta-analysis.</title>
 <link>https://www.alzforum.org/papers/head-injuries-risk-factor-amyotrophic-lateral-sclerosis-systematic-review-and-meta-analysis</link>
 <description>Clin Neurol Neurosurg. 2026 May 8;267:109466.  Epub 2026 May 8&lt;br&gt;Authors: Toubasi AA, Al-Sayegh TN&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42119241&quot;&gt;42119241&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/head-injuries-risk-factor-amyotrophic-lateral-sclerosis-systematic-review-and-meta-analysis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/head-injuries-risk-factor-amyotrophic-lateral-sclerosis-systematic-review-and-meta-analysis#comments</comments>
</item>
<item>
 <title>Bidirectional mediation between microbiota and immune system in Parkinson disease: A two-sample Mendelian randomization study.</title>
 <link>https://www.alzforum.org/papers/bidirectional-mediation-between-microbiota-and-immune-system-parkinson-disease-two-sample</link>
 <description>Medicine (Baltimore). 2026 May 8;105(19):e48681. &lt;br&gt;Authors: Qu T, Zhao Q, Fang J, Liang Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42116350&quot;&gt;42116350&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/bidirectional-mediation-between-microbiota-and-immune-system-parkinson-disease-two-sample#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/bidirectional-mediation-between-microbiota-and-immune-system-parkinson-disease-two-sample#comments</comments>
</item>
<item>
 <title>The causal relationship between neuroimaging and Parkinson&#039;s disease: A two-sample Mendelian randomization study.</title>
 <link>https://www.alzforum.org/papers/causal-relationship-between-neuroimaging-and-parkinsons-disease-two-sample-mendelian</link>
 <description>Medicine (Baltimore). 2026 May 8;105(19):e48406. &lt;br&gt;Authors: Wang Y, Zhou S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42116305&quot;&gt;42116305&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/causal-relationship-between-neuroimaging-and-parkinsons-disease-two-sample-mendelian#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/causal-relationship-between-neuroimaging-and-parkinsons-disease-two-sample-mendelian#comments</comments>
</item>
<item>
 <title>A validated ligand binding assay for the determination of etalanetug, a novel anti-tau therapeutic antibody, in rats and monkeys for nonclinical pharmacokinetic studies.</title>
 <link>https://www.alzforum.org/papers/validated-ligand-binding-assay-determination-etalanetug-novel-anti-tau-therapeutic-antibody</link>
 <description>J Pharm Biomed Anal. 2026 May 8;279:117549.  Epub 2026 May 8&lt;br&gt;Authors: Aoyama M, Noritake Y, Kita K, Mano Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42127553&quot;&gt;42127553&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/validated-ligand-binding-assay-determination-etalanetug-novel-anti-tau-therapeutic-antibody#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/validated-ligand-binding-assay-determination-etalanetug-novel-anti-tau-therapeutic-antibody#comments</comments>
</item>
<item>
 <title>Quantum dot-enhanced tunable FRET nanosensor for Alzheimer&#039;s-associated dual miR-34 detection.</title>
 <link>https://www.alzforum.org/papers/quantum-dot-enhanced-tunable-fret-nanosensor-alzheimers-associated-dual-mir-34-detection</link>
 <description>Spectrochim Acta A Mol Biomol Spectrosc. 2026 May 8;360:128045.  Epub 2026 May 8&lt;br&gt;Authors: Tu Y, Yang R, Li S, Huang R, Zhang Y, Yang Q, Li J, Zhou L, Zhang W&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42127435&quot;&gt;42127435&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/quantum-dot-enhanced-tunable-fret-nanosensor-alzheimers-associated-dual-mir-34-detection#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/quantum-dot-enhanced-tunable-fret-nanosensor-alzheimers-associated-dual-mir-34-detection#comments</comments>
</item>
<item>
 <title>Roles of RNA-Binding Nuclear Proteins in Alzheimer&#039;s Disease Pathophysiology.</title>
 <link>https://www.alzforum.org/papers/roles-rna-binding-nuclear-proteins-alzheimers-disease-pathophysiology</link>
 <description>ACS Pharmacol Transl Sci. 2026 May 8;9(5):1055-1067.  Epub 2026 Apr 20&lt;br&gt;Authors: Kumar S, Upadhyay A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42130721&quot;&gt;42130721&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/roles-rna-binding-nuclear-proteins-alzheimers-disease-pathophysiology#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/roles-rna-binding-nuclear-proteins-alzheimers-disease-pathophysiology#comments</comments>
</item>
<item>
 <title>Association of dietary copper intake with Alzheimer&#039;s disease, brain structure and cognitive function.</title>
 <link>https://www.alzforum.org/papers/association-dietary-copper-intake-alzheimers-disease-brain-structure-and-cognitive-function</link>
 <description>J Nutr Health Aging. 2026 May 7;30(7):100868.  Epub 2026 May 7&lt;br&gt;Authors: Wu X, Chen Y, Liu H, Sun Z, Sun P, Liu Y, Shuai P, Yang H, Yang L, Wan Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42102760&quot;&gt;42102760&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/association-dietary-copper-intake-alzheimers-disease-brain-structure-and-cognitive-function#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/association-dietary-copper-intake-alzheimers-disease-brain-structure-and-cognitive-function#comments</comments>
</item>
<item>
 <title>CAR-A astrocytes for Alzheimer&#039;s: Promise and challenge.</title>
 <link>https://www.alzforum.org/papers/car-astrocytes-alzheimers-promise-and-challenge</link>
 <description>Cell Stem Cell. 2026 May 7;33(5):720-721. &lt;br&gt;Authors: Lee SI, Luo W, Gan L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42102723&quot;&gt;42102723&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/car-astrocytes-alzheimers-promise-and-challenge#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/car-astrocytes-alzheimers-promise-and-challenge#comments</comments>
</item>
<item>
 <title>Top five Alzheimer Disease trial eligibility criteria favor men compared to women in a clinic-based cohort.</title>
 <link>https://www.alzforum.org/papers/top-five-alzheimer-disease-trial-eligibility-criteria-favor-men-compared-women-clinic-based</link>
 <description>J Prev Alzheimers Dis. 2026 May 7;13(7):100580.  Epub 2026 May 7&lt;br&gt;Authors: Exalto LG, Syaziyah SS, Fang XT, Prins ND, Sikkes SA, van der Flier WM, Vijverberg EG, Lim YM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42102518&quot;&gt;42102518&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/top-five-alzheimer-disease-trial-eligibility-criteria-favor-men-compared-women-clinic-based#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/top-five-alzheimer-disease-trial-eligibility-criteria-favor-men-compared-women-clinic-based#comments</comments>
</item>
<item>
 <title>RNA-based therapeutics for Alzheimer&#039;s disease and related tauopathies: challenges and opportunities.</title>
 <link>https://www.alzforum.org/papers/rna-based-therapeutics-alzheimers-disease-and-related-tauopathies-challenges-and</link>
 <description>J Prev Alzheimers Dis. 2026 May 7;13(7):100585.  Epub 2026 May 7&lt;br&gt;Authors: Rajbanshi B, Brentari I, Denti MA, Cummings JL, Guruacharya A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42102517&quot;&gt;42102517&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/rna-based-therapeutics-alzheimers-disease-and-related-tauopathies-challenges-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/rna-based-therapeutics-alzheimers-disease-and-related-tauopathies-challenges-and#comments</comments>
</item>
<item>
 <title>Beyond amyloid positivity: Biological heterogeneity in the real-world use of lecanemab.</title>
 <link>https://www.alzforum.org/papers/beyond-amyloid-positivity-biological-heterogeneity-real-world-use-lecanemab</link>
 <description>J Prev Alzheimers Dis. 2026 May 7;13(6):100584.  Epub 2026 May 7&lt;br&gt;Authors: Rafii MS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42102503&quot;&gt;42102503&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/beyond-amyloid-positivity-biological-heterogeneity-real-world-use-lecanemab#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/beyond-amyloid-positivity-biological-heterogeneity-real-world-use-lecanemab#comments</comments>
</item>
<item>
 <title>SUMOylation in Neural Health and Disease: From Cellular Homeostasis to Neurodegeneration.</title>
 <link>https://www.alzforum.org/papers/sumoylation-neural-health-and-disease-cellular-homeostasis-neurodegeneration</link>
 <description>DNA Cell Biol. 2026 May 7;:10445498261444640.  Epub 2026 May 7&lt;br&gt;Authors: Oriquat G, Jasim IK, Gajjar TB, Hanumanthayya M, Abdulhameed Ahmad I, Singh G, Maharana L, Bainsal N&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42099104&quot;&gt;42099104&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/sumoylation-neural-health-and-disease-cellular-homeostasis-neurodegeneration#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/sumoylation-neural-health-and-disease-cellular-homeostasis-neurodegeneration#comments</comments>
</item>
<item>
 <title>Methodological considerations on the network meta-analysis of brexpiprazole dosing for agitation in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/methodological-considerations-network-meta-analysis-brexpiprazole-dosing-agitation-alzheimers</link>
 <description>J Alzheimers Dis. 2026 May 7;:13872877261449394.  Epub 2026 May 7&lt;br&gt;Authors: Pereira da Silva AM, Haddad Santos D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42099051&quot;&gt;42099051&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/methodological-considerations-network-meta-analysis-brexpiprazole-dosing-agitation-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/methodological-considerations-network-meta-analysis-brexpiprazole-dosing-agitation-alzheimers#comments</comments>
</item>
<item>
 <title>An RNA-Focused DNA-Encoded Library Platform for Discovering Ligands of Pathogenic r(G4C2)exp RNA.</title>
 <link>https://www.alzforum.org/papers/rna-focused-dna-encoded-library-platform-discovering-ligands-pathogenic-rg4c2exp-rna</link>
 <description>ACS Chem Biol. 2026 May 7; Epub 2026 May 7&lt;br&gt;Authors: Yang X, Taghavi A, Akahori Y, Pedrini M, Ishii T, Disney MD&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42099046&quot;&gt;42099046&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/rna-focused-dna-encoded-library-platform-discovering-ligands-pathogenic-rg4c2exp-rna#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/rna-focused-dna-encoded-library-platform-discovering-ligands-pathogenic-rg4c2exp-rna#comments</comments>
</item>
<item>
 <title>The mitochondria-synapse axis in Alzheimer&#039;s disease: Lost coordination in early stages.</title>
 <link>https://www.alzforum.org/papers/mitochondria-synapse-axis-alzheimers-disease-lost-coordination-early-stages</link>
 <description>Ageing Res Rev. 2026 May 7;119:103168.  Epub 2026 May 7&lt;br&gt;Authors: Sharma P, Kaur N, Vasal N, Solanki K, Sunkaria A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42106151&quot;&gt;42106151&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mitochondria-synapse-axis-alzheimers-disease-lost-coordination-early-stages#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mitochondria-synapse-axis-alzheimers-disease-lost-coordination-early-stages#comments</comments>
</item>
<item>
 <title>Urolithin A: Potential to enhance autophagic clearance and mitigate neuroinflammation in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/urolithin-potential-enhance-autophagic-clearance-and-mitigate-neuroinflammation-alzheimers</link>
 <description>Ageing Res Rev. 2026 May 7;119:103157.  Epub 2026 May 7&lt;br&gt;Authors: Xiang J, Xu J, Zhang Y, Liu X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42106150&quot;&gt;42106150&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/urolithin-potential-enhance-autophagic-clearance-and-mitigate-neuroinflammation-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/urolithin-potential-enhance-autophagic-clearance-and-mitigate-neuroinflammation-alzheimers#comments</comments>
</item>
<item>
 <title>From mild cognitive impairment to normal cognition in Parkinson&#039;s disease: The role of brain network architecture.</title>
 <link>https://www.alzforum.org/papers/mild-cognitive-impairment-normal-cognition-parkinsons-disease-role-brain-network-architecture</link>
 <description>Neurobiol Dis. 2026 May 7;225:107438.  Epub 2026 May 7&lt;br&gt;Authors: Siciliano M, De Micco R, Pirozzi MA, Goldman JG, Sant&amp;#039;Elia V, Silvestro M, Chiorri C, Cirillo M, Trojano L, Caiazzo G, Esposito F, Tessitore A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42106118&quot;&gt;42106118&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mild-cognitive-impairment-normal-cognition-parkinsons-disease-role-brain-network-architecture#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mild-cognitive-impairment-normal-cognition-parkinsons-disease-role-brain-network-architecture#comments</comments>
</item>
<item>
 <title>Multitarget pharmacological effects of Lawsone in mitigating Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/multitarget-pharmacological-effects-lawsone-mitigating-alzheimers-disease</link>
 <description>Eur J Pharmacol. 2026 May 7;1027:178920.  Epub 2026 May 7&lt;br&gt;Authors: Bashir MA, Ullah I, Batool GA, Khan AU, Shah SU&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42105996&quot;&gt;42105996&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/multitarget-pharmacological-effects-lawsone-mitigating-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/multitarget-pharmacological-effects-lawsone-mitigating-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Cobalt and titanium levels in the brain are associated with Alzheimer&#039;s disease pathology but not cognition: A study of older adults with and without total joint replacement.</title>
 <link>https://www.alzforum.org/papers/cobalt-and-titanium-levels-brain-are-associated-alzheimers-disease-pathology-not-cognition</link>
 <description>Acta Biomater. 2026 May 7; Epub 2026 May 7&lt;br&gt;Authors: Pourzal R, Agarwal P, Leurgans SE, McCarthy SM, Hall DJ, McDevitt CA, Ganio K, Ayton S, Bush AI, Grodstein F, James BD, Agrawal S, Hallab NJ, Bennett DA, Schneider JA, Jacobs JJ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42105933&quot;&gt;42105933&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cobalt-and-titanium-levels-brain-are-associated-alzheimers-disease-pathology-not-cognition#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cobalt-and-titanium-levels-brain-are-associated-alzheimers-disease-pathology-not-cognition#comments</comments>
</item>
<item>
 <title>Spatiotemporal reconfiguration of functional networks by transcranial magnetic stimulation in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/spatiotemporal-reconfiguration-functional-networks-transcranial-magnetic-stimulation</link>
 <description>Neuroscience. 2026 May 7;607:123-132.  Epub 2026 May 7&lt;br&gt;Authors: Guo M, Zou Y, Wang T, Wu H, Ji Y, Liu S, Xu G, Wang P&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42105904&quot;&gt;42105904&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/spatiotemporal-reconfiguration-functional-networks-transcranial-magnetic-stimulation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/spatiotemporal-reconfiguration-functional-networks-transcranial-magnetic-stimulation#comments</comments>
</item>
<item>
 <title>A novel insight into the risk of depression and anxiety onset in Parkinson&#039;s disease: the implications of GBA1 and LRRK2.</title>
 <link>https://www.alzforum.org/papers/novel-insight-risk-depression-and-anxiety-onset-parkinsons-disease-implications-gba1-and</link>
 <description>Parkinsonism Relat Disord. 2026 May 7;148:108341.  Epub 2026 May 7&lt;br&gt;Authors: Yang D, Wang J, Huang H, Lin S, Liu Z, Zhang S, Xu J, Zhang B, Cai H, Lin H, Huang S, Chen G&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42114177&quot;&gt;42114177&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/novel-insight-risk-depression-and-anxiety-onset-parkinsons-disease-implications-gba1-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/novel-insight-risk-depression-and-anxiety-onset-parkinsons-disease-implications-gba1-and#comments</comments>
</item>
<item>
 <title>Turning as a single and dual task-associations with alzheimer&#039;s and vascular pathologies in cognitively healthy older people.</title>
 <link>https://www.alzforum.org/papers/turning-single-and-dual-task-associations-alzheimers-and-vascular-pathologies-cognitively</link>
 <description>J Gerontol A Biol Sci Med Sci. 2026 May 7; Epub 2026 May 7&lt;br&gt;Authors: Nilsson MH, Lindh-Rengifo M, Rochester L, Van Westen D, Smith R, Palmqvist S, Stomrud E, Mattsson-Carlgren N, Hansson O&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42109046&quot;&gt;42109046&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/turning-single-and-dual-task-associations-alzheimers-and-vascular-pathologies-cognitively#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/turning-single-and-dual-task-associations-alzheimers-and-vascular-pathologies-cognitively#comments</comments>
</item>
<item>
 <title>Microbiota-Gut-Brain Axis in Neurodegenerative diseases: The Role of Bacterial Amyloids.</title>
 <link>https://www.alzforum.org/papers/microbiota-gut-brain-axis-neurodegenerative-diseases-role-bacterial-amyloids</link>
 <description>Cell Mol Gastroenterol Hepatol. 2026 May 6;:101802.  Epub 2026 May 6&lt;br&gt;Authors: Cissé M, Moullé V, Brossaud R, Oullier T, Neunlist M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42103282&quot;&gt;42103282&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/microbiota-gut-brain-axis-neurodegenerative-diseases-role-bacterial-amyloids#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/microbiota-gut-brain-axis-neurodegenerative-diseases-role-bacterial-amyloids#comments</comments>
</item>
<item>
 <title>Mechanism-selective inhibition of α-synuclein aggregation by the chaperone-like BRICHOS domain.</title>
 <link>https://www.alzforum.org/papers/mechanism-selective-inhibition-synuclein-aggregation-chaperone-brichos-domain</link>
 <description>J Biol Chem. 2026 May 6;:113117.  Epub 2026 May 6&lt;br&gt;Authors: Adam L, Molenkamp WH, Nowak JS, Farzadfard A, Gaarthuis K, Kumar R, Nielsen J, Otzen DE, Johansson J, Abelein A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42103226&quot;&gt;42103226&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mechanism-selective-inhibition-synuclein-aggregation-chaperone-brichos-domain#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mechanism-selective-inhibition-synuclein-aggregation-chaperone-brichos-domain#comments</comments>
</item>
<item>
 <title>The Role of Phospho-ubiquitin in Mitochondrial Health and Diseases.</title>
 <link>https://www.alzforum.org/papers/role-phospho-ubiquitin-mitochondrial-health-and-diseases</link>
 <description>J Biol Chem. 2026 May 6;:113128.  Epub 2026 May 6&lt;br&gt;Authors: Suresh K, Rainvillee C, Sterner DE, Goldberg MS, Butt TR&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42103223&quot;&gt;42103223&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/role-phospho-ubiquitin-mitochondrial-health-and-diseases#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/role-phospho-ubiquitin-mitochondrial-health-and-diseases#comments</comments>
</item>
<item>
 <title>Targeted liposomal epigallocatechin delivery for Alzheimer&#039;s disease: Effect on amyloid β fibrillation and neutralization of free radicals.</title>
 <link>https://www.alzforum.org/papers/targeted-liposomal-epigallocatechin-delivery-alzheimers-disease-effect-amyloid-v-fibrillation</link>
 <description>Int J Biol Macromol. 2026 May 6;:152399.  Epub 2026 May 6&lt;br&gt;Authors: Andrade S, Ferreira Â, Ramalho MJ, do Carmo Pereira M, Loureiro JA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42103123&quot;&gt;42103123&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/targeted-liposomal-epigallocatechin-delivery-alzheimers-disease-effect-amyloid-v-fibrillation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/targeted-liposomal-epigallocatechin-delivery-alzheimers-disease-effect-amyloid-v-fibrillation#comments</comments>
</item>
<item>
 <title>Molecular basis of BACE1 modulation revealed by machine learning, molecular simulations, and experimental validation.</title>
 <link>https://www.alzforum.org/papers/molecular-basis-bace1-modulation-revealed-machine-learning-molecular-simulations-and</link>
 <description>Int J Biol Macromol. 2026 May 6;:152409.  Epub 2026 May 6&lt;br&gt;Authors: Shahab M, Xiao J, Wang J, Huang Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42103119&quot;&gt;42103119&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/molecular-basis-bace1-modulation-revealed-machine-learning-molecular-simulations-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/molecular-basis-bace1-modulation-revealed-machine-learning-molecular-simulations-and#comments</comments>
</item>
<item>
 <title>Polyamine and tau: a chemical framework for understanding the hyperphosphorylated tau condensation.</title>
 <link>https://www.alzforum.org/papers/polyamine-and-tau-chemical-framework-understanding-hyperphosphorylated-tau-condensation</link>
 <description>Int J Biol Macromol. 2026 May 6;365:152366.  Epub 2026 May 6&lt;br&gt;Authors: Lee J, Lee K, Kim M, Kim MW, Lim M, Yoo J, Lee SH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42103118&quot;&gt;42103118&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/polyamine-and-tau-chemical-framework-understanding-hyperphosphorylated-tau-condensation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/polyamine-and-tau-chemical-framework-understanding-hyperphosphorylated-tau-condensation#comments</comments>
</item>
<item>
 <title>Multimodal strategies for diagnosis, stratification, and therapeutic monitoring in ALS.</title>
 <link>https://www.alzforum.org/papers/multimodal-strategies-diagnosis-stratification-and-therapeutic-monitoring-als</link>
 <description>Neurosci Biobehav Rev. 2026 May 6;187:106727.  Epub 2026 May 6&lt;br&gt;Authors: López-Blanch R, Oriol-Caballo M, Estrela JM, Obrador E&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42103041&quot;&gt;42103041&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/multimodal-strategies-diagnosis-stratification-and-therapeutic-monitoring-als#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/multimodal-strategies-diagnosis-stratification-and-therapeutic-monitoring-als#comments</comments>
</item>
<item>
 <title>Neural substrates of apathy in Parkinson&#039;s disease: A systematic review of structural and functional neuroimaging studies.</title>
 <link>https://www.alzforum.org/papers/neural-substrates-apathy-parkinsons-disease-systematic-review-structural-and-functional</link>
 <description>Brain Res Bull. 2026 May 6;240:111922.  Epub 2026 May 6&lt;br&gt;Authors: Marafioti G, Culicetto L, Blundo C, Susinna C, Restuccia G, Di Lorenzo G, Quartarone A, Lo Buono V&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42103035&quot;&gt;42103035&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/neural-substrates-apathy-parkinsons-disease-systematic-review-structural-and-functional#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/neural-substrates-apathy-parkinsons-disease-systematic-review-structural-and-functional#comments</comments>
</item>
<item>
 <title>Lipid dysregulation as a central contributor of neurodegenerative diseases: Emerging therapeutic targets and strategies.</title>
 <link>https://www.alzforum.org/papers/lipid-dysregulation-central-contributor-neurodegenerative-diseases-emerging-therapeutic</link>
 <description>Ageing Res Rev. 2026 May 6;119:103159.  Epub 2026 May 6&lt;br&gt;Authors: Zhang J, Wang C, Li Y, Xiao Z, Cai Z, Qian Y, Shi L, Zhang Q&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42102977&quot;&gt;42102977&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/lipid-dysregulation-central-contributor-neurodegenerative-diseases-emerging-therapeutic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/lipid-dysregulation-central-contributor-neurodegenerative-diseases-emerging-therapeutic#comments</comments>
</item>
<item>
 <title>Differential confounds of identification methods in Parkinson&#039;s disease models: Neuroinflammatory aggravation by toe-clipping versus sensorimotor disruption by ear-tagging.</title>
 <link>https://www.alzforum.org/papers/differential-confounds-identification-methods-parkinsons-disease-models-neuroinflammatory</link>
 <description>J Neurosci Methods. 2026 May 6;433:110790.  Epub 2026 May 6&lt;br&gt;Authors: Jiang X, Wei Y, Wang R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42102894&quot;&gt;42102894&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/differential-confounds-identification-methods-parkinsons-disease-models-neuroinflammatory#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/differential-confounds-identification-methods-parkinsons-disease-models-neuroinflammatory#comments</comments>
</item>
<item>
 <title>Cueing to facilitate naming in MAPT-associated behavioral variant frontotemporal dementia: a preliminary report.</title>
 <link>https://www.alzforum.org/papers/cueing-facilitate-naming-mapt-associated-behavioral-variant-frontotemporal-dementia</link>
 <description>Arch Clin Neuropsychol. 2026 May 6;41(4)&lt;br&gt;Authors: Barker MS, Mejia A, Zheng EZ, Rizer S, Reid SM, Holmes Iii U, Manoochehri M, Huey ED, Cosentino S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42119153&quot;&gt;42119153&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cueing-facilitate-naming-mapt-associated-behavioral-variant-frontotemporal-dementia#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cueing-facilitate-naming-mapt-associated-behavioral-variant-frontotemporal-dementia#comments</comments>
</item>
<item>
 <title>[Establishment of reference intervals for plasma p-tau181, Aβ1-42, Aβ1-40, and Aβ1-42/40 ratio and a preliminary study of their correlation with corresponding cerebrospinal fluid reference intervals].</title>
 <link>https://www.alzforum.org/papers/establishment-reference-intervals-plasma-p-tau181-av1-42-av1-40-and-av1-4240-ratio-and</link>
 <description>Zhonghua Yu Fang Yi Xue Za Zhi. 2026 May 6;60(5):784-790. &lt;br&gt;Authors: Zhang QT, Wu WQ, Deng YH, Dong L, Xu YM, Fu XJ, Jiang HQ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42128684&quot;&gt;42128684&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/establishment-reference-intervals-plasma-p-tau181-av1-42-av1-40-and-av1-4240-ratio-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/establishment-reference-intervals-plasma-p-tau181-av1-42-av1-40-and-av1-4240-ratio-and#comments</comments>
</item>
<item>
 <title>Sleep quality is associated with default mode and salience network connectivity differently across age and sex.</title>
 <link>https://www.alzforum.org/papers/sleep-quality-associated-default-mode-and-salience-network-connectivity-differently-across</link>
 <description>Neurobiol Aging. 2026 May 6;165:76-91.  Epub 2026 May 6&lt;br&gt;Authors: Tan S, Gourabi S, Cribbet MR, Cundiff JM, McDonough IM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42128467&quot;&gt;42128467&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/sleep-quality-associated-default-mode-and-salience-network-connectivity-differently-across#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/sleep-quality-associated-default-mode-and-salience-network-connectivity-differently-across#comments</comments>
</item>
<item>
 <title>Astrocyte reactivity across the AD continuum measured by [18F]SMBT-1 and its relationship with the Aβ burden.</title>
 <link>https://www.alzforum.org/papers/astrocyte-reactivity-across-ad-continuum-measured-18fsmbt-1-and-its-relationship-av-burden</link>
 <description>Eur J Nucl Med Mol Imaging. 2026 May 6; Epub 2026 May 6&lt;br&gt;Authors: Wu Y, Hiraoka K, Mesfin B, Kikuchi A, Watanuki S, Mugikura S, Tomita N, Ishiki A, Furukawa K, Funaki Y, Toyohara J, Kimura Y, Harada R, Furumoto S, Kikuchi A, Watabe H, Kobayashi R, Nihashi T, Kato T, Ishii K, Kawakatsu S, Okamura N, Tashiro M, SMBTSD study project group*&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42126566&quot;&gt;42126566&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/astrocyte-reactivity-across-ad-continuum-measured-18fsmbt-1-and-its-relationship-av-burden#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/astrocyte-reactivity-across-ad-continuum-measured-18fsmbt-1-and-its-relationship-av-burden#comments</comments>
</item>
<item>
 <title>Resilience to mid-to-late-life depression as a risk factor for Alzheimer&#039;s disease: Physiological factors and the role of neuroimaging.</title>
 <link>https://www.alzforum.org/papers/resilience-mid-late-life-depression-risk-factor-alzheimers-disease-physiological-factors-and</link>
 <description>Neurobiol Aging. 2026 May 6;166:1-13.  Epub 2026 May 6&lt;br&gt;Authors: Chu TD, Hui LM, Khatri N, Jean Chen J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42134046&quot;&gt;42134046&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/resilience-mid-late-life-depression-risk-factor-alzheimers-disease-physiological-factors-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/resilience-mid-late-life-depression-risk-factor-alzheimers-disease-physiological-factors-and#comments</comments>
</item>
<item>
 <title>Targeting Shared Mechanisms in Atherosclerosis and Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/targeting-shared-mechanisms-atherosclerosis-and-alzheimers-disease</link>
 <description>Curr Alzheimer Res. 2026 May 5; Epub 2026 May 5&lt;br&gt;Authors: Chaudhari DB, Barve K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42099166&quot;&gt;42099166&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/targeting-shared-mechanisms-atherosclerosis-and-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/targeting-shared-mechanisms-atherosclerosis-and-alzheimers-disease#comments</comments>
</item>
<item>
 <title>The Role of Ectopic Fat in Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/role-ectopic-fat-alzheimers-disease</link>
 <description>Curr Alzheimer Res. 2026 May 5; Epub 2026 May 5&lt;br&gt;Authors: Yang Y, Huang X, Liu H, Yu C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42099165&quot;&gt;42099165&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/role-ectopic-fat-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/role-ectopic-fat-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Comparative Efficacy and Safety of Cholinesterase Inhibitors and NMDA Receptor Antagonists in Alzheimer&#039;s Disease: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.</title>
 <link>https://www.alzforum.org/papers/comparative-efficacy-and-safety-cholinesterase-inhibitors-and-nmda-receptor-antagonists</link>
 <description>Curr Alzheimer Res. 2026 May 5; Epub 2026 May 5&lt;br&gt;Authors: Li Y, Li L, Yang Q, Xiong J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42099163&quot;&gt;42099163&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/comparative-efficacy-and-safety-cholinesterase-inhibitors-and-nmda-receptor-antagonists#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/comparative-efficacy-and-safety-cholinesterase-inhibitors-and-nmda-receptor-antagonists#comments</comments>
</item>
<item>
 <title>A Multimodal Framework for Alzheimer&#039;s Prevention: Diet, Exercise, Fasting, Sleep, and Gut Microbiota.</title>
 <link>https://www.alzforum.org/papers/multimodal-framework-alzheimers-prevention-diet-exercise-fasting-sleep-and-gut-microbiota</link>
 <description>Curr Alzheimer Res. 2026 May 5; Epub 2026 May 5&lt;br&gt;Authors: Kurmi S, Shirodkar S, Parab SB, Doshi G&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42099162&quot;&gt;42099162&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/multimodal-framework-alzheimers-prevention-diet-exercise-fasting-sleep-and-gut-microbiota#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/multimodal-framework-alzheimers-prevention-diet-exercise-fasting-sleep-and-gut-microbiota#comments</comments>
</item>
<item>
 <title>Graphene field-effect transistor based multiplexed sensing platform for simultaneous detection of multiple Alzheimer&#039;s disease biomarkers.</title>
 <link>https://www.alzforum.org/papers/graphene-field-effect-transistor-based-multiplexed-sensing-platform-simultaneous-detection</link>
 <description>RSC Adv. 2026 May 5;16(26):23937-23944.  Epub 2026 May 7&lt;br&gt;Authors: Guo B, Wang J, Lou F, Yuan B, Chen Z, Tang C, Chen W, Yi F, Jiang J, Hu G, Cong C, Lu Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42111521&quot;&gt;42111521&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/graphene-field-effect-transistor-based-multiplexed-sensing-platform-simultaneous-detection#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/graphene-field-effect-transistor-based-multiplexed-sensing-platform-simultaneous-detection#comments</comments>
</item>
<item>
 <title>Rapid Detection of Amyloid β1-42 via PAMAM G4 Supported Molecularly Imprinted Sensor.</title>
 <link>https://www.alzforum.org/papers/rapid-detection-amyloid-v1-42-pamam-g4-supported-molecularly-imprinted-sensor</link>
 <description>ACS Omega. 2026 May 5;11(17):25960-25968.  Epub 2026 Apr 18&lt;br&gt;Authors: Ertuğrul Uygun HD, Demir MN&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42110765&quot;&gt;42110765&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/rapid-detection-amyloid-v1-42-pamam-g4-supported-molecularly-imprinted-sensor#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/rapid-detection-amyloid-v1-42-pamam-g4-supported-molecularly-imprinted-sensor#comments</comments>
</item>
<item>
 <title>Dietary Polyphenols in Brain Aging: Molecular Mechanisms and Implications for Neurodegeneration.</title>
 <link>https://www.alzforum.org/papers/dietary-polyphenols-brain-aging-molecular-mechanisms-and-implications-neurodegeneration</link>
 <description>Nutrients. 2026 May 5;18(9)&lt;br&gt;Authors: Mózes N, Varga JT, Szwajgier D, Kryczyk-Poprawa A, Zábó V, Lehoczki A, Lipécz Á, Csípő T, Fazekas-Pongor V, Major D, Varga P, Matiscsák A, Fekete M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42124071&quot;&gt;42124071&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/dietary-polyphenols-brain-aging-molecular-mechanisms-and-implications-neurodegeneration#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/dietary-polyphenols-brain-aging-molecular-mechanisms-and-implications-neurodegeneration#comments</comments>
</item>
<item>
 <title>Gut Microbiota Dysbiosis in Alzheimer&#039;s Disease and Possible Therapeutic Options.</title>
 <link>https://www.alzforum.org/papers/gut-microbiota-dysbiosis-alzheimers-disease-and-possible-therapeutic-options</link>
 <description>Curr Alzheimer Res. 2026 May 4; Epub 2026 May 4&lt;br&gt;Authors: Nayak RK, Mohapatra SR, Sahoo SK, Sahu SK, Chowdhury B, Banu Z, Das NR&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42099164&quot;&gt;42099164&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/gut-microbiota-dysbiosis-alzheimers-disease-and-possible-therapeutic-options#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/gut-microbiota-dysbiosis-alzheimers-disease-and-possible-therapeutic-options#comments</comments>
</item>
<item>
 <title>Examining adverse effects in a large clinical trial of rTMS application as a treatment for Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/examining-adverse-effects-large-clinical-trial-rtms-application-treatment-alzheimers-disease</link>
 <description>Psychiatry Res. 2026 May 4;362:117212.  Epub 2026 May 4&lt;br&gt;Authors: Uehara MA, Bretecher CA, Teschuk JM, Verot A, Saha C, Fitzgerald PB, Koski L, Millikin C, Moussavi Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42105452&quot;&gt;42105452&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/examining-adverse-effects-large-clinical-trial-rtms-application-treatment-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/examining-adverse-effects-large-clinical-trial-rtms-application-treatment-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Non-Invasive Brain Stimulation in Frontotemporal Dementia: A Systematic Review of Non-Pharmacological Treatment Approaches.</title>
 <link>https://www.alzforum.org/papers/non-invasive-brain-stimulation-frontotemporal-dementia-systematic-review-non-pharmacological</link>
 <description>Int J Mol Sci. 2026 May 4;27(9)&lt;br&gt;Authors: Dognini E, Cerino A, Manenti R, Cotelli M, Borroni B&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42123695&quot;&gt;42123695&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/non-invasive-brain-stimulation-frontotemporal-dementia-systematic-review-non-pharmacological#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/non-invasive-brain-stimulation-frontotemporal-dementia-systematic-review-non-pharmacological#comments</comments>
</item>
<item>
 <title>Fructose Intake Is Associated with Brain Metabolic Reprogramming and Exacerbation of Alzheimer-like Alterations in APP/PS1 Mice.</title>
 <link>https://www.alzforum.org/papers/fructose-intake-associated-brain-metabolic-reprogramming-and-exacerbation-alzheimer</link>
 <description>Int J Mol Sci. 2026 May 4;27(9)&lt;br&gt;Authors: Ormazabal P, Órdenes-Constenla P, Gherardelli C, Bastías-Pérez M, Brito-Valenzuela J, Flores-Opazo M, Inestrosa NC, Cisternas P&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42123692&quot;&gt;42123692&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/fructose-intake-associated-brain-metabolic-reprogramming-and-exacerbation-alzheimer#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/fructose-intake-associated-brain-metabolic-reprogramming-and-exacerbation-alzheimer#comments</comments>
</item>
<item>
 <title>Correction to: Factors influencing implementation of an Alzheimer&#039;s disease blood test among UK old age psychiatrists: mixed-methods study using the theoretical domains framework.</title>
 <link>https://www.alzforum.org/papers/correction-factors-influencing-implementation-alzheimers-disease-blood-test-among-uk-old-age</link>
 <description>Age Ageing. 2026 May 4;55(5)&lt;br&gt;Authors: &lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42132921&quot;&gt;42132921&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/correction-factors-influencing-implementation-alzheimers-disease-blood-test-among-uk-old-age#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/correction-factors-influencing-implementation-alzheimers-disease-blood-test-among-uk-old-age#comments</comments>
</item>
<item>
 <title>When complexity does not pay: benchmarking deep learning and ensemble methods for biomarker discovery.</title>
 <link>https://www.alzforum.org/papers/when-complexity-does-not-pay-benchmarking-deep-learning-and-ensemble-methods-biomarker</link>
 <description>Brief Bioinform. 2026 May 3;27(3)&lt;br&gt;Authors: Njume CM, Petracci I, Bellini S, Goljanek-Whysall K, Quinlan LR, Fiszer A, Borroni B, Ghidoni R, Kumbasar A, Cakmak A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42101927&quot;&gt;42101927&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/when-complexity-does-not-pay-benchmarking-deep-learning-and-ensemble-methods-biomarker#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/when-complexity-does-not-pay-benchmarking-deep-learning-and-ensemble-methods-biomarker#comments</comments>
</item>
<item>
 <title>Limitations of Stem Cell Therapy for Parkinson&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/limitations-stem-cell-therapy-parkinsons-disease</link>
 <description>Cells. 2026 May 3;15(9)&lt;br&gt;Authors: Li Z, Peng S, Ouyang J, Liu R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42121940&quot;&gt;42121940&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/limitations-stem-cell-therapy-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/limitations-stem-cell-therapy-parkinsons-disease#comments</comments>
</item>
<item>
 <title>Development of tacrine-based multitarget-directed ligands as dual AChE/EGFR inhibitors with neuroprotective activity.</title>
 <link>https://www.alzforum.org/papers/development-tacrine-based-multitarget-directed-ligands-dual-acheegfr-inhibitors</link>
 <description>Bioorg Med Chem. 2026 May 2;139:118677.  Epub 2026 May 2&lt;br&gt;Authors: Wei Y, Zhang A, Qiu W, Xiong B, Song Z, Zheng N, Wu Y, Zhang C, Cao Z, Wang X, Xu C, Zhao Q, Wu Y, Liu Z, Chen Y, Sun H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42107267&quot;&gt;42107267&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/development-tacrine-based-multitarget-directed-ligands-dual-acheegfr-inhibitors#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/development-tacrine-based-multitarget-directed-ligands-dual-acheegfr-inhibitors#comments</comments>
</item>
<item>
 <title>Cumulative Incidence in Monogenic Alzheimer&#039;s Disease and Frontotemporal Dementia: Gene-Gene Interaction Effect.</title>
 <link>https://www.alzforum.org/papers/cumulative-incidence-monogenic-alzheimers-disease-and-frontotemporal-dementia-gene-gene</link>
 <description>Int J Mol Sci. 2026 May 2;27(9)&lt;br&gt;Authors: Geviti A, Pagano L, Grassi M, Saraceno C, Facconi A, Fostinelli S, Laganà V, Giacomucci G, Cotelli MS, Cantoni V, Ingannato A, Bagnoli S, Bessi V, Longobardi A, Russotto A, Bellini S, Lagrotteria D, Paparazzo E, Binetti G, Montesanto A, Nacmias B, Maletta R, Borroni B, Ghidoni R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42123659&quot;&gt;42123659&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cumulative-incidence-monogenic-alzheimers-disease-and-frontotemporal-dementia-gene-gene#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cumulative-incidence-monogenic-alzheimers-disease-and-frontotemporal-dementia-gene-gene#comments</comments>
</item>
<item>
 <title>Exceptional Longevity Modifying Allele APOE2 Promotes DNA Signaling Pathways Resisting Cellular Senescence in Human Neurons.</title>
 <link>https://www.alzforum.org/papers/exceptional-longevity-modifying-allele-apoe2-promotes-dna-signaling-pathways-resisting</link>
 <description>Aging Cell. 2026 May;25(5):e70494. &lt;br&gt;Authors: Gerónimo-Olvera C, Scheeler SM, Aguirre CG, Vega-Hormazabal G, Garcia D, Wu L, Murad N, Schneider K, Wilson KA, Markov NT, Song S, Simons J, Gerencser AA, Parlan E, Mooney SD, Verdin E, Campisi J, Tracy TE, Furman D, Melov S, Ellerby LM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42103698&quot;&gt;42103698&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/exceptional-longevity-modifying-allele-apoe2-promotes-dna-signaling-pathways-resisting#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/exceptional-longevity-modifying-allele-apoe2-promotes-dna-signaling-pathways-resisting#comments</comments>
</item>
<item>
 <title>APOE4 Drives Sex- and Diet-Dependent Effects on AD-Like Pathology, Cognition, and Mitochondrial Function.</title>
 <link>https://www.alzforum.org/papers/apoe4-drives-sex-and-diet-dependent-effects-ad-pathology-cognition-and-mitochondrial-function</link>
 <description>FASEB Bioadv. 2026 May;8:e70113.  Epub 2026 May 6&lt;br&gt;Authors: Johnson CN, Lysaker CR, Cao X, Csikos V, Boakye F, Kueck PJ, Franczak E, Geiger PC, Morris JK, Thyfault JP, Wilkins HM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42100472&quot;&gt;42100472&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/apoe4-drives-sex-and-diet-dependent-effects-ad-pathology-cognition-and-mitochondrial-function#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/apoe4-drives-sex-and-diet-dependent-effects-ad-pathology-cognition-and-mitochondrial-function#comments</comments>
</item>
<item>
 <title>Circulating Sphingomyelins Correlate With Plasma T-Tau in Cognitively Unimpaired Older Adults at Risk of Developing Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/circulating-sphingomyelins-correlate-plasma-t-tau-cognitively-unimpaired-older-adults-risk</link>
 <description>J Neurochem. 2026 May;170(5):e70436. &lt;br&gt;Authors: Sharmin T, Doecke JD, Chatterjee P, Pedrini S, Sohrabi HR, Ashton NJ, Zetterberg H, Garg ML, Blennow K, Martins RN&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42104655&quot;&gt;42104655&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/circulating-sphingomyelins-correlate-plasma-t-tau-cognitively-unimpaired-older-adults-risk#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/circulating-sphingomyelins-correlate-plasma-t-tau-cognitively-unimpaired-older-adults-risk#comments</comments>
</item>
<item>
 <title>Multiscale Approximations to Understand the Complex Role of Microglia in Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/multiscale-approximations-understand-complex-role-microglia-alzheimers-disease</link>
 <description>Eur J Neurosci. 2026 May;63(9):e70536. &lt;br&gt;Authors: Martínez-Tazo P, Mejias-Ortega M, López-López V, Bhojwani-Cabrera AM, Saxton E, Canals S, Hardingham G, Gutierrez A, Lopez-Atalaya JP, De Santis S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42104633&quot;&gt;42104633&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/multiscale-approximations-understand-complex-role-microglia-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/multiscale-approximations-understand-complex-role-microglia-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Single-cell transcriptomic analysis reveals APOE genotype-dependent sex differences in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/single-cell-transcriptomic-analysis-reveals-apoe-genotype-dependent-sex-differences</link>
 <description>Alzheimers Dement. 2026 May;22(5):e71463. &lt;br&gt;Authors: Yu G, Thorpe A, Zeng Q, Wang E, Goate A, Cai D, Wang M, Zhang B&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42108391&quot;&gt;42108391&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/single-cell-transcriptomic-analysis-reveals-apoe-genotype-dependent-sex-differences#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/single-cell-transcriptomic-analysis-reveals-apoe-genotype-dependent-sex-differences#comments</comments>
</item>
<item>
 <title>Rethinking Alzheimer&#039;s disease susceptibility and heterogeneity. Comment on Miller et al.</title>
 <link>https://www.alzforum.org/papers/rethinking-alzheimers-disease-susceptibility-and-heterogeneity-comment-miller-et-al</link>
 <description>Alzheimers Dement. 2026 May;22(5):e71456. &lt;br&gt;Authors: Frijo A, Mazzeo S, Filippi M, Salsone M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42108388&quot;&gt;42108388&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/rethinking-alzheimers-disease-susceptibility-and-heterogeneity-comment-miller-et-al#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/rethinking-alzheimers-disease-susceptibility-and-heterogeneity-comment-miller-et-al#comments</comments>
</item>
<item>
 <title>Rational Design and Optimisation of CRISPR-Cas9 Delivery Systems for Targeted Genomic Transformation.</title>
 <link>https://www.alzforum.org/papers/rational-design-and-optimisation-crispr-cas9-delivery-systems-targeted-genomic-transformation</link>
 <description>J Gene Med. 2026 May;28(5):e70095. &lt;br&gt;Authors: Pandya K, Jaisinghani LS, Tripathi A, Kumar D, Saraf SK, Sahoo J, Kumar D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42108387&quot;&gt;42108387&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/rational-design-and-optimisation-crispr-cas9-delivery-systems-targeted-genomic-transformation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/rational-design-and-optimisation-crispr-cas9-delivery-systems-targeted-genomic-transformation#comments</comments>
</item>
<item>
 <title>Response to rethinking Alzheimer&#039;s disease susceptibility and heterogeneity. Comment on Miller et al.</title>
 <link>https://www.alzforum.org/papers/response-rethinking-alzheimers-disease-susceptibility-and-heterogeneity-comment-miller-et-al</link>
 <description>Alzheimers Dement. 2026 May;22(5):e71454. &lt;br&gt;Authors: Miller ZA, Miller BL, Rabinovici GD, Gorno-Tempini ML&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42108385&quot;&gt;42108385&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/response-rethinking-alzheimers-disease-susceptibility-and-heterogeneity-comment-miller-et-al#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/response-rethinking-alzheimers-disease-susceptibility-and-heterogeneity-comment-miller-et-al#comments</comments>
</item>
<item>
 <title>Correlation between in vivo 18F-flortaucipir PET and whole-brain postmortem histological tau signals in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/correlation-between-vivo-18f-flortaucipir-pet-and-whole-brain-postmortem-histological-tau</link>
 <description>Alzheimers Dement. 2026 May;22(5):e71453. &lt;br&gt;Authors: Chao Y, Chen Y, Chadwick TA, Harrison TM, Iaccarino L, Heinsen H, Ushizima D, Tosun D, Jagust WJ, Grinberg LT&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42108381&quot;&gt;42108381&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/correlation-between-vivo-18f-flortaucipir-pet-and-whole-brain-postmortem-histological-tau#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/correlation-between-vivo-18f-flortaucipir-pet-and-whole-brain-postmortem-histological-tau#comments</comments>
</item>
<item>
 <title>Disentangling amyloid polymorphs in normal aging and Alzheimer&#039;s disease using dual-probe spectral imaging.</title>
 <link>https://www.alzforum.org/papers/disentangling-amyloid-polymorphs-normal-aging-and-alzheimers-disease-using-dual-probe</link>
 <description>Neurobiol Aging. 2026 May 1;165:51-59.  Epub 2026 May 1&lt;br&gt;Authors: Stepanchuk AA, Joseph JT, Lashley T, Stys PK&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42107415&quot;&gt;42107415&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/disentangling-amyloid-polymorphs-normal-aging-and-alzheimers-disease-using-dual-probe#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/disentangling-amyloid-polymorphs-normal-aging-and-alzheimers-disease-using-dual-probe#comments</comments>
</item>
<item>
 <title>The role of quantitative susceptibility mapping in dementia with Lewy Bodies.</title>
 <link>https://www.alzforum.org/papers/role-quantitative-susceptibility-mapping-dementia-lewy-bodies</link>
 <description>Neuroimage Clin. 2026 May 1;50:104000.  Epub 2026 May 1&lt;br&gt;Authors: Capogna E, Venturi G, Motta L, Manners DN, Braghittoni D, Guidi L, Baldelli L, Calandra-Buonaura G, Sambati L, Venneri A, Tonon C, Mitolo M, Lodi R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42105648&quot;&gt;42105648&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/role-quantitative-susceptibility-mapping-dementia-lewy-bodies#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/role-quantitative-susceptibility-mapping-dementia-lewy-bodies#comments</comments>
</item>
<item>
 <title>Racial and Ethnic Representation in Dementia Clinical Trials Registered on ClinicalTrials.gov in the United States, United Kingdom, and Canada.</title>
 <link>https://www.alzforum.org/papers/racial-and-ethnic-representation-dementia-clinical-trials-registered-clinicaltrialsgov-united</link>
 <description>Int J Geriatr Psychiatry. 2026 May;41(5):e70211. &lt;br&gt;Authors: Kramarczyk D, Ballard C, Corbett A, Da Silva MV, Mcleish KI, Cummings J, Khan Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42104909&quot;&gt;42104909&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/racial-and-ethnic-representation-dementia-clinical-trials-registered-clinicaltrialsgov-united#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/racial-and-ethnic-representation-dementia-clinical-trials-registered-clinicaltrialsgov-united#comments</comments>
</item>
<item>
 <title>Correspondence of Basal Forebrain Resting-State Functional Connectivity and Cerebral Glucose Metabolism Alterations With Neurotransmitter Maps in Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/correspondence-basal-forebrain-resting-state-functional-connectivity-and-cerebral-glucose</link>
 <description>CNS Neurosci Ther. 2026 May;32(5):e70901. &lt;br&gt;Authors: He Y, Xue H, Bi S, Wang Y, Liu X, Li Y, Chen Z, Rong D, Cui B, Ma J, Yan S, Lu J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42104858&quot;&gt;42104858&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/correspondence-basal-forebrain-resting-state-functional-connectivity-and-cerebral-glucose#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/correspondence-basal-forebrain-resting-state-functional-connectivity-and-cerebral-glucose#comments</comments>
</item>
<item>
 <title>The Montreal Cognitive Assessment at the Framingham Heart Study: A Re-Examination of the Norms.</title>
 <link>https://www.alzforum.org/papers/montreal-cognitive-assessment-framingham-heart-study-re-examination-norms</link>
 <description>Brain Behav. 2026 May;16(5):e71487. &lt;br&gt;Authors: Muller E, Guan C, Gifford KA, Sunderaraman P, Devine S, Liu Y, Hwang PH, Gurnani AS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42112960&quot;&gt;42112960&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/montreal-cognitive-assessment-framingham-heart-study-re-examination-norms#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/montreal-cognitive-assessment-framingham-heart-study-re-examination-norms#comments</comments>
</item>
<item>
 <title>Corneal Immune Cell Alterations and Tau Pathology in a Mouse Model of Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/corneal-immune-cell-alterations-and-tau-pathology-mouse-model-alzheimers-disease</link>
 <description>Invest Ophthalmol Vis Sci. 2026 May 1;67(5):20. &lt;br&gt;Authors: Zhang D, Huang D, He J, Shen Y, Dai L, Shi L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42112683&quot;&gt;42112683&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/corneal-immune-cell-alterations-and-tau-pathology-mouse-model-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/corneal-immune-cell-alterations-and-tau-pathology-mouse-model-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Commentary on &quot;Peripheral Insulin Resistance and Alzheimer&#039;s Disease: Possible Mediators Including Extracellular Vesicles&quot;.</title>
 <link>https://www.alzforum.org/papers/commentary-peripheral-insulin-resistance-and-alzheimers-disease-possible-mediators-including</link>
 <description>Geriatr Gerontol Int. 2026 May;26(5):e70529. &lt;br&gt;Authors: Zhang P&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42108964&quot;&gt;42108964&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/commentary-peripheral-insulin-resistance-and-alzheimers-disease-possible-mediators-including#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/commentary-peripheral-insulin-resistance-and-alzheimers-disease-possible-mediators-including#comments</comments>
</item>
<item>
 <title>Sphingosine-1-Phosphate as an Immune-Metabolic Biomarker in Neurodegenerative Diseases.</title>
 <link>https://www.alzforum.org/papers/sphingosine-1-phosphate-immune-metabolic-biomarker-neurodegenerative-diseases</link>
 <description>J Clin Neurol. 2026 May;22(3):264-267. &lt;br&gt;Authors: Kim SH, Jin HK, Bae JS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42108841&quot;&gt;42108841&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/sphingosine-1-phosphate-immune-metabolic-biomarker-neurodegenerative-diseases#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/sphingosine-1-phosphate-immune-metabolic-biomarker-neurodegenerative-diseases#comments</comments>
</item>
<item>
 <title>Ginsenoside Rh2 Alleviates Alzheimer Disease Models via Effects on Ferroptosis-Related Neuroinflammation.</title>
 <link>https://www.alzforum.org/papers/ginsenoside-rh2-alleviates-alzheimer-disease-models-effects-ferroptosis-related</link>
 <description>J Biochem Mol Toxicol. 2026 May;40(5):e70860. &lt;br&gt;Authors: Meng Q, Li J, Xu G, Zhang W, Cao R, Cai K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42108759&quot;&gt;42108759&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/ginsenoside-rh2-alleviates-alzheimer-disease-models-effects-ferroptosis-related#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/ginsenoside-rh2-alleviates-alzheimer-disease-models-effects-ferroptosis-related#comments</comments>
</item>
<item>
 <title>Selective reduction of KCNA4 in vulnerable glutamatergic-serotonin neurons of the dorsal raphe nucleus in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/selective-reduction-kcna4-vulnerable-glutamatergic-serotonin-neurons-dorsal-raphe-nucleus</link>
 <description>Alzheimers Dement. 2026 May;22(5):e71317. &lt;br&gt;Authors: Kolling LJ, Balasubramanian N, Ismail S, Feller AJ, Alberhasky JM, Wang R, Jennings L, Hefti M, Marcinkiewcz CA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42117485&quot;&gt;42117485&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/selective-reduction-kcna4-vulnerable-glutamatergic-serotonin-neurons-dorsal-raphe-nucleus#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/selective-reduction-kcna4-vulnerable-glutamatergic-serotonin-neurons-dorsal-raphe-nucleus#comments</comments>
</item>
<item>
 <title>Insulin Receptor Isoform Pattern in Aged Normal and Alzheimer&#039;s Human Cortex.</title>
 <link>https://www.alzforum.org/papers/insulin-receptor-isoform-pattern-aged-normal-and-alzheimers-human-cortex</link>
 <description>J Neurochem. 2026 May;170(5):e70455. &lt;br&gt;Authors: Webb-Robinson C, Murray H, Turner CP, Palpagama T, Faull RL, Curtis MA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42117240&quot;&gt;42117240&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/insulin-receptor-isoform-pattern-aged-normal-and-alzheimers-human-cortex#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/insulin-receptor-isoform-pattern-aged-normal-and-alzheimers-human-cortex#comments</comments>
</item>
<item>
 <title>Disentangling treatment status from disease severity in studies of diabetes and Alzheimer&#039;s disease biomarkers.</title>
 <link>https://www.alzforum.org/papers/disentangling-treatment-status-disease-severity-studies-diabetes-and-alzheimers-disease</link>
 <description>Alzheimers Dement. 2026 May;22(5):e71465. &lt;br&gt;Authors: Fu Q, Yin X, Xu S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42115835&quot;&gt;42115835&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/disentangling-treatment-status-disease-severity-studies-diabetes-and-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/disentangling-treatment-status-disease-severity-studies-diabetes-and-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Technology access and preferences for remote assessments at Alzheimer&#039;s Disease Research Centers.</title>
 <link>https://www.alzforum.org/papers/technology-access-and-preferences-remote-assessments-alzheimers-disease-research-centers</link>
 <description>Alzheimers Dement. 2026 May;22(5):e71467. &lt;br&gt;Authors: Chan CK, Lane KA, Gao S, Adeoye-Olatunde OA, Shih P, Johnson DK, Saykin AJ, Wang S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42115824&quot;&gt;42115824&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/technology-access-and-preferences-remote-assessments-alzheimers-disease-research-centers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/technology-access-and-preferences-remote-assessments-alzheimers-disease-research-centers#comments</comments>
</item>
<item>
 <title>Minor neuropsychological deficits and stage 2 of Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/minor-neuropsychological-deficits-and-stage-2-alzheimers-disease</link>
 <description>Alzheimers Dement. 2026 May;22(5):e71458. &lt;br&gt;Authors: Stark M, Wagner M, Kuhn E, Roeske S, Amthauer H, Bartels C, Boecker H, Brosseron F, Buchert R, Buerger K, Daamen M, Drzezga A, Düzel E, Ersözlü E, Essler M, Ewers M, Fliessbach K, Glanz W, Hellmann-Regen J, Incesoy EI, Janowitz D, Kafali K, Kilimann I, Krause BJ, Kronmüller M, Laske C, Maier F, Maurer A, Michely J, Perneczky R, Peters O, Preis L, Priller J, Rauchmann BS, Reimold M, Rominger A, Schmid M, Schneider A, Sodenkamp S, Spottke A, Spruth EJ, Teipel S, Wiltfang J, Alzheimer´s Disease Neuroimaging Initiative (ADNI), Jessen F, Kleineidam L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42129577&quot;&gt;42129577&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/minor-neuropsychological-deficits-and-stage-2-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/minor-neuropsychological-deficits-and-stage-2-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Mandarin speech-based early detection of SCD: a feature-fusion residual network method.</title>
 <link>https://www.alzforum.org/papers/mandarin-speech-based-early-detection-scd-feature-fusion-residual-network-method</link>
 <description>Alzheimers Dement. 2026 May;22(5):e71460. &lt;br&gt;Authors: Liu Z, Che C, He G, Wu H, Cai L, Cui L, Liang L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42129462&quot;&gt;42129462&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mandarin-speech-based-early-detection-scd-feature-fusion-residual-network-method#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mandarin-speech-based-early-detection-scd-feature-fusion-residual-network-method#comments</comments>
</item>
<item>
 <title>Treating dementia with brain amyloid medications.</title>
 <link>https://www.alzforum.org/papers/treating-dementia-brain-amyloid-medications</link>
 <description>Can Fam Physician. 2026 May;72(5):330-331. &lt;br&gt;Authors: Kolber MR, Korownyk CS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42128656&quot;&gt;42128656&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/treating-dementia-brain-amyloid-medications#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/treating-dementia-brain-amyloid-medications#comments</comments>
</item>
<item>
 <title>Metabolomic ageing (MileAge) in mid-life predicts incident vascular, unspecified and all-cause dementia.</title>
 <link>https://www.alzforum.org/papers/metabolomic-ageing-mileage-mid-life-predicts-incident-vascular-unspecified-and-all-cause</link>
 <description>Alzheimers Dement. 2026 May;22(5):e71280. &lt;br&gt;Authors: Mutz J, Gilchrist L, Pain O, Proitsi P, Lewis CM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42126002&quot;&gt;42126002&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/metabolomic-ageing-mileage-mid-life-predicts-incident-vascular-unspecified-and-all-cause#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/metabolomic-ageing-mileage-mid-life-predicts-incident-vascular-unspecified-and-all-cause#comments</comments>
</item>
<item>
 <title>Value-based prices of emerging disease-modifying therapies for Alzheimer&#039;s disease in 174 countries: a cost-effectiveness and threshold analysis.</title>
 <link>https://www.alzforum.org/papers/value-based-prices-emerging-disease-modifying-therapies-alzheimers-disease-174-countries-cost</link>
 <description>Alzheimers Dement. 2026 May;22(5):e71308. &lt;br&gt;Authors: Hoang MT, Kahn JG, Saha S, Trépel D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42125995&quot;&gt;42125995&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/value-based-prices-emerging-disease-modifying-therapies-alzheimers-disease-174-countries-cost#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/value-based-prices-emerging-disease-modifying-therapies-alzheimers-disease-174-countries-cost#comments</comments>
</item>
<item>
 <title>Retinal Pathology and Synucleinopathy in the Visual Pathway of α-Synuclein Preformed Fibril Mouse Model of Parkinson&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/retinal-pathology-and-synucleinopathy-visual-pathway-synuclein-preformed-fibril-mouse-model</link>
 <description>Brain Behav. 2026 May;16(5):e71489. &lt;br&gt;Authors: Zhang Q, Qian XY, Peng T, Hou XO, Ma ZY, Huang J, Hu LF, Luo WF&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42133544&quot;&gt;42133544&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/retinal-pathology-and-synucleinopathy-visual-pathway-synuclein-preformed-fibril-mouse-model#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/retinal-pathology-and-synucleinopathy-visual-pathway-synuclein-preformed-fibril-mouse-model#comments</comments>
</item>
<item>
 <title>Exposure to Air Pollutants and Lewy Body and Parkinson Disease-Related Dementias.</title>
 <link>https://www.alzforum.org/papers/exposure-air-pollutants-and-lewy-body-and-parkinson-disease-related-dementias</link>
 <description>JAMA Netw Open. 2026 May 1;9(5):e2612601. &lt;br&gt;Authors: Davydow DS, Pontone GM, Okun MS, Armstrong MJ, Böttger TW, Geels C, Frohn LM, Brandt J, Dreier JW, Christensen J, Pedersen CB, Horsdal HT&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42133313&quot;&gt;42133313&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/exposure-air-pollutants-and-lewy-body-and-parkinson-disease-related-dementias#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/exposure-air-pollutants-and-lewy-body-and-parkinson-disease-related-dementias#comments</comments>
</item>
<item>
 <title>Glial Fibrillary Acidic Protein and Neurofilament Light Reference Intervals in Healthy Individuals.</title>
 <link>https://www.alzforum.org/papers/glial-fibrillary-acidic-protein-and-neurofilament-light-reference-intervals-healthy</link>
 <description>JAMA Netw Open. 2026 May 1;9(5):e2612793. &lt;br&gt;Authors: Rousset RZ, Honey MI, den Braber A, van der Flier WM, Holstege H, Lorenz L, Wessels MH, Killestein J, Huisman M, Kok A, Beekman M, Slagboom PE, Ligthart L, de Geus E, Verberk IM, Vermunt L, Teunissen CE&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42133312&quot;&gt;42133312&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/glial-fibrillary-acidic-protein-and-neurofilament-light-reference-intervals-healthy#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/glial-fibrillary-acidic-protein-and-neurofilament-light-reference-intervals-healthy#comments</comments>
</item>
<item>
 <title>Escin Attenuates Amyloid Beta 1-42-Induced Oxidative Stress, Apoptosis, and Neuroinflammation in Neuron-Like SH-SY5Y Cells.</title>
 <link>https://www.alzforum.org/papers/escin-attenuates-amyloid-beta-1-42-induced-oxidative-stress-apoptosis-and-neuroinflammation</link>
 <description>J Biochem Mol Toxicol. 2026 May;40(5):e70903. &lt;br&gt;Authors: Akar S, Alvur O, Evyapan G, Ozdem B, Porsuk Doru I&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42130250&quot;&gt;42130250&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/escin-attenuates-amyloid-beta-1-42-induced-oxidative-stress-apoptosis-and-neuroinflammation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/escin-attenuates-amyloid-beta-1-42-induced-oxidative-stress-apoptosis-and-neuroinflammation#comments</comments>
</item>
<item>
 <title>Brexpiprazole-Induced Pisa Syndrome in a Patient With Dementia With Lewy Bodies.</title>
 <link>https://www.alzforum.org/papers/brexpiprazole-induced-pisa-syndrome-patient-dementia-lewy-bodies</link>
 <description>Am J Ther. 2026 May-Jun 01;33(3):e271-e273. &lt;br&gt;Authors: Wang CH, Chen CY, Kuo SC, Yeh YW&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42101615&quot;&gt;42101615&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/brexpiprazole-induced-pisa-syndrome-patient-dementia-lewy-bodies#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/brexpiprazole-induced-pisa-syndrome-patient-dementia-lewy-bodies#comments</comments>
</item>
<item>
 <title>Proteomic comparison of human neural cell-derived extracellular vesicles and parental cells from Alzheimer&#039;s disease and cognitively normal individuals.</title>
 <link>https://www.alzforum.org/papers/proteomic-comparison-human-neural-cell-derived-extracellular-vesicles-and-parental-cells</link>
 <description>Sci China Life Sci. 2026 Apr 30; Epub 2026 Apr 30&lt;br&gt;Authors: Xin JY, Liu J, Dong HM, Yu HL, Xiao ZS, Hu JN, Jiang Q, Zhu YP, Feng L, Feng Y, Jia YJ, Yuan ZY, Yu ZY, Shi AY, Zeng GH, Wang J, Wang WY, Cheng L, Vella LJ, Li FZ, Masters CL, Wang YJ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42113447&quot;&gt;42113447&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/proteomic-comparison-human-neural-cell-derived-extracellular-vesicles-and-parental-cells#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/proteomic-comparison-human-neural-cell-derived-extracellular-vesicles-and-parental-cells#comments</comments>
</item>
<item>
 <title>The Gut Microbiota as a Mediator Linking the MIND Diet to Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/gut-microbiota-mediator-linking-mind-diet-alzheimers-disease</link>
 <description>Nutrients. 2026 Apr 30;18(9)&lt;br&gt;Authors: Ramezani F, Herfeh SS, Burke E&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42124045&quot;&gt;42124045&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/gut-microbiota-mediator-linking-mind-diet-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/gut-microbiota-mediator-linking-mind-diet-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Sex-Specific Patterns of Taste Dysfunction, Their Relationships with α-Synuclein Profiling, and Supervised Learning-Based Diagnosis in Parkinson&#039;s Disease (PD).</title>
 <link>https://www.alzforum.org/papers/sex-specific-patterns-taste-dysfunction-their-relationships-synuclein-profiling-and</link>
 <description>Int J Mol Sci. 2026 Apr 30;27(9)&lt;br&gt;Authors: Melis M, Angius F, Naciri LC, Sollai G, Deligia S, Fenu G, Mellino P, Pinna B, Crnjar R, Carta AR, Cossu G, Tomassini Barbarossa I&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42123627&quot;&gt;42123627&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/sex-specific-patterns-taste-dysfunction-their-relationships-synuclein-profiling-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/sex-specific-patterns-taste-dysfunction-their-relationships-synuclein-profiling-and#comments</comments>
</item>
<item>
 <title>The TREM2 R47H variant is associated with liver-plasma-brain axis dyshomeostasis in the 5xFAD mouse model of Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/trem2-r47h-variant-associated-liver-plasma-brain-axis-dyshomeostasis-5xfad-mouse-model</link>
 <description>Neurobiol Aging. 2026 Apr 29;165:24-37.  Epub 2026 Apr 29&lt;br&gt;Authors: Faraci G, Goodfriend B, Bishop J, Vu M, Avelar-Barragan J, Dunham SJ, Rothman JA, Whiteson KL, Cheema AK, Milinkeviciute G, Tenner AJ, LaFerla FM, MacGregor GR, Green KN, Mapstone M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42102578&quot;&gt;42102578&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/trem2-r47h-variant-associated-liver-plasma-brain-axis-dyshomeostasis-5xfad-mouse-model#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/trem2-r47h-variant-associated-liver-plasma-brain-axis-dyshomeostasis-5xfad-mouse-model#comments</comments>
</item>
<item>
 <title>Natural Products as a Pipeline for Next-Generation Neurodegenerative Drugs: From Single-Target Failure to Multi-Target Opportunity in Alzheimer&#039;s and Parkinson&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/natural-products-pipeline-next-generation-neurodegenerative-drugs-single-target-failure-multi</link>
 <description>Molecules. 2026 Apr 29;31(9)&lt;br&gt;Authors: Habtemariam S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42123855&quot;&gt;42123855&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/natural-products-pipeline-next-generation-neurodegenerative-drugs-single-target-failure-multi#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/natural-products-pipeline-next-generation-neurodegenerative-drugs-single-target-failure-multi#comments</comments>
</item>
<item>
 <title>Regulation of Tau Alternative Splicing: A Novel Role for the Ribonucleoprotein RBM20.</title>
 <link>https://www.alzforum.org/papers/regulation-tau-alternative-splicing-novel-role-ribonucleoprotein-rbm20</link>
 <description>Int J Mol Sci. 2026 Apr 29;27(9)&lt;br&gt;Authors: Corsi A, Valentino A, Bruno MG, Menichetti G, Belpinati F, Pereira MP, Valenti MT, Ruggiero A, Trabetti E, Bombieri C, Romanelli MG&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42123583&quot;&gt;42123583&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/regulation-tau-alternative-splicing-novel-role-ribonucleoprotein-rbm20#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/regulation-tau-alternative-splicing-novel-role-ribonucleoprotein-rbm20#comments</comments>
</item>
<item>
 <title>Small-Molecule Targeting of the Iron-Responsive Element in the APP mRNA 5&#039;-UTR to Control Amyloid Translation in Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/small-molecule-targeting-iron-responsive-element-app-mrna-5-utr-control-amyloid-translation</link>
 <description>Int J Mol Sci. 2026 Apr 29;27(9)&lt;br&gt;Authors: Khan MA, Shaibah HS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42123557&quot;&gt;42123557&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/small-molecule-targeting-iron-responsive-element-app-mrna-5-utr-control-amyloid-translation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/small-molecule-targeting-iron-responsive-element-app-mrna-5-utr-control-amyloid-translation#comments</comments>
</item>
<item>
 <title>Extracellular Vesicles in Alzheimer&#039;s Disease: Mechanisms, Biomarkers, and Therapeutic Engineering.</title>
 <link>https://www.alzforum.org/papers/extracellular-vesicles-alzheimers-disease-mechanisms-biomarkers-and-therapeutic-engineering</link>
 <description>Int J Mol Sci. 2026 Apr 29;27(9)&lt;br&gt;Authors: Wang L, Mao L, Zong X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42123555&quot;&gt;42123555&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/extracellular-vesicles-alzheimers-disease-mechanisms-biomarkers-and-therapeutic-engineering#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/extracellular-vesicles-alzheimers-disease-mechanisms-biomarkers-and-therapeutic-engineering#comments</comments>
</item>
<item>
 <title>The Role of Antidiabetic Therapies in Mild Cognitive Impairment and Alzheimer&#039;s Disease: A Systematic Review of Metformin, Pioglitazone, and GLP-1 Receptor Agonists.</title>
 <link>https://www.alzforum.org/papers/role-antidiabetic-therapies-mild-cognitive-impairment-and-alzheimers-disease-systematic</link>
 <description>Int J Mol Sci. 2026 Apr 29;27(9)&lt;br&gt;Authors: Mahoon DA, Hamad O, Butler AE&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42123553&quot;&gt;42123553&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/role-antidiabetic-therapies-mild-cognitive-impairment-and-alzheimers-disease-systematic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/role-antidiabetic-therapies-mild-cognitive-impairment-and-alzheimers-disease-systematic#comments</comments>
</item>
<item>
 <title>Autophagy-Neuroinflammation Axis in Neurodegenerative Diseases: Mechanisms and Therapeutic Potential.</title>
 <link>https://www.alzforum.org/papers/autophagy-neuroinflammation-axis-neurodegenerative-diseases-mechanisms-and-therapeutic</link>
 <description>Cells. 2026 Apr 29;15(9)&lt;br&gt;Authors: Sun L, Zou Y, Wang L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42121914&quot;&gt;42121914&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/autophagy-neuroinflammation-axis-neurodegenerative-diseases-mechanisms-and-therapeutic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/autophagy-neuroinflammation-axis-neurodegenerative-diseases-mechanisms-and-therapeutic#comments</comments>
</item>
<item>
 <title>GLP-1 and Parkinson&#039;s Disease: A Comprehensive Review of Biology, Mechanisms and Efficacy.</title>
 <link>https://www.alzforum.org/papers/glp-1-and-parkinsons-disease-comprehensive-review-biology-mechanisms-and-efficacy</link>
 <description>Cells. 2026 Apr 29;15(9)&lt;br&gt;Authors: Mezabrovschi R, Gegg ME, Schapira AH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42121905&quot;&gt;42121905&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/glp-1-and-parkinsons-disease-comprehensive-review-biology-mechanisms-and-efficacy#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/glp-1-and-parkinsons-disease-comprehensive-review-biology-mechanisms-and-efficacy#comments</comments>
</item>
<item>
 <title>Macro-event processing in Alzheimer&#039;s disease, mild cognitive impairment, and healthy aging: Evidence from a Turkish sample.</title>
 <link>https://www.alzforum.org/papers/macro-event-processing-alzheimers-disease-mild-cognitive-impairment-and-healthy-aging</link>
 <description>Cortex. 2026 Apr 28;200:216-236.  Epub 2026 Apr 28&lt;br&gt;Authors: Karalı FS, Tosun S, Çınar N, Gerwien J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42105724&quot;&gt;42105724&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/macro-event-processing-alzheimers-disease-mild-cognitive-impairment-and-healthy-aging#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/macro-event-processing-alzheimers-disease-mild-cognitive-impairment-and-healthy-aging#comments</comments>
</item>
<item>
 <title>Long-Chain Fatty Acids as Drivers of Neuroinflammation in Neurodegeneration: Mechanistic Links to Lipid Peroxidation, Ferroptosis, and Mitochondrial Dysfunction.</title>
 <link>https://www.alzforum.org/papers/long-chain-fatty-acids-drivers-neuroinflammation-neurodegeneration-mechanistic-links-lipid</link>
 <description>Nutrients. 2026 Apr 28;18(9)&lt;br&gt;Authors: Christodoulou RC, Lorentzen L, Eller D, Vassiliou E&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42123994&quot;&gt;42123994&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/long-chain-fatty-acids-drivers-neuroinflammation-neurodegeneration-mechanistic-links-lipid#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/long-chain-fatty-acids-drivers-neuroinflammation-neurodegeneration-mechanistic-links-lipid#comments</comments>
</item>
<item>
 <title>Serum Neurofilament Light Chain and GFAP Levels Are Associated with Structural Brain Connectivity in Parkinson&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/serum-neurofilament-light-chain-and-gfap-levels-are-associated-structural-brain-connectivity</link>
 <description>Int J Mol Sci. 2026 Apr 28;27(9)&lt;br&gt;Authors: Bonacci MC, Buonocore J, Calomino C, Bianco MG, Battocchio M, Bontempi P, Daducci A, Cristiani CM, Quattrone A, Caligiuri ME, Quattrone A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42123514&quot;&gt;42123514&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/serum-neurofilament-light-chain-and-gfap-levels-are-associated-structural-brain-connectivity#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/serum-neurofilament-light-chain-and-gfap-levels-are-associated-structural-brain-connectivity#comments</comments>
</item>
<item>
 <title>Genome-Wide CRISPR Screening Identifies Genetic Modulators of Amyloid Precursor Protein Processing.</title>
 <link>https://www.alzforum.org/papers/genome-wide-crispr-screening-identifies-genetic-modulators-amyloid-precursor-protein</link>
 <description>Int J Mol Sci. 2026 Apr 28;27(9)&lt;br&gt;Authors: Li Y, Yao Y, Xu Z, Xiong Y, Zhang C, Yu L, Gao H, Fei T&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42123509&quot;&gt;42123509&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/genome-wide-crispr-screening-identifies-genetic-modulators-amyloid-precursor-protein#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/genome-wide-crispr-screening-identifies-genetic-modulators-amyloid-precursor-protein#comments</comments>
</item>
<item>
 <title>Re-Purposing a Rho-Associated Coiled-Coil Kinase (ROCK) Inhibitor for Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/re-purposing-rho-associated-coiled-coil-kinase-rock-inhibitor-alzheimers-disease</link>
 <description>J Clin Med. 2026 Apr 28;15(9)&lt;br&gt;Authors: Cambi X, Liu Z, Guo K, Xia W&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42123112&quot;&gt;42123112&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/re-purposing-rho-associated-coiled-coil-kinase-rock-inhibitor-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/re-purposing-rho-associated-coiled-coil-kinase-rock-inhibitor-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Early Müller Glial Activation and Retinal Ganglion Cell Synaptic Dysfunction in APP/PS1 Mice.</title>
 <link>https://www.alzforum.org/papers/early-muller-glial-activation-and-retinal-ganglion-cell-synaptic-dysfunction-appps1-mice</link>
 <description>Cells. 2026 Apr 28;15(9)&lt;br&gt;Authors: Zhou Y, Qi G, Zhou H, Gong P, Wang Z, Song X, Tian C, Wu H, Qin S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42121902&quot;&gt;42121902&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/early-muller-glial-activation-and-retinal-ganglion-cell-synaptic-dysfunction-appps1-mice#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/early-muller-glial-activation-and-retinal-ganglion-cell-synaptic-dysfunction-appps1-mice#comments</comments>
</item>
<item>
 <title>Amyloid Precursor Protein Abnormalities Destabilize Membrane Ferroportin: A Novel Mechanism Underlying Early Brain Pathologies and Memory Impairment in Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/amyloid-precursor-protein-abnormalities-destabilize-membrane-ferroportin-novel-mechanism</link>
 <description>Int J Mol Sci. 2026 Apr 27;27(9)&lt;br&gt;Authors: Xiao Y, Huang W, Chen L, Huang R, Guo Y, Liu W, Wang X, Wang J, Bao J, Shu X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42123478&quot;&gt;42123478&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/amyloid-precursor-protein-abnormalities-destabilize-membrane-ferroportin-novel-mechanism#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/amyloid-precursor-protein-abnormalities-destabilize-membrane-ferroportin-novel-mechanism#comments</comments>
</item>
<item>
 <title>Suppression of Tau Phosphorylation Induces Neurotoxicity, Causing Developmental Defects and Degeneration in C. elegans.</title>
 <link>https://www.alzforum.org/papers/suppression-tau-phosphorylation-induces-neurotoxicity-causing-developmental-defects-and</link>
 <description>Cells. 2026 Apr 27;15(9)&lt;br&gt;Authors: Lu MP, Rong Y, Wang J, Yu X, Liu H, Wu Y, Zhang M, Chen Y, Li Y, Yan Y, Liu A, Li Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42121894&quot;&gt;42121894&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/suppression-tau-phosphorylation-induces-neurotoxicity-causing-developmental-defects-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/suppression-tau-phosphorylation-induces-neurotoxicity-causing-developmental-defects-and#comments</comments>
</item>
<item>
 <title>Distinct Molecular Mechanisms Underlie Modulation of Seeded α-Synuclein Aggregation and Toxicity by Salvianolic Acid B and Dihydromyricetin.</title>
 <link>https://www.alzforum.org/papers/distinct-molecular-mechanisms-underlie-modulation-seeded-synuclein-aggregation-and-toxicity</link>
 <description>Int J Mol Sci. 2026 Apr 26;27(9)&lt;br&gt;Authors: Vaikath NN, Achkar IW, Sudhakaran IP, Abdi IY, Ponraj J, El-Agnaf OM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42123431&quot;&gt;42123431&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/distinct-molecular-mechanisms-underlie-modulation-seeded-synuclein-aggregation-and-toxicity#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/distinct-molecular-mechanisms-underlie-modulation-seeded-synuclein-aggregation-and-toxicity#comments</comments>
</item>
<item>
 <title>Anomic primary progressive aphasia with kanji-predominant dyslexia and dysgraphia.</title>
 <link>https://www.alzforum.org/papers/anomic-primary-progressive-aphasia-kanji-predominant-dyslexia-and-dysgraphia</link>
 <description>Cortex. 2026 Apr 25;200:116-123.  Epub 2026 Apr 25&lt;br&gt;Authors: Ota S, Kakinuma K, Katsuse K, Kawakami N, Morita A, Kawamura A, Ogawa N, Iseki C, Kanno S, Matsuda M, Suzuki K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42102541&quot;&gt;42102541&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/anomic-primary-progressive-aphasia-kanji-predominant-dyslexia-and-dysgraphia#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/anomic-primary-progressive-aphasia-kanji-predominant-dyslexia-and-dysgraphia#comments</comments>
</item>
<item>
 <title>Baseline brain volumes predict cognitive decline more robustly than atrophy rates: Evidence for brain reserve.</title>
 <link>https://www.alzforum.org/papers/baseline-brain-volumes-predict-cognitive-decline-more-robustly-atrophy-rates-evidence-brain</link>
 <description>Cortex. 2026 Apr 24;200:200-215.  Epub 2026 Apr 24&lt;br&gt;Authors: Sambuco N, Scaramuzzi GF, Gasparre D, Cornacchia E, Bonvino A, Antonucci LA, Pergola G, Taurisano P&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42105723&quot;&gt;42105723&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/baseline-brain-volumes-predict-cognitive-decline-more-robustly-atrophy-rates-evidence-brain#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/baseline-brain-volumes-predict-cognitive-decline-more-robustly-atrophy-rates-evidence-brain#comments</comments>
</item>
<item>
 <title>Human and Mouse Alpha-Synuclein Fibrillation: Impact on h-FTAA Binding and Advancing Strain-Specific Biomarkers in PD Animal Models.</title>
 <link>https://www.alzforum.org/papers/human-and-mouse-alpha-synuclein-fibrillation-impact-h-ftaa-binding-and-advancing-strain</link>
 <description>Int J Mol Sci. 2026 Apr 24;27(9)&lt;br&gt;Authors: Swaminathan P, Theologidis V, Gram H, Chatterjee D, Hammarström P, Van Den Berge N, Lindgren M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42123392&quot;&gt;42123392&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/human-and-mouse-alpha-synuclein-fibrillation-impact-h-ftaa-binding-and-advancing-strain#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/human-and-mouse-alpha-synuclein-fibrillation-impact-h-ftaa-binding-and-advancing-strain#comments</comments>
</item>
<item>
 <title>Targeting Neuroinflammation and Oxidative Stress to Slow Neurodegeneration in the Visual System.</title>
 <link>https://www.alzforum.org/papers/targeting-neuroinflammation-and-oxidative-stress-slow-neurodegeneration-visual-system</link>
 <description>J Clin Med. 2026 Apr 24;15(9)&lt;br&gt;Authors: Shakaki N, Yu M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42122986&quot;&gt;42122986&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/targeting-neuroinflammation-and-oxidative-stress-slow-neurodegeneration-visual-system#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/targeting-neuroinflammation-and-oxidative-stress-slow-neurodegeneration-visual-system#comments</comments>
</item>
<item>
 <title>Assessing the Relationship Between Volumetric Changes and Functional Connectivity in Patients with Mild Cognitive Impairment.</title>
 <link>https://www.alzforum.org/papers/assessing-relationship-between-volumetric-changes-and-functional-connectivity-patients-mild</link>
 <description>J Clin Med. 2026 Apr 23;15(9)&lt;br&gt;Authors: Machaj W, Podgorski P, Maciaszek J, Szczesniak D, Rymaszewska J, Piotrowski P, Zimny A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42122964&quot;&gt;42122964&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/assessing-relationship-between-volumetric-changes-and-functional-connectivity-patients-mild#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/assessing-relationship-between-volumetric-changes-and-functional-connectivity-patients-mild#comments</comments>
</item>
<item>
 <title>The Possible Significance of Proteomics in Understanding Molecular Mechanisms of Progressive Supranuclear Palsy, Corticobasal Degeneration, Multiple System Atrophy, and Dementia with Lewy Bodies.</title>
 <link>https://www.alzforum.org/papers/possible-significance-proteomics-understanding-molecular-mechanisms-progressive-supranuclear</link>
 <description>Cells. 2026 Apr 23;15(9)&lt;br&gt;Authors: Madetko-Alster N, Otto-Ślusarczyk D, Struga M, Alster P&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42121860&quot;&gt;42121860&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/possible-significance-proteomics-understanding-molecular-mechanisms-progressive-supranuclear#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/possible-significance-proteomics-understanding-molecular-mechanisms-progressive-supranuclear#comments</comments>
</item>
<item>
 <title>Cytoskeletal Imbalance and Axonal Vulnerability in Sporadic PSP-RS: Early Changes in a Human iPSC-Derived Neuronal Model with Altered mTOR Signaling.</title>
 <link>https://www.alzforum.org/papers/cytoskeletal-imbalance-and-axonal-vulnerability-sporadic-psp-rs-early-changes-human-ipsc</link>
 <description>Cells. 2026 Apr 23;15(9)&lt;br&gt;Authors: Covello R, Benedetto GL, Scalise S, Gabriele C, Valente D, Zannino C, Puccio B, Quattrone A, Guzzi PH, Gaspari M, Quattrone A, Cuda G, Parrotta EI&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42121856&quot;&gt;42121856&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cytoskeletal-imbalance-and-axonal-vulnerability-sporadic-psp-rs-early-changes-human-ipsc#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cytoskeletal-imbalance-and-axonal-vulnerability-sporadic-psp-rs-early-changes-human-ipsc#comments</comments>
</item>
<item>
 <title>Imaging Strategies for Acupuncture Intervention in Alzheimer&#039;s Disease Model Mice.</title>
 <link>https://www.alzforum.org/papers/imaging-strategies-acupuncture-intervention-alzheimers-disease-model-mice</link>
 <description>J Vis Exp. 2026 Apr 21;(230)&lt;br&gt;Authors: Sun R, Wang J, Liu S, Tian H, Wang X, Zhang Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42113787&quot;&gt;42113787&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/imaging-strategies-acupuncture-intervention-alzheimers-disease-model-mice#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/imaging-strategies-acupuncture-intervention-alzheimers-disease-model-mice#comments</comments>
</item>
<item>
 <title>Comment on &quot;profiling mitochondrial DNA indices across whole blood, plasma, and CSF in amyotrophic lateral sclerosis&quot;.</title>
 <link>https://www.alzforum.org/papers/comment-profiling-mitochondrial-dna-indices-across-whole-blood-plasma-and-csf-amyotrophic</link>
 <description>J Neurol Sci. 2026 Apr 15;487:125920.  Epub 2026 Apr 15&lt;br&gt;Authors: Shubham, Mathur A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42114311&quot;&gt;42114311&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/comment-profiling-mitochondrial-dna-indices-across-whole-blood-plasma-and-csf-amyotrophic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/comment-profiling-mitochondrial-dna-indices-across-whole-blood-plasma-and-csf-amyotrophic#comments</comments>
</item>
<item>
 <title>Piperine-loaded solid dispersions mitigate amyloid-β-mediated oxidative stress and mitochondrial dysfunction in SH-SY5Y cells: A possible therapeutic strategy for Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/piperine-loaded-solid-dispersions-mitigate-amyloid-v-mediated-oxidative-stress-and</link>
 <description>J Pharmacol Exp Ther. 2026 Apr 8;393(5):104788.  Epub 2026 Apr 8&lt;br&gt;Authors: Mishra J, Singh C, Bhatti JS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42119549&quot;&gt;42119549&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/piperine-loaded-solid-dispersions-mitigate-amyloid-v-mediated-oxidative-stress-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/piperine-loaded-solid-dispersions-mitigate-amyloid-v-mediated-oxidative-stress-and#comments</comments>
</item>
<item>
 <title>Reduced CB1 Cannabinoid Receptor Expression in Alzheimer&#039;s Disease and Transgenic Mouse Models.</title>
 <link>https://www.alzforum.org/papers/reduced-cb1-cannabinoid-receptor-expression-alzheimers-disease-and-transgenic-mouse-models</link>
 <description>Aging Med (Milton). 2026 Apr;9(2):168-184.  Epub 2026 Apr 24&lt;br&gt;Authors: von Borcke N, Purwien AV, Steiert A, Hasecke H, Bouter Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42130756&quot;&gt;42130756&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/reduced-cb1-cannabinoid-receptor-expression-alzheimers-disease-and-transgenic-mouse-models#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/reduced-cb1-cannabinoid-receptor-expression-alzheimers-disease-and-transgenic-mouse-models#comments</comments>
</item>
<item>
 <title>Neurodegenerative biomarkers and heart failure: is there a neurodegenerative cardiomyopathy? a systematic review and meta-analysis.</title>
 <link>https://www.alzforum.org/papers/neurodegenerative-biomarkers-and-heart-failure-there-neurodegenerative-cardiomyopathy</link>
 <description>J Geriatr Cardiol. 2026 Mar 28;23(3):152-172. &lt;br&gt;Authors: Shokravi A, Luo Y, Rabkin SW&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42109758&quot;&gt;42109758&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/neurodegenerative-biomarkers-and-heart-failure-there-neurodegenerative-cardiomyopathy#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/neurodegenerative-biomarkers-and-heart-failure-there-neurodegenerative-cardiomyopathy#comments</comments>
</item>
<item>
 <title>[Preliminary validation of the Quebec French version of the Memory Binding Test: Comparison with the Rey Auditory Verbal Learning Test in adults aged 55 and older].</title>
 <link>https://www.alzforum.org/papers/preliminary-validation-quebec-french-version-memory-binding-test-comparison-rey-auditory</link>
 <description>Geriatr Psychol Neuropsychiatr Vieil. 2026 Mar 1;24(1):90-101. &lt;br&gt;Authors: Laflamme E, Rioux É, Breton C, Brizard N, Desjardins S, Gagnon S, Laplante A, Pépin É, Boller B, Vallet GT&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42112644&quot;&gt;42112644&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/preliminary-validation-quebec-french-version-memory-binding-test-comparison-rey-auditory#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/preliminary-validation-quebec-french-version-memory-binding-test-comparison-rey-auditory#comments</comments>
</item>
<item>
 <title>[Historical approach to late visual hallucinations, from Charles Bonnet to Lewy body disease].</title>
 <link>https://www.alzforum.org/papers/historical-approach-late-visual-hallucinations-charles-bonnet-lewy-body-disease</link>
 <description>Geriatr Psychol Neuropsychiatr Vieil. 2026 Mar 1;24(1):60-70. &lt;br&gt;Authors: Albou P&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42112641&quot;&gt;42112641&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/historical-approach-late-visual-hallucinations-charles-bonnet-lewy-body-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/historical-approach-late-visual-hallucinations-charles-bonnet-lewy-body-disease#comments</comments>
</item>
<item>
 <title>[Late-onset frontotemporal degenerations].</title>
 <link>https://www.alzforum.org/papers/late-onset-frontotemporal-degenerations</link>
 <description>Geriatr Psychol Neuropsychiatr Vieil. 2026 Mar 1;24(1):42-58. &lt;br&gt;Authors: Bertrand F, Gaudiez A, Valadoux AS, Delbeuck X, Deramecourt V, Lebouvier T&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42112640&quot;&gt;42112640&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/late-onset-frontotemporal-degenerations#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/late-onset-frontotemporal-degenerations#comments</comments>
</item>
<item>
 <title>Biases and consistency of different assay methods for neurological biomarkers using Quanterix single-molecule-array technology: A secondary analysis method comparison study.</title>
 <link>https://www.alzforum.org/papers/biases-and-consistency-different-assay-methods-neurological-biomarkers-using-quanterix-single</link>
 <description>NeuroMarkers. 2026 Mar;3(1) Epub 2025 Nov 19&lt;br&gt;Authors: Go KD, Hutchison J, Wang K, Karikari TK, Mondello S, Diaz-Arrastia R, Puccio A, Stukas S, Cooper JG, Wellington CL&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42131469&quot;&gt;42131469&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/biases-and-consistency-different-assay-methods-neurological-biomarkers-using-quanterix-single#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/biases-and-consistency-different-assay-methods-neurological-biomarkers-using-quanterix-single#comments</comments>
</item>
<item>
 <title>Sleep quality metrics combined with virtual reality motion parameters enhance early detection of mild cognitive impairment.</title>
 <link>https://www.alzforum.org/papers/sleep-quality-metrics-combined-virtual-reality-motion-parameters-enhance-early-detection-mild</link>
 <description>Front Psychiatry. 2026;17:1727576.  Epub 2026 Apr 22&lt;br&gt;Authors: Zhang R, Sun H, Di Y, Cao H, Zhang C, Yao H, Yan H, Ding D, He Q, Wu T&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42100782&quot;&gt;42100782&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/sleep-quality-metrics-combined-virtual-reality-motion-parameters-enhance-early-detection-mild#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/sleep-quality-metrics-combined-virtual-reality-motion-parameters-enhance-early-detection-mild#comments</comments>
</item>
<item>
 <title>Neuroprotective cellular and molecular mechanisms of physical exercise on neurodegenerative diseases.</title>
 <link>https://www.alzforum.org/papers/neuroprotective-cellular-and-molecular-mechanisms-physical-exercise-neurodegenerative</link>
 <description>ADMET DMPK. 2026;14:3058.  Epub 2026 Mar 11&lt;br&gt;Authors: Sahoo SS, Sahu PK, Sa N, Behera A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42100633&quot;&gt;42100633&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/neuroprotective-cellular-and-molecular-mechanisms-physical-exercise-neurodegenerative#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/neuroprotective-cellular-and-molecular-mechanisms-physical-exercise-neurodegenerative#comments</comments>
</item>
<item>
 <title>The characteristics and performance of health data domains in supporting dementia identification: A systematic review.</title>
 <link>https://www.alzforum.org/papers/characteristics-and-performance-health-data-domains-supporting-dementia-identification</link>
 <description>Alzheimers Dement (Amst). 2026;18(2):e70313.  Epub 2026 May 6&lt;br&gt;Authors: Siette J, Kim JW, Zammit JL, Butt A, Sonego S, Ginige JA, Georgiou A, Low LF&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42100599&quot;&gt;42100599&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/characteristics-and-performance-health-data-domains-supporting-dementia-identification#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/characteristics-and-performance-health-data-domains-supporting-dementia-identification#comments</comments>
</item>
<item>
 <title>Social engagement, pleasure, and memory in musical reminiscence workshops for individuals with Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/social-engagement-pleasure-and-memory-musical-reminiscence-workshops-individuals-alzheimers</link>
 <description>Front Hum Neurosci. 2026;20:1803210.  Epub 2026 Apr 22&lt;br&gt;Authors: Genguelou M, Platel H, Bourgeois C, Gambonnet M, Bayard S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42100568&quot;&gt;42100568&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/social-engagement-pleasure-and-memory-musical-reminiscence-workshops-individuals-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/social-engagement-pleasure-and-memory-musical-reminiscence-workshops-individuals-alzheimers#comments</comments>
</item>
<item>
 <title>Secretory form of viral protease NIa ameliorates amyloid-β pathology and cognitive deficits in a mouse model of Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/secretory-form-viral-protease-nia-ameliorates-amyloid-v-pathology-and-cognitive-deficits</link>
 <description>Front Aging Neurosci. 2026;18:1720518.  Epub 2026 Apr 22&lt;br&gt;Authors: Park EJ, Mun BR, Kim SY, Elangovan M, Kim SB, Choi WS, Park WJ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42100486&quot;&gt;42100486&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/secretory-form-viral-protease-nia-ameliorates-amyloid-v-pathology-and-cognitive-deficits#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/secretory-form-viral-protease-nia-ameliorates-amyloid-v-pathology-and-cognitive-deficits#comments</comments>
</item>
<item>
 <title>Modulating the default mode network with deep TMS: a proof-of-concept framework with potential relevance to circuits implicated in lack of awareness of cognitive decline.</title>
 <link>https://www.alzforum.org/papers/modulating-default-mode-network-deep-tms-proof-concept-framework-potential-relevance-circuits</link>
 <description>Front Aging Neurosci. 2026;18:1742759.  Epub 2026 Apr 22&lt;br&gt;Authors: Bellaali Y, Sulcova D, Salatino A, Dricot L, Hanseeuw BJ, Woodard JL, Ivanoiu A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42100484&quot;&gt;42100484&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/modulating-default-mode-network-deep-tms-proof-concept-framework-potential-relevance-circuits#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/modulating-default-mode-network-deep-tms-proof-concept-framework-potential-relevance-circuits#comments</comments>
</item>
<item>
 <title>Limbic-predominant neuroimaging correlates of plasma p-Tau217 in preclinical and clinical Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/limbic-predominant-neuroimaging-correlates-plasma-p-tau217-preclinical-and-clinical</link>
 <description>Front Aging Neurosci. 2026;18:1748524.  Epub 2026 Apr 22&lt;br&gt;Authors: Patel A, Guiler W, Pepper S, Kemna RE, Kueck PJ, Weidling IW, Mayfield HD, John CS, Mudaranthakam DP, Wilkins HM, Swerdlow RH, Burns JM, Morris JK, Honea RA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42100483&quot;&gt;42100483&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/limbic-predominant-neuroimaging-correlates-plasma-p-tau217-preclinical-and-clinical#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/limbic-predominant-neuroimaging-correlates-plasma-p-tau217-preclinical-and-clinical#comments</comments>
</item>
<item>
 <title>Integrated transcriptomic profiling combined with in vitro validation reveals the involvement of TMEM140 in the link between periodontitis and brain aging.</title>
 <link>https://www.alzforum.org/papers/integrated-transcriptomic-profiling-combined-vitro-validation-reveals-involvement-tmem140</link>
 <description>Front Aging Neurosci. 2026;18:1761218.  Epub 2026 Apr 22&lt;br&gt;Authors: Zhao H, Wang H, Li W, Su R, Li J, Liu Y, Wang L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42100482&quot;&gt;42100482&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/integrated-transcriptomic-profiling-combined-vitro-validation-reveals-involvement-tmem140#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/integrated-transcriptomic-profiling-combined-vitro-validation-reveals-involvement-tmem140#comments</comments>
</item>
<item>
 <title>APOE ε4 as a predictor of cognitive decline and its interaction with hippocampal volume in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/apoe-e4-predictor-cognitive-decline-and-its-interaction-hippocampal-volume-alzheimers-disease</link>
 <description>Front Aging Neurosci. 2026;18:1730265.  Epub 2026 Apr 22&lt;br&gt;Authors: Khan FF, Kim JH, Kim JI, Kwon GR&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42100481&quot;&gt;42100481&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/apoe-e4-predictor-cognitive-decline-and-its-interaction-hippocampal-volume-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/apoe-e4-predictor-cognitive-decline-and-its-interaction-hippocampal-volume-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Modulation of programmed cell death by botanical drugs in Alzheimer&#039;s disease: a review from a traditional Chinese medicine perspective.</title>
 <link>https://www.alzforum.org/papers/modulation-programmed-cell-death-botanical-drugs-alzheimers-disease-review-traditional</link>
 <description>Front Pharmacol. 2026;17:1811185.  Epub 2026 Apr 22&lt;br&gt;Authors: Li B, Cui Z, Xu Y, Xu M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42100327&quot;&gt;42100327&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/modulation-programmed-cell-death-botanical-drugs-alzheimers-disease-review-traditional#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/modulation-programmed-cell-death-botanical-drugs-alzheimers-disease-review-traditional#comments</comments>
</item>
<item>
 <title>Correction: Edaravone plays protective effects on LPS-induced microglia by switching M1/M2 phenotypes and regulating NLRP3 inflammasome activation.</title>
 <link>https://www.alzforum.org/papers/correction-edaravone-plays-protective-effects-lps-induced-microglia-switching-m1m2-phenotypes</link>
 <description>Front Pharmacol. 2026;17:1774570.  Epub 2026 Apr 22&lt;br&gt;Authors: Li J, Dai X, Zhou L, Li X, Pan D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42100319&quot;&gt;42100319&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/correction-edaravone-plays-protective-effects-lps-induced-microglia-switching-m1m2-phenotypes#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/correction-edaravone-plays-protective-effects-lps-induced-microglia-switching-m1m2-phenotypes#comments</comments>
</item>
<item>
 <title>Clinical outcomes and anti-inflammatory mechanisms of nucleus basalis of Meynert deep brain stimulation in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/clinical-outcomes-and-anti-inflammatory-mechanisms-nucleus-basalis-meynert-deep-brain</link>
 <description>Front Neurol. 2026;17:1773910.  Epub 2026 Apr 22&lt;br&gt;Authors: Chen Y, Du T, Lian T, Jiang Y, Yuan T, Li J, Meng F, Yang A, Zhang W, Zhang J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42099973&quot;&gt;42099973&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/clinical-outcomes-and-anti-inflammatory-mechanisms-nucleus-basalis-meynert-deep-brain#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/clinical-outcomes-and-anti-inflammatory-mechanisms-nucleus-basalis-meynert-deep-brain#comments</comments>
</item>
<item>
 <title>The choroid plexus- cerebrospinal fluid axis as a lifespan regulator of neural stem cells and circuit plasticity.</title>
 <link>https://www.alzforum.org/papers/choroid-plexus-cerebrospinal-fluid-axis-lifespan-regulator-neural-stem-cells-and-circuit</link>
 <description>Front Neural Circuits. 2026;20:1818927.  Epub 2026 Apr 22&lt;br&gt;Authors: Rodrigues KS, Yamashita R, Katada S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42099804&quot;&gt;42099804&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/choroid-plexus-cerebrospinal-fluid-axis-lifespan-regulator-neural-stem-cells-and-circuit#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/choroid-plexus-cerebrospinal-fluid-axis-lifespan-regulator-neural-stem-cells-and-circuit#comments</comments>
</item>
<item>
 <title>Scoping review of episodic future thinking and delay discounting observed in Alzheimer&#039;s disease, depression, and PTSD.</title>
 <link>https://www.alzforum.org/papers/scoping-review-episodic-future-thinking-and-delay-discounting-observed-alzheimers-disease</link>
 <description>Front Psychol. 2026;17:1764387.  Epub 2026 Apr 22&lt;br&gt;Authors: Dubois JR, Kim E, Pando-Bravo J, Martin LE, Yi R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42099715&quot;&gt;42099715&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/scoping-review-episodic-future-thinking-and-delay-discounting-observed-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/scoping-review-episodic-future-thinking-and-delay-discounting-observed-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Nerve growth factor responsive elements modulate immune cell inflammation and are dysregulated in an Alzheimer&#039;s disease mouse model.</title>
 <link>https://www.alzforum.org/papers/nerve-growth-factor-responsive-elements-modulate-immune-cell-inflammation-and-are</link>
 <description>Front Immunol. 2026;17:1722477.  Epub 2026 Apr 23&lt;br&gt;Authors: Gera R, Mocci G, Tambaro S, Vanlandewijck M, Nilsson P, Eriksdotter M, Mitra S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42112371&quot;&gt;42112371&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/nerve-growth-factor-responsive-elements-modulate-immune-cell-inflammation-and-are#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/nerve-growth-factor-responsive-elements-modulate-immune-cell-inflammation-and-are#comments</comments>
</item>
<item>
 <title>Irisin hampers β-amyloid-induced microglial inflammation via the miR-451a/TLR4/NLRP3 axis.</title>
 <link>https://www.alzforum.org/papers/irisin-hampers-v-amyloid-induced-microglial-inflammation-mir-451atlr4nlrp3-axis</link>
 <description>Front Immunol. 2026;17:1761520.  Epub 2026 Apr 23&lt;br&gt;Authors: Mancuso R, Saresella M, Nuzzi R, Agostini S, Marventano I, Hernis A, La Rosa F, Piancone F, Clerici M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42112331&quot;&gt;42112331&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/irisin-hampers-v-amyloid-induced-microglial-inflammation-mir-451atlr4nlrp3-axis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/irisin-hampers-v-amyloid-induced-microglial-inflammation-mir-451atlr4nlrp3-axis#comments</comments>
</item>
<item>
 <title>Investigating white matter functional network connectivity across the Alzheimer&#039;s disease spectrum using resting-state fMRI.</title>
 <link>https://www.alzforum.org/papers/investigating-white-matter-functional-network-connectivity-across-alzheimers-disease-0</link>
 <description>Front Neuroimaging. 2026;5:1796824.  Epub 2026 Apr 23&lt;br&gt;Authors: Itkyal VS, LaGrow TJ, Jensen KM, Iraji A, Calhoun VD&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42112106&quot;&gt;42112106&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/investigating-white-matter-functional-network-connectivity-across-alzheimers-disease-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/investigating-white-matter-functional-network-connectivity-across-alzheimers-disease-0#comments</comments>
</item>
<item>
 <title>The modifier matrix: emerging roles of ubiquitin-like proteins in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/modifier-matrix-emerging-roles-ubiquitin-proteins-alzheimers-disease</link>
 <description>Mol Neurodegener Adv. 2026;2(1):18.  Epub 2026 May 8&lt;br&gt;Authors: Yan T, Vaquer J, Springer W, Fiesel FC&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42111249&quot;&gt;42111249&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/modifier-matrix-emerging-roles-ubiquitin-proteins-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/modifier-matrix-emerging-roles-ubiquitin-proteins-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Glial biomarkers improve classification of cognitive impairment: an explainable artificial intelligence study using CSF biomarkers.</title>
 <link>https://www.alzforum.org/papers/glial-biomarkers-improve-classification-cognitive-impairment-explainable-artificial</link>
 <description>Front Neurol. 2026;17:1787915.  Epub 2026 Apr 23&lt;br&gt;Authors: Türkegün Şengül M, Nemutlu Samur D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42111079&quot;&gt;42111079&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/glial-biomarkers-improve-classification-cognitive-impairment-explainable-artificial#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/glial-biomarkers-improve-classification-cognitive-impairment-explainable-artificial#comments</comments>
</item>
<item>
 <title>Efficacy and safety of pharmacological and biological therapies for amyotrophic lateral sclerosis: a network meta-analysis.</title>
 <link>https://www.alzforum.org/papers/efficacy-and-safety-pharmacological-and-biological-therapies-amyotrophic-lateral-sclerosis</link>
 <description>Front Neurol. 2026;17:1754716.  Epub 2026 Apr 24&lt;br&gt;Authors: Zhou S, Li X, Jiao Y, Wu J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42111077&quot;&gt;42111077&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/efficacy-and-safety-pharmacological-and-biological-therapies-amyotrophic-lateral-sclerosis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/efficacy-and-safety-pharmacological-and-biological-therapies-amyotrophic-lateral-sclerosis#comments</comments>
</item>
<item>
 <title>Genetic susceptibility and environmental factors in dementia with Lewy bodies: Converging pathogenic mechanisms.</title>
 <link>https://www.alzforum.org/papers/genetic-susceptibility-and-environmental-factors-dementia-lewy-bodies-converging-pathogenic</link>
 <description>Front Neurol. 2026;17:1825397.  Epub 2026 Apr 24&lt;br&gt;Authors: Berrios W, Golimstok A, Fernández MC&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42111061&quot;&gt;42111061&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/genetic-susceptibility-and-environmental-factors-dementia-lewy-bodies-converging-pathogenic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/genetic-susceptibility-and-environmental-factors-dementia-lewy-bodies-converging-pathogenic#comments</comments>
</item>
<item>
 <title>Leveraging Hamiltonian neural flow for robust single-cell multi-omics integration: application to Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/leveraging-hamiltonian-neural-flow-robust-single-cell-multi-omics-integration-application</link>
 <description>Front Genet. 2026;17:1795752.  Epub 2026 Apr 24&lt;br&gt;Authors: Huang Z, Kong W, Wang S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42110915&quot;&gt;42110915&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/leveraging-hamiltonian-neural-flow-robust-single-cell-multi-omics-integration-application#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/leveraging-hamiltonian-neural-flow-robust-single-cell-multi-omics-integration-application#comments</comments>
</item>
<item>
 <title>The importance of TNF-α signaling: a potential risk factor in neurodegenerative and cardiovascular diseases.</title>
 <link>https://www.alzforum.org/papers/importance-tnf-signaling-potential-risk-factor-neurodegenerative-and-cardiovascular-diseases</link>
 <description>Arch Med Sci. 2026 Jan;22(1):27-44.  Epub 2025 Apr 20&lt;br&gt;Authors: Białecka M, Białecka M, Machoy-Mokrzyńska A, Malinowski D, Rać M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42110595&quot;&gt;42110595&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/importance-tnf-signaling-potential-risk-factor-neurodegenerative-and-cardiovascular-diseases#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/importance-tnf-signaling-potential-risk-factor-neurodegenerative-and-cardiovascular-diseases#comments</comments>
</item>
<item>
 <title>Age- and sex-related glymphatic differences and hemispheric asymmetry in healthy adults at 7.0T magnetic resonance imaging.</title>
 <link>https://www.alzforum.org/papers/age-and-sex-related-glymphatic-differences-and-hemispheric-asymmetry-healthy-adults-70t</link>
 <description>Psychoradiology. 2026;6:kkag012.  Epub 2026 Mar 10&lt;br&gt;Authors: Yue Y, Tang X, Shen T, Qu B, Lv W, Zhang W, Feng S, Lai HY&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42110580&quot;&gt;42110580&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/age-and-sex-related-glymphatic-differences-and-hemispheric-asymmetry-healthy-adults-70t#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/age-and-sex-related-glymphatic-differences-and-hemispheric-asymmetry-healthy-adults-70t#comments</comments>
</item>
<item>
 <title>Efficacy and possible mechanism of Kai-xin-san in animal models of Alzheimer&#039;s disease: a systematic review and meta-analysis of preclinical studies.</title>
 <link>https://www.alzforum.org/papers/efficacy-and-possible-mechanism-kai-xin-san-animal-models-alzheimers-disease-systematic</link>
 <description>Front Pharmacol. 2026;17:1806181.  Epub 2026 Apr 23&lt;br&gt;Authors: Wang Y, Wang Q, Xie H, Liu X, Ju Y, Liu X, Sun S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42110549&quot;&gt;42110549&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/efficacy-and-possible-mechanism-kai-xin-san-animal-models-alzheimers-disease-systematic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/efficacy-and-possible-mechanism-kai-xin-san-animal-models-alzheimers-disease-systematic#comments</comments>
</item>
<item>
 <title>Unraveling the anti-neuroinflammatory mechanisms of Cervus cucumis polypeptide injection in Alzheimer&#039;s disease: insights from network pharmacology, molecular docking, molecular dynamics simulation, and experimental validation.</title>
 <link>https://www.alzforum.org/papers/unraveling-anti-neuroinflammatory-mechanisms-cervus-cucumis-polypeptide-injection-alzheimers</link>
 <description>Front Aging Neurosci. 2026;18:1797302.  Epub 2026 Apr 22&lt;br&gt;Authors: Fu X, Huang J, Liu Y, Li H, Zhang Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42109914&quot;&gt;42109914&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/unraveling-anti-neuroinflammatory-mechanisms-cervus-cucumis-polypeptide-injection-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/unraveling-anti-neuroinflammatory-mechanisms-cervus-cucumis-polypeptide-injection-alzheimers#comments</comments>
</item>
<item>
 <title>Editorial: Unravelling Aβ toxicity: implications for Alzheimer&#039;s cognitive and behavioral deficits.</title>
 <link>https://www.alzforum.org/papers/editorial-unravelling-av-toxicity-implications-alzheimers-cognitive-and-behavioral-deficits</link>
 <description>Front Aging Neurosci. 2026;18:1848776.  Epub 2026 Apr 23&lt;br&gt;Authors: Sharoar MG, Singh N, Hu XY&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42109913&quot;&gt;42109913&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/editorial-unravelling-av-toxicity-implications-alzheimers-cognitive-and-behavioral-deficits#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/editorial-unravelling-av-toxicity-implications-alzheimers-cognitive-and-behavioral-deficits#comments</comments>
</item>
<item>
 <title>Effects of Baduanjin exercise on working memory in mild cognitive impairment: an fNIRS-based randomized controlled trial.</title>
 <link>https://www.alzforum.org/papers/effects-baduanjin-exercise-working-memory-mild-cognitive-impairment-fnirs-based-randomized</link>
 <description>Front Aging Neurosci. 2026;18:1829586.  Epub 2026 Apr 23&lt;br&gt;Authors: Duan C, Chong Y, Zheng C, Li Z, Ai H, Sun Y, Zhang P, Zou G, Zhang Y, Xia W&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42109910&quot;&gt;42109910&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/effects-baduanjin-exercise-working-memory-mild-cognitive-impairment-fnirs-based-randomized#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/effects-baduanjin-exercise-working-memory-mild-cognitive-impairment-fnirs-based-randomized#comments</comments>
</item>
<item>
 <title>Noninvasive Terahertz Wave Binocular Stimulation Improves Cognition in Amyloid-β-Related Dementia.</title>
 <link>https://www.alzforum.org/papers/noninvasive-terahertz-wave-binocular-stimulation-improves-cognition-amyloid-v-related</link>
 <description>Research (Wash D C). 2026;9:1268.  Epub 2026 May 7&lt;br&gt;Authors: Wu H, Zhang T, Ma J, Yin J, Liu J, Lin H, Yu Y, He Y, Cheng W, Song Z, Chang C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42109888&quot;&gt;42109888&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/noninvasive-terahertz-wave-binocular-stimulation-improves-cognition-amyloid-v-related#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/noninvasive-terahertz-wave-binocular-stimulation-improves-cognition-amyloid-v-related#comments</comments>
</item>
<item>
 <title>Predicting progression of Alzheimer&#039;s disease using blood-based multi-omics data.</title>
 <link>https://www.alzforum.org/papers/predicting-progression-alzheimers-disease-using-blood-based-multi-omics-data</link>
 <description>Bioinform Adv. 2026;6(1):vbag085.  Epub 2026 Mar 28&lt;br&gt;Authors: Vashishath Y, Pijani BA, Goud Baddam N, Saeed F, Bozdag S, Alzheimer’s Disease Neuroimaging Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42109582&quot;&gt;42109582&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/predicting-progression-alzheimers-disease-using-blood-based-multi-omics-data#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/predicting-progression-alzheimers-disease-using-blood-based-multi-omics-data#comments</comments>
</item>
<item>
 <title>Peripheral oxidative stress related biomarkers in Alzheimer&#039;s disease: A systematic review of their implications for diagnosis and disease monitoring.</title>
 <link>https://www.alzforum.org/papers/peripheral-oxidative-stress-related-biomarkers-alzheimers-disease-systematic-review-their</link>
 <description>Alzheimers Dement (Amst). 2026;18:e70354.  Epub 2026 May 6&lt;br&gt;Authors: Osei GN, Kpelle L, Appiah F, Nartey K, Adu AM, Simpong DL, Afrifa J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42109539&quot;&gt;42109539&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/peripheral-oxidative-stress-related-biomarkers-alzheimers-disease-systematic-review-their#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/peripheral-oxidative-stress-related-biomarkers-alzheimers-disease-systematic-review-their#comments</comments>
</item>
<item>
 <title>RETRACTION: Aβ-Induced Repressor Element 1-Silencing Transcription Factor (REST) Gene Delivery Suppresses Activation of Microglia-Like BV-2 Cells.</title>
 <link>https://www.alzforum.org/papers/retraction-av-induced-repressor-element-1-silencing-transcription-factor-rest-gene-delivery</link>
 <description>Neural Plast. 2026;2026(1):e9758713. &lt;br&gt;Authors: Plasticity N&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42117260&quot;&gt;42117260&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/retraction-av-induced-repressor-element-1-silencing-transcription-factor-rest-gene-delivery#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/retraction-av-induced-repressor-element-1-silencing-transcription-factor-rest-gene-delivery#comments</comments>
</item>
<item>
 <title>RETRACTION: Repressor Element 1 Silencing Transcription Factor (REST) Governs Microglia-Like BV2 Cell Migration via Progranulin (PGRN).</title>
 <link>https://www.alzforum.org/papers/retraction-repressor-element-1-silencing-transcription-factor-rest-governs-microglia-bv2-cell</link>
 <description>Neural Plast. 2026;2026(1):e9896268. &lt;br&gt;Authors: Plasticity N&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42117219&quot;&gt;42117219&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/retraction-repressor-element-1-silencing-transcription-factor-rest-governs-microglia-bv2-cell#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/retraction-repressor-element-1-silencing-transcription-factor-rest-governs-microglia-bv2-cell#comments</comments>
</item>
<item>
 <title>Integrative Transcriptomics Identifies Ubiquitination-Related Genes BIRC2, COPS5, and TBK1 as Novel Biomarkers of T-Cell Dysregulation in Amyotrophic Lateral Sclerosis.</title>
 <link>https://www.alzforum.org/papers/integrative-transcriptomics-identifies-ubiquitination-related-genes-birc2-cops5-and-tbk1</link>
 <description>J Inflamm Res. 2026;19:585872.  Epub 2026 May 5&lt;br&gt;Authors: Jiang A, Huang Y, Que X, Li C, Lin Z, Huang W&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42117108&quot;&gt;42117108&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/integrative-transcriptomics-identifies-ubiquitination-related-genes-birc2-cops5-and-tbk1#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/integrative-transcriptomics-identifies-ubiquitination-related-genes-birc2-cops5-and-tbk1#comments</comments>
</item>
<item>
 <title>Clinical recognition memory testing in older adults should move beyond accuracy alone.</title>
 <link>https://www.alzforum.org/papers/clinical-recognition-memory-testing-older-adults-should-move-beyond-accuracy-alone</link>
 <description>Front Psychol. 2026;17:1764573.  Epub 2026 Apr 24&lt;br&gt;Authors: Kuruvilla MV&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42117071&quot;&gt;42117071&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/clinical-recognition-memory-testing-older-adults-should-move-beyond-accuracy-alone#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/clinical-recognition-memory-testing-older-adults-should-move-beyond-accuracy-alone#comments</comments>
</item>
<item>
 <title>Methodology for human-induced pluripotent stem cell-derived excitatory and inhibitory neuron coculture with astrocytes for Alzheimer&#039;s disease modelling.</title>
 <link>https://www.alzforum.org/papers/methodology-human-induced-pluripotent-stem-cell-derived-excitatory-and-inhibitory-neuron</link>
 <description>Brain Commun. 2026;8(3):fcag135.  Epub 2026 May 11&lt;br&gt;Authors: Li J, Brown LE, Rambarack N, Chan A, Prakash P, Arber C, Wray S, Ali AB&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42117065&quot;&gt;42117065&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/methodology-human-induced-pluripotent-stem-cell-derived-excitatory-and-inhibitory-neuron#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/methodology-human-induced-pluripotent-stem-cell-derived-excitatory-and-inhibitory-neuron#comments</comments>
</item>
<item>
 <title>Targeting α-Synuclein: Current Strategies and Emerging Therapies for Synucleinopathies.</title>
 <link>https://www.alzforum.org/papers/targeting-synuclein-current-strategies-and-emerging-therapies-synucleinopathies</link>
 <description>Protein Pept Lett. 2026;33(1):258-274. &lt;br&gt;Authors: Bala VC, Singh MK, Kumar A, Tiwari SK, Gupta AK, Chawla R, Kumar S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42116584&quot;&gt;42116584&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/targeting-synuclein-current-strategies-and-emerging-therapies-synucleinopathies#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/targeting-synuclein-current-strategies-and-emerging-therapies-synucleinopathies#comments</comments>
</item>
<item>
 <title>Community-Based Physician Attitudes Related to the Diagnosis and Treatment of Early Alzheimer&#039;s Disease in the United States.</title>
 <link>https://www.alzforum.org/papers/community-based-physician-attitudes-related-diagnosis-and-treatment-early-alzheimers-disease</link>
 <description>Am J Alzheimers Dis Other Demen. 2026;41:15333175261433309.  Epub 2026 May 13&lt;br&gt;Authors: Juday TR, Holub A, Mattke S, Betts KA, Kitchen SA, Liu H, Frech FH, Khachaturian AS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42125963&quot;&gt;42125963&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/community-based-physician-attitudes-related-diagnosis-and-treatment-early-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/community-based-physician-attitudes-related-diagnosis-and-treatment-early-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Reliability of remote self-administered Web-based digital cognitive measures and comparison to in-person neuropsychological tests: Stricker Learning Span, Symbols Test, and the Mayo Test Drive Screening Battery Composite.</title>
 <link>https://www.alzforum.org/papers/reliability-remote-self-administered-web-based-digital-cognitive-measures-and-comparison-0</link>
 <description>Alzheimers Dement (Amst). 2026;18:e70338.  Epub 2026 May 10&lt;br&gt;Authors: Hughes MA, Frank RD, Taylor RL, Fan WZ, Christianson TJ, Kremers WK, Stricker JL, Machulda MM, Hassenstab J, Mielke MM, Lucas JA, Aduen PA, Day GS, Graff-Radford NR, Jack CR Jr, Graff-Radford J, Petersen RC, Stricker NH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42125541&quot;&gt;42125541&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/reliability-remote-self-administered-web-based-digital-cognitive-measures-and-comparison-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/reliability-remote-self-administered-web-based-digital-cognitive-measures-and-comparison-0#comments</comments>
</item>
<item>
 <title>Novel insights into early Alzheimer&#039;s disease: quantitative gradient recalled echo MRI reveals preatrophic neuronal and myelin injury concurrent with emerging amyloid pathology.</title>
 <link>https://www.alzforum.org/papers/novel-insights-early-alzheimers-disease-quantitative-gradient-recalled-echo-mri-reveals</link>
 <description>Alzheimers Dement (Amst). 2026;18:e70355.  Epub 2026 May 10&lt;br&gt;Authors: Kothapalli SV, Benzinger TL, Bateman RJ, Li M, Eldeniz C, Morris JC, Yablonskiy DA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42125540&quot;&gt;42125540&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/novel-insights-early-alzheimers-disease-quantitative-gradient-recalled-echo-mri-reveals#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/novel-insights-early-alzheimers-disease-quantitative-gradient-recalled-echo-mri-reveals#comments</comments>
</item>
<item>
 <title>Characterization and evaluation of the ability of graphene quantum dots to affect α-synuclein aggregation in synucleinopathy models.</title>
 <link>https://www.alzforum.org/papers/characterization-and-evaluation-ability-graphene-quantum-dots-affect-synuclein-aggregation</link>
 <description>Sci Technol Adv Mater. 2026;27(1):2662693.  Epub 2026 May 7&lt;br&gt;Authors: Oz T, Alwani A, Kamińska A, Jachimska B, Timmon Tanaka M, Miki Y, Wakabayashi K, Maziarz K, Kaushik Bhardwaj S, Kaushik A, Figiel M, Chmielarz P, Kujawska M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42125450&quot;&gt;42125450&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/characterization-and-evaluation-ability-graphene-quantum-dots-affect-synuclein-aggregation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/characterization-and-evaluation-ability-graphene-quantum-dots-affect-synuclein-aggregation#comments</comments>
</item>
<item>
 <title>Integrating acoustic, prosodic, and phonological features for automatic Alzheimer&#039;s detection.</title>
 <link>https://www.alzforum.org/papers/integrating-acoustic-prosodic-and-phonological-features-automatic-alzheimers-detection</link>
 <description>Front Aging Neurosci. 2026;18:1786269.  Epub 2026 Apr 16&lt;br&gt;Authors: Zakaria Kurdi M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42125251&quot;&gt;42125251&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/integrating-acoustic-prosodic-and-phonological-features-automatic-alzheimers-detection#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/integrating-acoustic-prosodic-and-phonological-features-automatic-alzheimers-detection#comments</comments>
</item>
<item>
 <title>Light-based 40 Hz sensory therapy for brain disorders: physiological basis, therapeutic mechanisms, and future prospects.</title>
 <link>https://www.alzforum.org/papers/light-based-40-hz-sensory-therapy-brain-disorders-physiological-basis-therapeutic-mechanisms</link>
 <description>Front Med (Lausanne). 2026;13:1730333.  Epub 2026 Apr 27&lt;br&gt;Authors: Zhao C, Peng X, Cheng Z, Yue S, Wang Z, Ma L, Li J, Shang M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42125083&quot;&gt;42125083&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/light-based-40-hz-sensory-therapy-brain-disorders-physiological-basis-therapeutic-mechanisms#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/light-based-40-hz-sensory-therapy-brain-disorders-physiological-basis-therapeutic-mechanisms#comments</comments>
</item>
<item>
 <title>Antioxidants as immunomodulators for Tau and Amyloid-β in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/antioxidants-immunomodulators-tau-and-amyloid-v-alzheimers-disease</link>
 <description>Adv Protein Chem Struct Biol. 2026;151:303-365.  Epub 2025 Nov 7&lt;br&gt;Authors: Chinnathambi S, Rangappa N, Chandrashekar M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42134891&quot;&gt;42134891&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/antioxidants-immunomodulators-tau-and-amyloid-v-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/antioxidants-immunomodulators-tau-and-amyloid-v-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Therapeutics immunotargets for Tauopathy.</title>
 <link>https://www.alzforum.org/papers/therapeutics-immunotargets-tauopathy</link>
 <description>Adv Protein Chem Struct Biol. 2026;151:267-302.  Epub 2025 Nov 4&lt;br&gt;Authors: Chinnathambi S, Rangappa N&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42134889&quot;&gt;42134889&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/therapeutics-immunotargets-tauopathy#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/therapeutics-immunotargets-tauopathy#comments</comments>
</item>
<item>
 <title>Antibodies targeting amyloid-β and Tau oligomers in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/antibodies-targeting-amyloid-v-and-tau-oligomers-alzheimers-disease</link>
 <description>Adv Protein Chem Struct Biol. 2026;151:225-265.  Epub 2025 Nov 5&lt;br&gt;Authors: Chinnathambi S, Rangappa N, Chandrashekar M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42134888&quot;&gt;42134888&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/antibodies-targeting-amyloid-v-and-tau-oligomers-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/antibodies-targeting-amyloid-v-and-tau-oligomers-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Induced-pluripotent stem cell-derived immunotherapy for Tau and Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/induced-pluripotent-stem-cell-derived-immunotherapy-tau-and-alzheimers-disease</link>
 <description>Adv Protein Chem Struct Biol. 2026;151:197-224.  Epub 2025 Nov 4&lt;br&gt;Authors: Chinnathambi S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42134887&quot;&gt;42134887&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/induced-pluripotent-stem-cell-derived-immunotherapy-tau-and-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/induced-pluripotent-stem-cell-derived-immunotherapy-tau-and-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Biosimilars: Antibody and nanobody-based therapeutic approaches towards protein misfolding diseases.</title>
 <link>https://www.alzforum.org/papers/biosimilars-antibody-and-nanobody-based-therapeutic-approaches-towards-protein-misfolding</link>
 <description>Adv Protein Chem Struct Biol. 2026;151:157-195.  Epub 2025 Nov 4&lt;br&gt;Authors: Chinnathambi S, Rangappa N&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42134886&quot;&gt;42134886&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/biosimilars-antibody-and-nanobody-based-therapeutic-approaches-towards-protein-misfolding#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/biosimilars-antibody-and-nanobody-based-therapeutic-approaches-towards-protein-misfolding#comments</comments>
</item>
<item>
 <title>Treatment of Clinically Diagnosed Alzheimer&#039;s Disease by External Counterpulsation A Randomized Clinical Trial.</title>
 <link>https://www.alzforum.org/papers/treatment-clinically-diagnosed-alzheimers-disease-external-counterpulsation-randomized</link>
 <description>Am J Alzheimers Dis Other Demen. 2026;41:15333175261451918.  Epub 2026 May 14&lt;br&gt;Authors: Juni JE, Burns JM, Salat DH, Hill D, Tally S, Martin JS, Devous MD, Moriarty PM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42133852&quot;&gt;42133852&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/treatment-clinically-diagnosed-alzheimers-disease-external-counterpulsation-randomized#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/treatment-clinically-diagnosed-alzheimers-disease-external-counterpulsation-randomized#comments</comments>
</item>
<item>
 <title>Retraction: Bioassays guided isolation of berberine from Berberis lycium and its neuroprotective role in aluminium chloride induced rat model of Alzheimer&#039;s disease combined with insilico molecular docking.</title>
 <link>https://www.alzforum.org/papers/retraction-bioassays-guided-isolation-berberine-berberis-lycium-and-its-neuroprotective-role</link>
 <description>PLoS One. 2026;21(5):e0349363.  Epub 2026 May 14&lt;br&gt;Authors: PLOS One
 Editors&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42133594&quot;&gt;42133594&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/retraction-bioassays-guided-isolation-berberine-berberis-lycium-and-its-neuroprotective-role#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/retraction-bioassays-guided-isolation-berberine-berberis-lycium-and-its-neuroprotective-role#comments</comments>
</item>
<item>
 <title>[Gerstmann-Sträussler-Scheinker disease].</title>
 <link>https://www.alzforum.org/papers/gerstmann-straussler-scheinker-disease-0</link>
 <description>Zh Nevrol Psikhiatr Im S S Korsakova. 2026;126(4):143-149. &lt;br&gt;Authors: Katunina EA, Putyatin IA, Dolgushin MB, Nadelyaev RV&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42133427&quot;&gt;42133427&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/gerstmann-straussler-scheinker-disease-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/gerstmann-straussler-scheinker-disease-0#comments</comments>
</item>
<item>
 <title>[Choline alfoscerate in the treatment of cognitive impairment].</title>
 <link>https://www.alzforum.org/papers/choline-alfoscerate-treatment-cognitive-impairment</link>
 <description>Zh Nevrol Psikhiatr Im S S Korsakova. 2026;126(4):48-55. &lt;br&gt;Authors: Shavlovskaya OA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42133414&quot;&gt;42133414&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/choline-alfoscerate-treatment-cognitive-impairment#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/choline-alfoscerate-treatment-cognitive-impairment#comments</comments>
</item>
<item>
 <title>[Acteoside: neurobiological activity spectrum, potential in the treatment of age-associated neurodegenerative diseases].</title>
 <link>https://www.alzforum.org/papers/acteoside-neurobiological-activity-spectrum-potential-treatment-age-associated</link>
 <description>Zh Nevrol Psikhiatr Im S S Korsakova. 2026;126(4):41-47. &lt;br&gt;Authors: Berezutsky MA, Andronova TA, Belonogova YV, Durnova NA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42133413&quot;&gt;42133413&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/acteoside-neurobiological-activity-spectrum-potential-treatment-age-associated#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/acteoside-neurobiological-activity-spectrum-potential-treatment-age-associated#comments</comments>
</item>
<item>
 <title>AI-driven telerehabilitation for older adults with mild cognitive impairment: a randomized controlled trial.</title>
 <link>https://www.alzforum.org/papers/ai-driven-telerehabilitation-older-adults-mild-cognitive-impairment-randomized-controlled</link>
 <description>Front Neurol. 2026;17:1813694.  Epub 2026 Apr 28&lt;br&gt;Authors: Kim M, Kim DY, Jeong T, Park SW&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42131831&quot;&gt;42131831&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/ai-driven-telerehabilitation-older-adults-mild-cognitive-impairment-randomized-controlled#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/ai-driven-telerehabilitation-older-adults-mild-cognitive-impairment-randomized-controlled#comments</comments>
</item>
<item>
 <title>Decoding Pathogenic Mutational Landscapes in Alzheimer&#039;s Disease Through Integrated Transcriptomics.</title>
 <link>https://www.alzforum.org/papers/decoding-pathogenic-mutational-landscapes-alzheimers-disease-through-integrated</link>
 <description>Hum Mutat. 2026;2026:6627566.  Epub 2026 May 12&lt;br&gt;Authors: Ma W, Zhou F, Cai H, Fang L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42131724&quot;&gt;42131724&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/decoding-pathogenic-mutational-landscapes-alzheimers-disease-through-integrated#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/decoding-pathogenic-mutational-landscapes-alzheimers-disease-through-integrated#comments</comments>
</item>
<item>
 <title>Oxygen extraction fraction is differentially associated with pathological biomarkers in Alzheimer&#039;s disease and non-Alzheimer&#039;s dementias.</title>
 <link>https://www.alzforum.org/papers/oxygen-extraction-fraction-differentially-associated-pathological-biomarkers-alzheimers</link>
 <description>Front Neurosci. 2026;20:1754415.  Epub 2026 Apr 28&lt;br&gt;Authors: Misra A, Wang Y, Taheri MR, Chiang GC, Cho J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42131707&quot;&gt;42131707&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/oxygen-extraction-fraction-differentially-associated-pathological-biomarkers-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/oxygen-extraction-fraction-differentially-associated-pathological-biomarkers-alzheimers#comments</comments>
</item>
<item>
 <title>Glycemic dysregulation and cognitive impairment in aging adults: a cross-sectional study with amyloid biomarker correlation.</title>
 <link>https://www.alzforum.org/papers/glycemic-dysregulation-and-cognitive-impairment-aging-adults-cross-sectional-study-amyloid</link>
 <description>Front Aging. 2026;7:1696711.  Epub 2026 Apr 28&lt;br&gt;Authors: Rajalakshmi R, Ramya CM, Naaz R, Madhunapantula SV, Uthaiah CA, Salimath PV&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42130812&quot;&gt;42130812&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/glycemic-dysregulation-and-cognitive-impairment-aging-adults-cross-sectional-study-amyloid#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/glycemic-dysregulation-and-cognitive-impairment-aging-adults-cross-sectional-study-amyloid#comments</comments>
</item>
<item>
 <title>Evaluation of conductivity tensor image along the perivascular space in the brains of patients with cognitive impairments.</title>
 <link>https://www.alzforum.org/papers/evaluation-conductivity-tensor-image-along-perivascular-space-brains-patients-cognitive</link>
 <description>Front Aging Neurosci. 2026;18:1794175.  Epub 2026 Apr 28&lt;br&gt;Authors: Ahn J, Kim SY, Lee MB, Kwon OI, Rhee HY, Jung YJ, Kim Y, Park S, Ryu CW, Lee J, Jahng GH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42130761&quot;&gt;42130761&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/evaluation-conductivity-tensor-image-along-perivascular-space-brains-patients-cognitive#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/evaluation-conductivity-tensor-image-along-perivascular-space-brains-patients-cognitive#comments</comments>
</item>
<item>
 <title>Functional connectome metrics reveal distinct prognostic subtypes in two Phase 3 gantenerumab trials.</title>
 <link>https://www.alzforum.org/papers/functional-connectome-metrics-reveal-distinct-prognostic-subtypes-two-phase-3-gantenerumab</link>
 <description>Alzheimers Dement (N Y). 2026;12:e70259.  Epub 2026 May 11&lt;br&gt;Authors: Gobbi S, Silvestri E, Tonietto M, Klein G, van den Heuvel M, Magon S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42130609&quot;&gt;42130609&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/functional-connectome-metrics-reveal-distinct-prognostic-subtypes-two-phase-3-gantenerumab#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/functional-connectome-metrics-reveal-distinct-prognostic-subtypes-two-phase-3-gantenerumab#comments</comments>
</item>
<item>
 <title>Neuroengineering Frontiers: A Selective Review of Neural Interfaces, Brain-Machine Interactions, and Artificial Intelligence in Neurodegenerative Diseases.</title>
 <link>https://www.alzforum.org/papers/neuroengineering-frontiers-selective-review-neural-interfaces-brain-machine-interactions-and</link>
 <description>Appl Sci (Basel). 2025 Nov;15(21) Epub 2025 Oct 22&lt;br&gt;Authors: Usman M, Ashebir S, Okey-Mbata C, Yun Y, Kim S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42112453&quot;&gt;42112453&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/neuroengineering-frontiers-selective-review-neural-interfaces-brain-machine-interactions-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/neuroengineering-frontiers-selective-review-neural-interfaces-brain-machine-interactions-and#comments</comments>
</item>
<item>
 <title>N-Amino Peptide-Graphene Quantum Dot Loaded Small Extracellular Vesicles for Targeted Therapy of Tauopathies.</title>
 <link>https://www.alzforum.org/papers/n-amino-peptide-graphene-quantum-dot-loaded-small-extracellular-vesicles-targeted-therapy-0</link>
 <description>Adv Nanobiomed Res. 2025 Nov;5(11) Epub 2025 Jul 22&lt;br&gt;Authors: Zhu R, Kim G, Wang Y, Rajewski BH, Angera IJ, Del Valle JR&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42131476&quot;&gt;42131476&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/n-amino-peptide-graphene-quantum-dot-loaded-small-extracellular-vesicles-targeted-therapy-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/n-amino-peptide-graphene-quantum-dot-loaded-small-extracellular-vesicles-targeted-therapy-0#comments</comments>
</item>
</channel>
</rss>
